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ABSTRACT 
This thesis investigated the role of O2-dependent substances in mediating the 
vasodilatation seen following exercise (post-exercise hyperaemia) and in fatigue 
development. Additionally we compared young and old subjects to investigate 
the effects of ageing in both of these phenomena.  
Breathing supplementary 40% O2 during handgrip exercise at 50% of maximum 
voluntary contraction had no effect of the magnitude of post-exercise 
hyperaemia compared to air breathing control. Furthermore, aspirin 
administration did not alter magnitude of post-exercise hyperaemia or the levels 
of prostaglandin E metabolites assayed from the forearm venous efflux. 
Similarly the magnitude of post-exercise hyperaemia was not affected by 
aminophylline administration. Collectively these suggest that prostaglandins and 
adenosine are not obligatory mediators of post-exercise hyperaemia.  
Supplementary O2 breathed during recovery had no effect on fatigue in a 
second bout of exercise or any of the substances proposed to mediate fatigue, 
in young subjects. We demonstrated that older subjects showed no changes in 
the magnitude of post-exercise hyperaemia, but they were more fatigue 
resistant. There was no O2-dependence of either post-exercise hyperaemia or 
fatigue in older subjects. 
In conclusion, we have found no evidence of O2-dependent mediators in either 
post-exercise hyperaemia or fatigue.   
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CHAPTER 1: GENERAL INTRODUCTION 
 2 
1.1 Overview 
Muscle contraction plays an important role in all our lives, whether as part of the 
walking and lifting that occurs as part of our daily activity or in a more structured 
programme of exercise. As well as playing an important role in health, exercise 
dysfunction is an important factor in many diseases, such as the reduction in 
exercise tolerance seen in patients with chronic heart failure (CHF) (see e.g. 
Witte & Clark, 2007). The initiation and maintenance of cardiovascular changes 
associated with muscle contraction, whether sustained or rhythmic, involves a 
complex interplay between local vascular responses and reflex regulation of the 
cardiovascular and respiratory systems, with the higher parts of the central 
nervous system also having a role to play, especially during voluntary 
contractions. This makes exercise physiology a fascinating topic for the 
integrative physiologist. 
During muscle contraction, the demand for oxygen (O2) increases. In order to 
match this demand the blood flow to muscle must increase. This is partly 
achieved through an increase in the cardiac output, but it has been shown that 
vasodilatation in working muscle occurs leading to a process called exercise 
hyperaemia (sometimes also called active or functional hyperaemia). This 
phenomenon was first described by Gaskell (1877) and since then a lot of 
research has been performed to try to find out the cause of exercise 
hyperaemia. A number of mechanisms have been proposed, which are 
discussed in more detail below, although it seems likely that there is a degree of 
interdependency or redundancy within the mechanisms such that blocking one 
 3 
mechanism leads to an increased contribution of others (Clifford & Hellsten, 
2004; Joyner & Wilkins, 2007).  
As a result of muscle contraction, fatigue occurs. For the purposes of this 
thesis, muscle fatigue is defined as a transient and recoverable decline in 
muscle force and/or power with repeated or continuous muscle contractions 
(Allen et al., 2008). This may manifest as a decreased peak force or a 
decreased ability to maintain a force. Fatigue is to be at least in part caused by 
substances which are produced inside the muscle, several of which are similar 
to those implicated in mediating exercise hyperaemia (Allen et al., 2008).  
Previous work done in this laboratory has looked at the importance of O2 in 
muscle contraction and the effects of different timings of O2 delivery and are 
discussed further below (Fordy & Marshall, 2004; Win & Marshall, 2005). The 
conclusion of their findings were that O2-dependent substances are produced 
during contraction that contribute to hyperaemia immediately post-exercise and 
that O2-dependent substances produced or acting during recovery influence 
fatigue development. 
Thus the aim of the studies described in this thesis was to further investigate 
the role of O2-dependent substances in hyperaemia immediately post-exercise 
and fatigue. In addition, we hypothesize that O2-dependent substances play a 
reduced role during exercise in elderly subjects. Therefore, the second aim of 
these studies was to investigate the effects of ageing on post-exercise 
hyperaemia and fatigue. 
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1.2 Muscle blood flow 
When muscle contraction occurs it is accompanied by an increase in blood flow 
known as exercise hyperaemia, allowing close matching between O2 delivery 
and consumption. The magnitude of the hyperaemia is proportional to the 
increase in exercise intensity (Saunders et al., 2005b).  When rhythmic exercise 
is taking place there is a hyperaemia in the periods between contractions, even 
though the blood flow during the contraction may be reduced due to 
compression by the muscle. During moderate intensity exercise this 
“intermittent hyperaemia” may be sufficient to meet the O2 demands of the 
tissue, such that blood flow drops back to baseline levels when exercise 
ceases, whilst with heavier exercise the period of increased blood flow may 
continue after exercise has stopped (van Beekvelt et al., 2001b). By contrast, 
during isometric contraction hyperaemia is limited by muscle compression, 
resulting in a rapid, large increase in muscle blood flow on release of the 
contraction. Since the original work of Gaskell in 1877, exercise hyperaemia 
has become a well-described phenomenon although there is still disagreement 
about what mediates it. The main theories of neural, mechanical, metabolic and 
shear stress are reviewed in the pages below. 
1.2.1 Neural regulation of blood flow 
Involvement of changes in neural activity in the regulation of blood flow is a 
mechanism that offers an attractive link between muscle contraction and the 
increase in muscle blood flow, especially in light of the rapidity of the 
hyperaemia (~1 sec) (Sheriff et al., 1993). There have been three main theories 
linking neural activity to vasodilatation in exercise. The first theory considers 
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that withdrawal of sympathetic vasoconstriction or tone leads to an increased 
blood flow to the exercising muscle. This has been discounted because of 
evidence showing that muscle sympathetic activity actually increases to both 
active and resting muscle (Hansen et al., 1994). The second theory suggests 
that sympathetic cholinergic neurones supply muscle blood vessels and that 
their activation contributes to the vasodilatation of exercise. The presence of 
these neurones has been shown in cats and dogs (Bolme & Fuxe, 1970) and 
they have been shown to contribute to the increased blood flow in skeletal 
muscle, in exercising conscious cats (Komine et al., 2008). Early work seemed 
to suggest that these neurones were present in humans as well, with Roddie 
(1977) implicating them in the human vasodilator response to emotional stress  
and Sanders et al. (1989) finding evidence of cholinergic vasodilatation in the 
non-exercising arm of human subjects. This contrasts with histological work 
which shows no evidence of the presence of sympathetic cholinergic vasodilator 
neurones (Bolme & Fuxe, 1970), as well as more recent work using 
microelectrodes to measure activity in the nerves supplying the forearm muscle 
(Halliwill et al., 1997). Halliwill et al. found that the dilatation during emotional 
stress was due to a withdrawal of sympathetic vasoconstriction and found no 
evidence of dilator fibres. It is now considered unlikely that there is any direct 
sympathetic vasodilator influence in human skeletal muscle (Joyner & Halliwill, 
2000; Joyner & Dietz, 2003). 
The third theory to link nerve activity with blood flow, initially proposed by Segal 
and Kurjiaka (1995), hypothesises that acetylcholine (ACh) released from motor 
neurones during skeletal muscle activation “spills over” and dilates the terminal 
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arterioles. Segal and colleagues obtained evidence for this phenomenon by 
using intravital microscopy on hamster muscle, showing that there was indeed 
an acetylcholine-mediated dilatation when motor neurones were stimulated in 
the presence of a neuromuscular–blocking drug (Welsh & Segal, 1997). 
However, despite the appeal of this proposal, there is no evidence to support it 
as an important contributor to exercise hyperaemia in whole muscle in animals 
or human subjects. Studies on the infusion of atropine (an acetylcholine 
receptor antagonist) into hindlimb muscle have found no effect on blood flow 
during exercise in either rats (Armstrong & Laughlin, 1986) or dogs (Buckwalter 
et al., 1997). Further, in a study by Dyke et al. (1998), 5 healthy human 
volunteers attempted to try to contract their forearm muscle after paralysis with 
a neuromuscular-blocking drug. This would have the effect of causing motor 
neurone activation, without the metabolic factors released by contracting 
muscle. They found that there was only a modest increase in forearm blood flow 
which rules out a major role for ACh spillover in exercise hyperaemia. 
In summary, although a mechanism linking neural activity with exercise 
hyperaemia is theoretically sound, experimental evidence suggests that it does 
not play a significant role in humans, although sympathetic cholinergic neurones 
may play a role in animals. 
1.2.2 Mechanical regulation of blood flow 
As indicated above, the increased blood flow that occurs in response to 
exercise is rapid, beginning within 1-2 seconds of the onset of exercise (Sheriff 
et al., 1993). In a recent study, Wunsch and colleagues (2000) investigated 
whether it was possible for the rapid hyperaemia to be caused by vasodilator 
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substances by measuring the time taken to cause vasodilatation in vitro. They 
used applications of potassium chloride, adenosine, acetylcholine, and sodium 
nitroprusside. Their results showed that it took at least 4 seconds for any of the 
substances tested to cause vasodilatation, and suggested that there must be 
some other mechanism causing the initial rapid rise in blood flow. Mechanical 
mechanisms potentially meet the criteria and come under the umbrella of the 
so-called “Muscle Pump” theory that was popularised in a seminal review by 
Laughlin (1987). Put simply, this proposes that the contraction of muscle directly 
leads to an increased perfusion of the active muscle by increasing the arterio-
venous pressure gradient and by propelling blood through the muscle (Laughlin, 
1987; Tschakovsky & Sheriff, 2004). Since 1987, there has been a general 
consensus that the muscle pump is active in the initial stages of hyperaemia, 
although, as a recent Point-Counter Point discussion in the Journal of Applied 
Physiology shows (Sheriff et al., 2005), opinion is still divided as to whether it is 
an important determinant of muscle blood flow in exercise. The following 
discussion analyses the evidence for and against an important role for the 
muscle pump. 
There has been evidence for the muscle pump from a number of different 
experimental models, which were designed to isolate any mechanical effect. 
Sheriff and Van Bibber (1998) used a pig model in which an extracorporeal 
shunt was placed between the inferior vena cava and the terminal aorta so they 
could remove any effect of pumping of blood by the heart. Using this model they 
found that the isolated hindlimb skeletal muscle was capable of initiating and 
sustaining blood flow without input from the heart. In humans, Rådegran and 
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Saltin (1998) found that arterial blood flow was significantly increased during 
passive knee extension as compared to rest. In the same study they also 
showed that there was an immediate increase in blood velocity and flow 
following a single contraction. These results suggest that the muscle pump has 
the potential to contribute to the increase in muscle blood flow at the very onset 
of exercise. 
The contribution of the muscle pump to the exercise hyperaemia of steady state 
exercise has been assessed by manipulating the force intensity and the 
frequency of contractions, such that when one increases the other decreases, 
thus keeping the total work rate the same. Two studies from Sheriff’s laboratory 
on rats and dogs running on a treadmill found that doubling stride frequency 
(i.e. doubling contraction frequency) led to a doubling of muscle blood flow, 
even when the overall work rate was the same (Sheriff & Hakeman, 2001; 
Sheriff, 2003). A similar experiment on human cyclists showed that systemic 
vascular resistance decreased as pedalling frequency increased, despite overall 
work being the same (Gotshall et al., 1996). These studies are all consistent 
with the muscle pump theory. By contrast, in a study performed on human 
volunteers using forearm exercise, lifting heavy or light weights in a slow or fast 
cadence respectively, so that the total work rate was the same, it was found that 
vascular conductance rose at the same rate in both conditions (Shoemaker et 
al., 1998). From this they concluded that the muscle pump does not have an 
important effect and that there are vasodilator influences present early in the 
exercise period. The discrepancy between these studies may be due to the 
importance of gravity and a hydrostatic column of blood in the muscle pump as 
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described in an editorial by Laughlin and Joyner (2003). They theorise that the 
muscle pump may only lead to an increased blood flow when there is significant 
hydrostatic pressure, such as in upright exercise in humans. This is a condition 
that would not have been present in the forearm exercise in the study of 
Shoemaker et al. (1998), but would occur during locomotion in the studies from 
Sheriff’s laboratory (Sheriff & Hakeman, 2001; Sheriff, 2003). 
On the other hand, there have also been recent studies that support the theory 
of a rapid vasodilatation occurring due to metabolic substances. A study by 
Tschakovsky et al. (1996) used cuff inflation around the forearm to reproduce 
the mechanical effect of muscle contraction without any metabolic influence. 
They found no increase in blood flow when the arm was positioned above heart 
level, although there was an increase when the arm was below heart level, a 
finding that supports the idea that a hydrostatic column of blood is necessary. 
However, they also found that the increase in blood flow in response to muscle 
contraction was higher than that seen due to cuff inflation, this difference 
becoming noticeable after as little as 2 seconds. This indicates that there is a 
rapid non-mechanical vasodilator component present at the initiation of the 
increase in blood flow.  
A recent study by Hamann et al. (2003) used a different approach. They gave 
an adenosine infusion to increase the hindlimb blood flow of dogs to a level 
greater than that seen performing treadmill exercise, reasoning that if there is a 
significant muscle pump effect, exercise would result in a further increase in 
blood flow. They found that exercise did not increase blood flow in this 
condition, a result they interpreted to show that the initial increase in blood flow 
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is due to vasodilation, not the muscle pump. A further study by the same group 
(Hamann et al., 2004) used a potassium infusion to clamp the smooth muscle 
membrane potential so that vasodilation could not occur. When the dogs started 
treadmill exercise, during the potassium infusion protocol the hyperaemia was 
less than 10% of that seen during control exercise, indicating that vasodilatation 
is obligatory in exercise hyperaemia.  
In summary, there is still controversy about whether the muscle pump is 
important in exercise hyperaemia. This may partly be due to the protocols used 
to investigate the phenomenon. As has already been discussed, it is believed 
that a significant hydrostatic pressure is necessary for the effects to be seen 
(Laughlin & Joyner, 2003). It has also been theorised that electrical stimulation 
may not be ideal to investigate the muscle pump as all the muscle fibres 
contract at the same time as opposed to the sequential activation seen in 
voluntary exercise (Laughlin, 1987). On balance it is likely that the muscle pump 
does play a role in exercise hyperaemia, particularly during exercise in large 
animals such as humans when the exercising muscle is below heart level. 
However, it is also likely that there is a vasodilator mechanism active in the 
initial stages of exercise. Potassium ions (K+) are a possible candidate for this 
and evidence for their contribution is discussed below (1.2.3.5). 
1.2.3 Metabolic regulation of blood flow 
Given the direct relationship between intensity or frequency of contractions and 
the increase in blood flow, the presence of a vasodilator substance that is 
released as a result of muscle contraction is a logical conclusion. The idea that 
a vasodilator substance is released directly from the muscle fibres was first 
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proposed by Gaskell in the 1870s (Gaskell, 1877). More recently, studies have 
also provided evidence that vasodilator substances may be released from the 
endothelium and from red blood cells. In a recent review of the possible causes 
of exercise hyperaemia (Joyner & Wilkins, 2007), 5 criteria were set out for 
candidate vasodilator substance(s): 
The substance(s) or its precursor(s) should be present in skeletal muscle 
(or perhaps blood or nerves). 
The substance(s) should have access to the muscle resistance vessels. 
The concentration in the interstitial fluid (or at the endothelium) must be 
sufficient to cause dilation and the concentration should be proportional 
to the contractile activity. 
Exogenous administration of the substance(s) should be capable of 
causing prolonged dilation without sensations in humans. 
Pharmacologic agents or physiological manoeuvres which modify the 
blood flow responses to exercise should also modify the dilator 
responses to any putative substance given exogenously.  
With these criteria in mind, one of the main problems in finding the vasodilator 
substance or substances is the apparent interdependency or redundancy in the 
system, whereby when the actions of one substance are blocked, other 
substances may be able to act or appear to play a greater role, as discussed 
below. Another factor complicating interpretation is the apparent difference in 
how hyperaemia is mediated during exercise and immediately post-exercise, 
with the different methodologies used to measure blood flow affecting which is 
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actually being measured. The following discussion will analyse the evidence for 
and against the major substances proposed to play a role in exercise 
hyperaemia, as well as how they might interact. 
1.2.3.1 Role of oxygen 
Oxygen is an obvious candidate for a metabolic regulator of muscle blood flow 
given the role it plays in metabolic processes in both the skeletal muscle and in 
the vascular smooth muscle. It is generally accepted that in the skeletal muscle 
bed at rest, acute systemic hypoxia causes a vasodilatation (e.g. Hutchins et 
al., 1974; Marshall, 2000). Increasing the pO2 of the solution bathing muscle 
preparations causes vasoconstriction (Duling, 1972; Pries et al., 1995). Similarly 
it has recently been shown in human calf that vasoconstriction occurs when 
breathing hyperoxic gas mixes and that this effect is dose-dependent between 
room air (21%) and 100% O2 (Rousseau et al., 2005). The rate of O2 delivery is 
a function of the O2 content in arterial blood and the blood flow. It is therefore a 
reasonable theory that if O2 delivery is inadequate for metabolic needs then this 
relative lack of O2 may be sensed in either a direct or indirect way to cause an 
increase in blood flow to rectify it. The following discussion describes the efforts 
to investigate the direct and indirect effects of O2 during exercise (see Table 1.1 
for summary of human studies investigating effect of altering inspired O2).  
The efforts to assess the effects of the partial pressure of O2 (pO2) have for a 
long time been hampered by methodological difficulties in assessing pO2 at the 
level of the muscle. Initial efforts used direct visualisation and O2 electrodes 
placed in easily isolated muscles such as hamster cremaster muscle 
(Gorczynski & Duling, 1978) or rat spinotrapezius (Lash & Bohlen, 1987). Both 
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groups used electrical stimulation to initiate contractions in small muscle fibres. 
Gorczynski and Duling (1978) found that periarteriolar pO2 remained relatively 
constant despite muscle contraction, although muscle tissue pO2 declined in a 
progressive manner with increasing stimulation frequency. Simultaneous 
visualization of the arterioles supplying the muscle fibres showed that they 
dilated rapidly after initiation of contraction in a biphasic manner with an early 
peak, a return towards resting levels and then a further sustained late peak of 
vasodilatation. When contrasting this with the monophasic decline in muscle 
pO2 and considering the fact that the latency from initiation of contraction to 
dilatation is shorter than the latency of tissue pO2 decline they suggested that 
pO2 may be more important in the maintenance of vasodilatation than in the 
initiation. Their evidence points to the O2-dependence being due to tissue O2 as 
periarteriolar pO2 remained relatively constant. This is supported by further 
experiments in which bathing the muscle in O2-rich superfusate, thus 
eliminating this drop in tissue pO2, reduced the vasodilatation during contraction 
(Gorczynski & Duling, 1978).  
Lash and Bohlen (1987) made similar findings of a small transient decline in 
periarteriolar pO2 following electrical stimulation of rat spinotrapezius muscle 
which returned to normal as the exercise hyperaemia developed. They found a 
more significant decline in perivenular pO2, with a decrease to ~50% of resting 
values which remained below 70% resting for the duration of the contraction. 
They hypothesised that instead of a direct effect of low pO2 on the arterioles, 
vasodilatator substances were produced as a result of declining perivenular pO2 
and diffuse to dilate the nearby arterioles. 
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A similar approach was used by Bylund-Fellenius (1981) in humans. A flexible 
catheter with an O2 transducer was inserted into the gastrocnemius muscle to 
measure tissue pO2 at rest and at the end of a bout of foot pedal exercise. They 
found that in normal healthy subjects the pO2 fell to approximately 70% of 
resting values following exercise at 8kg force with a further decrease at more 
intense levels of exercise. A similar study was performed more recently and 
found similar results in the tibialis anterior muscle during treadmill exercise 
(Jung et al., 1999). 
A method widely used to assess the effects on muscle blood flow of changes in 
Po2 in humans is to manipulate O2 delivery. Rowell et. al. (1986) showed that 
breathing 10% O2 invariably augmented the increase in leg blood flow during 
dynamic quadriceps exercise at all workloads up to and including peak 
workload. This suggests that the magnitude of the hyperaemia is determined by 
the delivery of O2 to the active muscle. These data have been supported in 
studies done breathing 11% O2 during 2-legged knee extension exercise, where 
a 20-25% increase in exercise hyperaemia was seen during submaximal 
exercise, which was shown to be due to a vasodilatation (Koskolou et al., 1997). 
However, hypoxia alone causes vasodilatation so these findings could simply 
show that exercise hyperaemia and hypoxic vasodilatation are summative.  
An alternative to giving hypoxic gas is to use supplemental O2 in order to 
ameliorate any decrease in pO2, which might occur as a result of performing 
exercise. This was first used in exercise by Welch et al. (1977) in healthy active 
young men performing cycling exercise at either 55-70% of their maximum 
aerobic capacity, or just below their maximal aerobic capacity. They found that, 
 15 
when compared to breathing room air, breathing 100% O2 throughout caused 
an 11% reduction in exercise hyperaemia. Similar findings have been made 
more recently in physically active young subjects performing dynamic single leg 
knee extension at 70% peak workrate (Pedersen et al., 1999). In this study, 
breathing 60% O2 reduced the vasodilatation caused by exercise by ~12% 
compared to breathing room air, a value that is consistent with the findings of 
Welch et al. (1977) described above. However, another more recent study also 
using a dynamic leg kicking model at ~40% maximum power investigated the 
effects of breathing either room air, 70% O2 (hyperoxia), or 14% O2 (hypoxia) in 
healthy untrained young subjects (MacDonald et al., 2000). They found no 
differences in leg blood flow during exercise as measured by Doppler 
ultrasound between any of the gas concentrations. This discrepancy between 
the studies could possibly be explained simply by differences in the level of 
hyperoxia given. However, given the findings of Fordy and Marshall (2004) 
described below using 40% O2, this hypothesis is unlikely. Alternatively, it may 
be that trained subjects have an O2-dependent component of exercise 
hyperaemia that is absent in less trained subjects. 
The effect of hyperoxia on hyperaemia immediately post-exercise has been 
investigated further in this laboratory with respect to the timing of any O2-
dependent contribution (Fordy & Marshall, 2004). In this study, fit recreationally 
active young male subjects breathed 40% O2 during a period of handgrip 
exercise at maximum effort until exhaustion with room air breathed before and 
after exercise, or simply breathed room air throughout. The major findings in 
this protocol were that 40% O2, breathed during contraction only, was able to 
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reduce the hyperaemia seen after exercise by ~25%. This was in line with 
findings in a separate protocol in which 40% O2 was breathed before, during 
and after static exercise at 70%MVC, whereas when 40% O2 was breathed only 
during a recovery period following static handgrip exercise, there was no effect 
on forearm blood flow (unpublished PhD thesis: Fordy, 2007). This suggests 
that post-exercise hyperaemia following static handgrip exercise is partly 
mediated by an O2-dependent substance, which is produced during the period 
of contraction itself.  
This was supported by the results of a different protocol, in which the 
hyperaemic response to performing rhythmic handgrip exercise at 10% MVC for 
5 minutes with concurrent arterial occlusion with a sphygmomanometer cuff was 
measured (unpublished PhD thesis: Fordy, 2007). Subjects breathed either 
room air or 40% O2 for 5 minutes before starting the exercise with occlusion, in 
an attempt to see whether ‘loading’ the muscles with O2 had any effect. There 
were no differences in the post-exercise hyperaemia between the 2 conditions, 
showing that the effect of hyperoxia on reducing post-exercise hyperaemia only 
occurs when administered during exercise.  
Results obtained recently with high resolution proton magnetic resonance 
spectroscopy to detect levels of myoglobin deoxygenation as a measure of 
intramuscular pO2 are also highly relevant to this issue. This methodology can 
be performed non-invasively and in real time and is therefore a useful tool in 
assessing the changes that occur during exercise and recovery. One of the 
initial studies by Richardson et. al. (1995) looked at human quadriceps muscle 
and found evidence of a steep O2 gradient from blood to muscle. Six healthy 
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competitive cyclists were instrumented for blood flow and blood gas 
measurements before performing two bouts of leg extension exercise 
increasing from 25% to 100% peak force whilst breathing 21% O2 (normoxia) or 
12% O2 (hypoxia). They then repeated the protocol in a 2-Tesla MRI machine to 
assess myoglobin deoxygenation during exercise (Richardson et al., 1995).  
Maximum deoxy-myoglobin levels were taken to be those reached in the last 
two minutes of a 10-minute period of vascular occlusion and levels reached in 
exercise were reported as a percentage of this value. The group found that in 
both normoxic and hypoxic exercise deoxy-myoglobin levels rapidly increased 
to 50% and 60% of occlusion levels respectively within the first 20 seconds of 
exercise and then remained at these levels until maximum workrate was 
achieved. A further study by the same group again found no evidence of a 
progressive fall in intramuscular pO2 with increasing workrate (Richardson et 
al., 2001). However, another group has found a linear response with increasing 
intensity in the gastrocnemius muscle (Mole et al., 1999). Therefore the 
question arises as to whether there is an O2 gradient from the blood to the 
muscle and how much this gradient changes from rest.  
Even in normoxia it was calculated that there was a steep O2 gradient from the 
~37mmHg in capillary blood to the ~3mmHg in muscle at maximal workrates 
(Richardson et al., 1995). Using a higher powered magnet it has recently been 
possible to visualise the levels of deoxy-myoglobin even at rest (Richardson et 
al., 2006). This has shown that in resting muscle the pO2 is not hugely different 
from capillary levels (34mmHg compared to this studies capillary value of 
44mmHg), indicating that during exercise there is a rapid drop in intramuscular 
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Po2 to allow a larger diffusion gradient. When combined with the early findings 
described above from hamster cremaster muscle (Gorczynski & Duling, 1978), 
this gives weight to the hypothesis that any O2 contribution to exercise 
hyperaemia is likely at the tissue level. 
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Table 1.1 Summary of studies assessing effect of altering inspired O2 on blood flow in humans 
Study Muscle group Exercise Blood flow 
measurements 
O2 supplementation Results 
Rowell et. al. (1986) Quadriceps Dynamic - ~30% - 
100% MVC. 
Thermal dilution 
during exercise. 
Normoxia vs. 10% 
O2. 
Exercise blood flow 
higher in hypoxia 
than normoxia at all 
workloads. 
Koskolou et. al. 
(1997) 
Quadriceps Two-legged knee 
extension. 
Doppler Ultrasound 
during exercise. 
Normoxia vs. 15% O2 
vs. 11% O2. 
Exercise hyperaemia 
increased in hypoxia. 
Welch et. al. (1977) Leg Cycling – 55-70% 
and just below 
maximum aerobic 
capacity 
Dye dilution 
technique during 
exercise. 
100% O2 vs. 
normoxia. 
Hyperoxia reduces 
exercise hyperaemia 
by 11%. 
Pedersen et. al. 
(1999) 
Quadriceps Dynamic single leg 
extension – 70% 
peak workrate. 
Thermodilution during 
exercise. 
60% O2 vs. normoxia. Hyperoxia reduces 
exercise hyperaemia 
by 12%. 
MacDonald et. al. 
(2000) 
Quadriceps Dynamic single leg 
kicking – 40% max. 
Untrained subjects. 
Doppler Ultrasound 
during exercise. 
70% vs. normoxia vs. 
14%. 
No differences in 
exercise hyperaemia 
at any level of O2. 
Fordy & Marshall 
(2004) 
Forearm Static – 100% MVE 
until exhaustion 
Venous occlusion 
plethysmography 
(immediately post-
exercise). 
40% vs. normoxia 
(gas given during 
contraction) 
Hyperoxia reduced 
post-exercise 
hyperaemia by 25%. 
Win & Marshall 
(2005) 
Forearm Static – 60% MVC for 
2 minutes. 
Venous occlusion 
plethysmography 
(immediately post-
exercise). 
40% vs. normoxia. Hyperoxia reduces 
post-exercise 
hyperaemia by 40% 
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1.2.3.2 Nitric oxide (NO) 
Since the discovery of NO and the realisation of its importance in maintaining 
basal vascular tone in the late 1980s (Palmer et al., 1987; Moncada et al., 
1988) there has been much interest in a possible role for NO in mediating 
exercise hyperaemia. NO is produced from L-arginine by the enzyme nitric 
oxide synthase (NOS) which is present in 2 main constitutive isoforms, 
endothelial and neuronal, which in humans can be found in the vascular 
endothelium and skeletal muscle respectively (Frandsen et al., 1996; Stamler & 
Meissner, 2001). There have been a number of studies over the last 20 years 
that have attempted to elucidate the role of NO, with varied results.  
The first study to look at the contribution of NO to exercise hyperaemia in 
humans used dynamic wrist flexion and extension at 0.2 and 0.4W and 
measured forearm blood flow with venous occlusion plethysmography (Wilson & 
Kapoor, 1993a). They found that NOS inhibition with L-NMMA reduced resting 
forearm blood flow from 2.5 to 1.5ml/100ml tissue/min, a finding that is 
consistent in all studies on the effects of NOS inhibition (Rådegran & Hellsten, 
2000). However, they did not find any change in the increase in FBF during 
exercise, indicating that NO does not play an additional role in exercise 
hyperaemia.  
Other studies have yielded similar findings. Shoemaker et al. (1997) used 
Doppler ultrasound to investigate the effect of prior inhibition of muscarinic 
acetylcholine receptors with atropine and NOS with L-NMMA on the increase in 
blood flow evoked by rhythmic handgrip at 10% maximum voluntary contraction 
(MVC). They found no difference in the steady state blood flow response 
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compared to control exercise without drug intervention. Similarly, Radegran and 
Saltin (1999) found no effect of prior L-NMMA infusion on the hyperaemia seen 
in response to a graded single leg knee extension protocol from ~65% peak 
power until peak exercise (pre-defined as the maximum force subjects could 
sustain for 3 minutes). However, it is worth noting that both studies noted a 
decrease in the total recovery blood flow response over 5 minutes (Shoemaker 
et al., 1997) and 10 minutes (Radegran & Saltin, 1999) following exercise. 
Thus, these studies both appear to show that NO is important in regulating post-
exercise blood flow but not during steady state exercise.  
This hypothesis is supported by the findings of Frandsen et al. (2001) who used 
a different NOS inhibitor. They used L-NAME on the basis that it can enter into 
the interstitium, hypothesising that it would give a more complete inhibition of 
NOS activity as it can block neuronal NOS in the skeletal muscle as well as the 
endothelial NOS in the vascular endothelium. In their study 8 young men 
performed submaximal single leg knee extension at 30W for 30 mins (~30% 
peak force) and 5 performed a graded exercise protocol until exhaustion, with 
blood flow measured using the thermodilution method. Their findings were that 
leg blood flow was similar during exercise with or without NOS inhibition in both 
submaximal exercise and exhaustive exercise. They did find a lower level of leg 
vascular conductance (i.e. FBF) in the submaximal exercise following NOS 
inhibition, indicating reduced vasodilatation in extensor muscles. However, they 
attributed this to vasoconstriction in non-active tissue included in the measure of 
limb blood flow, a theory that is supported by the finding that this difference was 
not present in the intense exercise protocol. In agreement with the studies 
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described above, Frandsen et al. found a role for NO in the post-exercise 
period, with the LBF after submaximal exercise reduced by L-NAME compared 
to control.  
There are however other studies which do indicate an effect of NOS inhibition 
on exercise hyperaemia. In a study by Gilligan et al. (1994) 18 subjects 
performed rhythmic handgrip exercise at 15, 30 and 45% of their MVC for 5 
minutes each and used venous occlusion plethysmography to measure the 
blood flow during these relaxation periods. NOS was blocked prior to the 
exercise trial using an L-NMMA infusion. They found that NOS inhibition 
decreased the vasodilator response to exercise by ~18% compared to control 
and the increased exercise blood flow was reduced by 7%. It is worth noting 
however that venous occlusion plethysmography requires the exercise to be 
stopped for measurements of FBF to be made. Therefore, it is possible that 
they were measuring the decreased post-exercise blood flow response that the 
studies described above have also shown (Shoemaker et al., 1997; Radegran & 
Saltin, 1999; Frandsen et al., 2001).  
A later study also using venous occlusion plethysmography during rhythmic 
handgrip exercise at 15% MVC for 20 minutes investigated the effect of infusing 
L-NMMA intra-arterially whilst steady state exercise was occurring (i.e. 5 
minutes into the exercise protocol) (Dyke et al., 1995). They found that NOS 
inhibition reduced the hyperaemia in the final 10 minutes of exercise compared 
to the first 5 minutes prior to the infusion and compared to a time control in 
which the same exercise was performed without L-NMMA infusion. This 
suggests that NOS inhibition during exercise may elicit a reduction in exercise 
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blood flow that was not visible in the studies described above where NOS 
inhibition occurred prior to commencing exercise.  
However, two recent studies have both found a role for NO in exercise 
hyperaemia when using Doppler ultrasound, consistent with the findings of 
Dyke et al. (1995) above. This can give a measure of blood flow without 
stopping exercise, thus avoiding the limitation of venous occlusion 
plethysmography (Gilligan et al., 1994). When using Doppler, Casey and Joyner 
(2009) found that L-NMMA infusion during rhythmic handgrip exercise at 10 and 
20% MVC caused reductions in exercise blood flow of 12.3% and 11.3% 
respectively. Further, Wray et al. (2011) investigated the effect of blocking NOS 
with L-NMMA infusion prior to and during progressive handgrip exercise 
consisting of 3 minutes each of exercise at 4, 8, 12, 16, 20 and 24kg (mean 
MVC was ~50kg). Their main findings were that blood flow was significantly 
lower during L-NMMA infusion at all forces apart from 4kg, as well as at rest. 
Importantly, when the lower blood flow at rest was taken into account, the 
change in blood flow during exercise was only significantly lower at 20 and 
24kg. This indicates that the contribution of NO to exercise hyperaemia may be 
intensity-dependent, and that some of the studies described above were 
perhaps using too low a force of exercise to demonstrate a role for NO. 
Thus, taking all the studies discussed above into account, NO definitely has a 
role in mediating post-exercise blood flow. The evidence that NO plays a role in 
mediating steady state exercise blood flow is not as clear. It appears that the 
role of NO in mediating exercise hyperaemia is intensity dependent, only 
making a significant contribution at higher intensities of exercise. It would also 
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appear that when NO inhibition occurs either during or just prior to exercise, a 
reduction in blood flow may be visible, but if inhibition occurs in advance of 
exercise then other substances may play a greater role. This idea is supported 
by studies that investigate the effect of inhibition of multiple substances and 
suggest that there may be interdependency or redundancy between the actions 
of NO, prostaglandins, adenosine and ATP. These studies are discussed further 
below. 
1.2.3.3 Prostaglandins 
One of the groups of substances that have been implicated in mediating 
exercise hyperaemia are vasodilator prostanoids (see Table 1.2 for summary of 
studies investigating effect of cyclooxygenase inhibition in humans). The 
prostanoid family are formed from the metabolism of arachidonic acid by the 
enzyme cyclooxygenase (COX) into endoperoxides, which are in turn converted 
to the various prostanoids by specific prostanoid synthases (for review see 
Tang & Vanhoutte, 2009). Prostanoids can be either vasodilator such as PGE2 
or prostacyclin (PGI2) or vasoconstrictor such as thromboxane A2 (TXA2). A role 
for prostanoids in the vasodilatation of exercise was first demonstrated by 
Kilbom and Wennmalm (1976). They used venous occlusion plethysmography 
to assess the post-exercise hyperaemia following 5 minutes of rhythmic 
handgrip exercise and 5 minutes of static handgrip exercise at 15% of 
maximum voluntary contraction (MVC) in healthy young subjects, both before 
and after rectal administration of the COX inhibitor indomethacin. Their main 
findings were that COX inhibition reduced both the peak and the total blood flow 
following both rhythmic and static exercise.  
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Efflux of prostanoids into venous blood has also been shown to increase in 
response to high intensity repeated static contractions in cat triceps surae 
(PGE2 and PGI2) (Symons et al., 1991). Further, these findings have been 
replicated in human subjects in venous efflux (Wilson & Kapoor, 1993b) and by 
using microdialysis to measure levels of substances within the muscle 
interstitium (Karamouzis et al., 2001a; Karamouzis et al., 2001b). The first study 
by Wilson and Kapoor (1993b) demonstrated that the increase in forearm post-
exercise blood flow elicited by rhythmic wrist flexion and extension was 
associated with an increase in venous efflux of both 6-keto PGF1 (the stable 
breakdown product of prostacyclin) and PGE2. Further, COX inhibition with 
indomethacin reduced post-exercise hyperaemia by ~20% and virtually 
abolished release of both 6-keto PGF1 and PGE2. Evidence that the increase 
in venous efflux of 6-keto PGF1 and PGE2 is due to increased release from the 
muscle comes from studies using microdialysis (Karamouzis et al., 2001a; 
Karamouzis et al., 2001b). When young male subjects performed either 40 
minutes of plantarflexion of the foot (1.5 second contraction – 1.5 second 
relaxation) or 60 minutes of single leg knee extensor exercise at 20W, the 
interstitial levels of PGE2 and 6-keto PGF1 remained constant in the calf 
exercise and PGE2 increased in the dynamic leg extension exercise 
(Karamouzis et al., 2001b). Given the increase in blood flow that is present in 
these exercise conditions, it is likely that muscle production of both these 
substances actually increased during exercise. Another study by the same 
group used similar microdialysis techniques and demonstrated that both PGI2 
and PGE2 increased with dynamic cycling exercise, while levels of thromboxane 
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B2 (TXB2 – a vasoconstrictor prostanoid) decreased (Karamouzis et al., 2001a). 
Of interest given the close relationship of increasing blood flow with increasing 
exercise intensity, this last study also found that PGI2 and PGE2 production was 
greater at 150W cycling than it was at 100W. Collectively, these studies 
therefore seemed to demonstrate a conclusive role for vasodilator 
prostaglandins, particularly PGI2 and PGE2 in mediating exercise hyperaemia. 
Since these studies different groups have tested the effects of COX inhibition 
with differing results. Duffy et al. (1999) used light wrist flexion and extension 
(similar exercise protocol to that used by Wilson and Kapoor (1993b)) and found 
that a different COX inhibitor, aspisol, also reduced both the peak post-exercise 
hyperaemia and the total volume of blood flow over 5 minutes. However, a 
study using ibuprofen to block COX inhibition in young men performing low load 
rhythmic handgrip exercise (4.4kg – approximately 10%MVC) found no effect 
on blood flow during exercise, as measured by Doppler ultrasound (Shoemaker 
et al., 1996a). This was the case both in exercise performed above heart level 
and in exercise performed below heart level, where they had hypothesised that 
the increase in shear stress would increase the role of prostaglandins.  
More recent studies indicate that differing results may be dependent on the 
muscle group studied, the intensity of the exercise and the timing of the 
measurements. Boushel et al. (2002) used Near-Infrared Spectroscopy (NIRS) 
to measure the microvascular blood flow in the quadriceps muscles (vastus 
lateralis and medialis – VL and VM) of 6 healthy young subjects whilst 
performing 10 minutes of dynamic knee extension at four different workloads. 
Combined NOS and COX inhibition (with L-NAME and indomethacin 
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respectively) attenuated the hyperaemia seen during control exercise at 30W, 
45W and 60W exercise, but not at 15W exercise. They also used microdialysis 
to measure PGE2 released into the interstitium of active muscle and found a 
decrease in [PGE2] at 15 and 30W, and an increase at 45 and 60W, which was 
prevented when COX was blocked. These results indicate that PGE2 plays a 
role in hyperaemia during more intense exercise.  
Saunders at al. (2005a) used a novel alternative approach, using Doppler 
ultrasound to measure the change in exercise blood flow when transitioning 
from steady state rhythmic handgrip exercise at ~10% MVC to ~20% MVC. The 
rationale for this protocol was that they had previously demonstrated that this 
increase in intensity does not further reduce the minimum venous volume 
(Saunders & Tschakovsky, 2004) and so reasoned that this would allow them to 
assess any rapid contribution of vasodilator substances in the absence of any 
muscle pump effect. The main findings were that combined inhibition of COX 
and NOS had no effect on the rapid vasodilatation when exercise intensity 
increased (Saunders et al., 2005a). However, when low intensity rhythmic 
handgrip exercise at 10%MVC was performed for 20 minutes, dual inhibition did 
reduce the blood flow and vascular conductance (Saunders et al., 2005a), 
supporting the results from the study by Boushel et al. (2002).  
This study served as a basis for another study by Schrage et al. (2004) in which 
14 young subjects performed 20 minutes of rhythmic handgrip exercise at ~10% 
MVC with 1 second contraction-2 second relaxation. After beginning exercise, 
subjects received either COX inhibition with ketorolac or NOS inhibition with L-
NAME to study the individual effects of prostaglandins and NO. Subjects then 
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received the second drug to produce a dual COX/NOS blockade. It was shown 
that ketorolac led to a transient reduction in FBF during exercise of ~12%, 
which had returned to control levels by the end of the 5 minute infusion. NOS 
inhibition alone caused about a 20% reduction in blood flow. When ketorolac 
was added to the L-NAME there was a further transient decrease which then 
returned to levels seen with NOS inhibition alone. NOS inhibition after COX 
inhibition had the same effect as NOS inhibition alone. These data combined 
suggest that prostaglandins normally contribute to exercise hyperaemia but 
when their synthesis is inhibited, another substance other than NO can restore 
the hyperaemic response.  
It has previously been shown that hypoxia increased PGI2 production in cultured 
endothelial cells (Michiels et al., 1993). Further, Messina et al. (1992) 
demonstrated that removal of the endothelium in rat skeletal muscle arterioles 
abolished the vasodilator response to hypoxia, a response which was mirrored 
by administration of the COX inhibitor indomethacin. Thus they concluded that 
the vasodilatation in response to hypoxia was mediated via prostaglandin 
release from endothelial cells. On the basis of this, Win and Marshall (2005) 
hypothesized that ameliorating hypoxia by administering hyperoxic gas (40% 
O2) would reduce the vasodilatation following static handgrip exercise by 
reducing release of vasodilator prostaglandins. The COX inhibitor aspirin was 
administered orally to block prostaglandin synthesis. The important findings of 
this study were that aspirin reduced post-contraction peak hyperaemia and 
vasodilatation by ~35% compared to control, a magnitude of reduction that was 
matched by both hyperoxia alone and by hyperoxia combined with aspirin. This 
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provides strong evidence that vasodilator prostaglandins mediate post-exercise 
hyperaemia and that either their production or mechanism of action is O2-
dependent. This study hypothesized that these O2-dependent prostaglandins 
originated from the endothelium based on the previous in vivo work (Messina et 
al., 1992; Michiels et al., 1993). However, given the most recent findings by 
Richardson et al. (2006) described above that show a significant decrease in 
muscle interstitial pO2, it is equally possible that the 40% O2 acts by 
ameliorating hypoxia within the muscle (see Figure 1.1 for summary). 
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Table 1.2 Summary of studies assessing effect of COX inhibition on blood flow in humans 
Study Muscle group Exercise Blood flow 
measurements 
COX inhibition Results 
Kilbom & 
Wennmalm (1976) 
Forearm Static and Dynamic 
handgrip – 15% MVC 
for 5 min  
Venous occlusion 
plethysmography 
Indomethacin prior to 
exercise. 
COX inhibition 
reduces both peak 
and total blood flow 
post-exercise. 
Wilson & Kapoor 
(1993b) 
Forearm Dynamic wrist flexion 
and extension 
Venous occlusion 
plethysmography 
Indomethacin prior to 
exercise. 
COX inhibition 
reduces post-
exercise hyperaemia 
by 20%. 
Duffy et. al. (1999) Forearm Dynamic wrist flexion 
and extension 
Doppler ultrasound Aspisol prior to 
exercise. 
COX inhibition 
reduces post-
exercise hyperaemia. 
Shoemaker et. al. 
(1996a) 
Forearm Dynamic handgrip – 
~10% MVC. 
Doppler ultrasound Ibuprofen Exercise hyperaemia 
not affected by COX 
inhibition. 
Boushel  et. al. 
(2002) 
Quadriceps Dynamic knee 
extension for 10 
minutes – different 
workloads 
Near-Infrared 
Spectroscopy. 
Indomethacin (+NOS 
inhibition with L-
NAME) 
Combined NOS and 
COX inhibition 
reduced exercise 
hyperaemia at higher 
intensity (30-60W) 
but not at lower 
(15W). 
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Study Muscle group Exercise Blood flow 
measurements 
COX inhibition Results 
Saunders et. al. 
(2005a) 
Forearm Dynamic handgrip – 
10%MVC for 20 mins 
and transition from 
10% to 20%MVC. 
Doppler ultrasound Ketorolac (+NOS 
inhibition with L-
NAME). 
Combined NOS and 
COX inhibition 
reduces steady state 
exercise hyperaemia 
but no effect on rapid 
vasodilatation in 
transition. 
Schrage et. al. 
(2004) 
Forearm Dynamic handgrip – 
10%MVC for 20 
minutes. 
Doppler ultrasound Ketorolac during 
exercise. 
COX inhibition 
caused a transient 
12% decrease in 
exercise hyperaemia, 
that returned to 
control levels within 5 
minutes.  
Win & Marshall 
(2005) 
Forearm Static handgrip – 
60%MVC for 2 
minutes. 
Venous occlusion 
plethysmography 
Aspirin. COX inhibition 
decreased post-
exercise hyperaemia 
reduced by 35%. 
Mortensen et. al. 
(2007) 
Quadriceps Single leg extension 
– 20% MVC for 5 
minutes 
Doppler ultrasound Intra-arterial 
indomethacin 
COX inhibition alone 
had no effect on 
exercise hyperaemia. 
  
 32 
Study Muscle group Exercise Blood flow 
measurements 
COX inhibition Results 
Heinonen et. al. 
(2011) 
Quadriceps Single leg extension 
– low intensity (4.5kg) 
Positron emission 
tomography with 
radiolabelled water. 
Indomethacin before 
exercise (+ NOS 
blockade with L-
NMMA). 
Combined NOS and 
COX inhibition 
reduced exercise 
hyperaemia by15-
20%. 
Mortensen et. al. 
(2009b) 
Quadriceps Knee extension – 
30%MVC. 
Doppler ultrasound. Indomethacin (+NOS 
blockade with L-
NMMA and 
adenosine receptor 
antagonism with 
theophylline) 
Exercise hyperaemia 
reduced by 30% in 
COX and NOS dual 
blockade. No 
additional effect of 
theophylline.  
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1.2.3.4 Adenosine and ATP 
The cellular source of energy is adenosine triphosphate (ATP), which is 
dephosphorylated to adenosine diphosphate (ADP) and can be further broken 
down to form adenosine monophosphate (AMP) and finally adenosine. As 
concentrations of these substances change significantly during muscle 
contraction, it is a plausible theory that they might play a role in exercise 
hyperaemia. Adenosine and ATP in particular have received a lot of attention 
(see Table 1.3 for summary of studies assessing role of adenosine in humans).  
The ‘adenosine hypothesis’ was originally formulated by Berne (1963) when 
considering the coronary circulation. It stated that blood flow is regulated by 
interstitial adenosine generated when there is insufficient O2 to regenerate ATP, 
in a negative feedback loop to increase blood flow and therefore O2 supply. 
Since then evidence has emerged linking adenosine to exercise hyperaemia in 
skeletal muscle. Blood samples taken from dog calf muscles showed an 
increase in adenosine concentrations in the venous efflux following muscle 
stimulation (Fuchs et al., 1986). More recently, microdialysis of human vastus 
lateralis muscle during knee extension exercise showed an increase in 
interstitial adenosine concentrations with exercise that increased further with 
increasing work rates (Hellsten et al., 1998). More importantly, this study 
showed a very strong correlation (r=0.98) between the interstitial adenosine 
concentration and increased leg blood flow. Further studies have used various 
pharmacological agents to antagonise the effects of adenosine. Adenosine 
deaminase, which breaks down adenosine to inosine, reduced exercise 
hyperaemia in oxidative dog gracilis muscle (Kille & Klabunde, 1984) and in 
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oxidative cat soleus muscle (Schwartz & McKenzie, 1990), despite the fact that 
inosine is a vasodilator. Dipyridamole, which blocks the reuptake of adenosine 
thereby leading to increased extracellular concentrations of adenosine, 
increased exercise hyperaemia in both pigs (Laughlin et al., 1989) and dogs 
(Kille & Klabunde, 1984). Although these studies imply that the adenosine is 
released directly from skeletal muscle fibres, it is equally possible that the 
adenosine is formed extracellularly from breakdown of ATP, ADP and AMP by 
ecto 5’nucleotidases and ecto-phosphatases either in the interstitium itself or 
within the vessel lumen before diffusing across the endothelium (for review see 
Marshall, 2007). See Figure 1.2 for summary of sources of adenosine. 
Various experimental methods have been used to try to quantify the magnitude 
of the hyperaemic effect of adenosine and have generally concluded that it is 
responsible for 20-40% of the maintained phase of exercise hyperaemia and 
~80% of post-exercise hyperaemia over 5 minutes (Marshall, 2007). For 
example, Ballard et al. (1987) perfused dog gracilis muscle at a constant high 
rate and took arterial and venous blood samples. They found that contraction 
resulted in an elevated venous adenosine concentration although arterial 
concentrations remained unchanged, showing that adenosine is released. They 
then infused adenosine and compared the vasodilatation and venous 
adenosine concentrations during contraction and adenosine infusion to 
calculate the contribution of adenosine to exercise hyperaemia. They concluded 
that 15% of the vasodilatation at 1 minute, 40% between 5 and 20 minutes and 
80% of the vasodilatation 5 minutes after cessation of contractions was due to 
adenosine. These findings are supported by Poucher and colleagues (1990) 
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from studies in the cat, in which they observed around a 40% reduction in 
exercise hyperaemia following infusion of 8-phenyltheophylline (8-PT), a potent 
non-selective adenosine receptor antagonist, compared to a control infusion of 
vehicle. A second study by Poucher (1996) compared the non-selective 
adenosine receptor antagonist 8-PT with the A2A receptor specific antagonist 
ZM 241395 and found that both resulted in a similar 30%, reduction in 
hyperaemia, showing that the A2A receptor subtype is responsible for the 
adenosine component, at least in cats.   
In humans, the only adenosine receptor antagonists available for use are 
theophylline or the more soluble analogue aminophylline (Rådegran & Hellsten, 
2000; Marshall, 2007). Theophylline compounds have been demonstrated to 
blunt the vasodilatation in response to intra-arterial infusion of adenosine in the 
human forearm vasculature (Taddei et al., 1991). It should however be noted 
that they are not complete inhibitors of the action of adenosine, with a recent 
study by Casey et al. (2009) demonstrating that aminophylline blunted the 
vasodilatation to low, medium and high doses of adenosine by approximately 
60%, 50% and 30% respectively. With regards to investigating exercise 
hyperaemia, a study has tested the effect of theophylline infusion during single 
leg rhythmic knee extension exercise at 33W, equivalent to ~48% of peak 
power (Radegran & Calbet, 2001). They observed an approximately 20% 
reduction in exercise hyperaemia with adenosine receptor antagonism 
compared to control. They also infused adenosine at rest and found that it can 
mimic the rapidity and peak increase in blood flow that is seen during exercise 
and concluded that there is an obligatory role for adenosine in mediating 
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exercise hyperaemia in humans. This view is supported in the review published 
around the same time (Rådegran & Hellsten, 2000). 
Additionally, it is worth noting that there is evidence of a bimodal distribution of 
responsiveness to exogenous adenosine in humans (Martin et al., 2006a, b; 
Martin et al., 2007). The initial study hypothesised that previous disparities in 
the literature regarding the effect of adenosine were due to differences in 
adenosine response between subjects (Martin et al., 2006a). They tested the 
vasodilator response to intra-arterial adenosine infusion and to rhythmic 
handgrip exercise at intensities equal to ~7, 14 and 21% MVC. Responders 
were categorised as having a robust vasodilator response to both intra-arterial 
adenosine infusion and handgrip exercise, whereas non-responders had a 
bunted vasodilator response to intra-arterial adenosine. Additionally, NOS 
inhibition with L-NMMA blunted the response to adenosine infusion in 
responders but not non-responders, whilst exercise hyperaemia was unaffected 
by NOS inhibition in either group, thus confirming that NO is not obligatory to 
exercise (see above). A later study by the same group found that aminophylline 
blocked the response to adenosine infusion in responders but non-responders 
were unaffected (Martin et al., 2006b). However, both responders and non-
responders had an approximately 15% reduction in FVC during rhythmic 
handgrip at ~21% MVC, but not at 7 or 14% MVC. This suggests that at more 
intense levels of exercise, adenosine plays a modest role in mediating exercise 
hyperaemia. The fact that this occurs in both responders and non-responders 
gives weight to the hypothesis that adenosine released from muscle is 
responsible for mediating exercise hyperaemia. The effects of increasing 
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interstitial concentrations of adenosine by using dipyridamole to block the 
equilibrative nucleoside transporters, which transport adenosine across the cell 
membrane (Martin et al., 2007). This failed to increase the exercise hyperaemia 
in either the responders or the non-responders, which combined with their other 
study (Martin et al., 2006b) suggests that adenosine may not be obligatory. 
Interestingly, dipyridamole increased the response to adenosine infusion at rest 
in both responders and non-responders, with non-responders responding 
identically to the responders after administration of the dipyridamole. This 
suggests that the group classified as non-responders actually have a naturally 
increased activity of the adenosine transporter, and so are more efficient at 
clearing adenosine from the interstitium.  
ATP is a substance for which a role in exercise hyperaemia has been 
suggested for years, but which has only recently been thoroughly investigated. 
Forrester and Lind (1969) first measured resting plasma ATP concentrations of 
0.63g/ml in blood taken from human forearm veins and reported a clear 
increase in plasma ATP following static handgrip exercise at 10% and 20% of 
MVC, although the actual amounts were difficult to assess experimentally. It has 
since been found that ATP is released from human erythrocytes when they are 
exposed in vitro to a hypoxic/hypercapnic gas mixture (Bergfeld & Forrester, 
1992). Further, Dietrich et al. (2000) demonstrated in perfused, isolated rat 
cerebral arterioles that an hypoxic solution only causes vasodilatation and 
increase efflux of ATP when they were being perfused by red blood cells. Both 
the vasodilatation and the increased ATP efflux returned to baseline levels 
when the solution around the arterioles was returned to normoxia. Therefore, in 
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hypoxic conditions erythrocytes are capable of releasing ATP, which can cause 
vasodilatation, raising the possibility that decreased pO2 is important in causing 
ATP release from red blood cells in exercise. In addition, there is evidence that 
ATP can be released from motor and sympathetic nerves (for review see 
Marshall, 2007) and from endothelial cells in response to hypoxia (Burnstock, 
2006). When ATP is applied to hamster cheek pouch arterioles and found that 
extraluminal application causes vasoconstriction via P2X receptors, whilst 
intraluminal application causes vasodilatation due to stimulation of P2Y 
receptors (McCullough et al., 1997). Thus it is likely that any direct effect of ATP 
on mediating exercise hyperaemia is due to ATP within the lumen, i.e. released 
from erythrocytes or endothelial cells.   
In-vitro work using rat red blood cells found that ATP release correlated better 
with the percentage of relaxed haemoglobin (rHb – the haemoglobin state when 
either O2 or CO is bound) than it did to the pO2 of the blood (r2 = 0.88 vs. 0.54) 
(Jagger et al., 2001). This idea has been further explored in humans by 
Gonzalez-Alonso et al. (2002). They found that ATP is important in mediating 
exercise hyperaemia in healthy young men performing 4 minutes of 1 legged 
rhythmic knee extension at intensities ranging from 27% to 85% of the peak 
workload. They found that leg exercise raised [ATP] in both the femoral artery 
and vein, as well as raising the arterio-venous [ATP] difference. This was 
associated with an increase in thigh blood flow and vascular conductance. The 
increase in venous [ATP] tended to be higher in hypoxia (P=0.14), despite 
arterial O2 content being similar in both the hypoxia and the normoxia+carbon 
monoxide conditions. As carbon monoxide causes a decreased blood O2 
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content but the haemoglobin structure remains the same as if O2 were bound, 
this indicates that the release of ATP from erythrocytes may be due to the 
conformational change which haemoglobin undergoes as it becomes 
deoxygenated. Additionally, infusion of ATP into the femoral artery reproduced 
the increase in blood flow seen during maximal exercise (Gonzalez-Alonso et 
al., 2002). This vasodilatation has since been shown to be due to action via the 
P2Y2 receptor (Rosenmeier et al., 2008).  
Recently however, there has been some evidence that the increase in ATP from 
erythrocytes seen in hypoxia may be an artefact of mechanical deformation. A 
recent study from the Gonzalez-Alonso group found that femoral venous 
plasma [ATP] was not altered by administration of either graded hypoxia or low 
intensity knee extension (Dufour et al., 2010). Similarly, leg blood flow during 
submaximal single leg knee extension exercise was not affected by anaemia 
brought on acutely by withdrawing 20% of the subjects blood volume (resulting 
in an 11% decrease red blood cell count) suggesting that it is not simply 
deoxygenation which causes the hyperaemia (González-Alonso et al., 2006). 
Finally, Mortensen et al. (2011) recently used microdialysis to measure [ATP] in 
the femoral artery and vein, thus removing the confounding factor of ex vivo 
ATP release from red blood cells and reducing the time from sampling to 
analysis. They demonstrated that single leg knee extension breathing normoxic 
gas caused a progressive rise in [ATP] in the femoral artery and vein. Breathing 
hypoxic gas (10-12.5% O2) caused an increase in resting venous [ATP], but did 
not change venous [ATP] in exercise. This group interpreted this as showing 
that the decrease in endothelial pO2 in the muscle during exercise was not 
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significantly different when breathing normoxic or hypoxic gas. However, given 
the results discussed above (Dufour et al., 2010), an alternative explanation 
may be that the mechanical deformation induced by the exercise was the same 
in both groups and that this was the cause for the increased [ATP] seen in 
exercise. They also tested the contribution of shear stress induced by the 
increase in blood flow by passively moving the leg at 60r.p.m. and by inflating a 
sphygmomanometer cuff around the thigh at 60r.p.m. (Mortensen et al., 2011). 
Both interventions caused an increase in leg blood flow and vascular 
conductance, although only the thigh compressions caused [ATP] to increase, 
particularly in venous plasma. This supports the theory that mechanical 
deformation causes ATP to be released from red blood cells or endothelium. 
In summary, it appears that in more intense exercise, adenosine alone can be 
responsible for a modest amount of the vasodilatation that occurs (15-20%) 
although it is not obligatory. Unfortunately, due to a lack of specific antagonists 
for vasodilatory P2Y receptors, it is difficult to fully test the involvement of ATP 
in mediating exercise hyperaemia (Clifford & Hellsten, 2004). However, the 
evidence provided above suggests that ATP released intraluminally by red 
blood cells or endothelial cells either in response to hypoxia or mechanical 
deformation may play a role in mediating exercise hyperaemia, specifically 
through actions at the P2Y2 receptor. Recently however, there has been some 
evidence that adenosine and ATP may act interdependently with other 
substances such as NO and prostaglandins to mediate exercise hyperaemia. 
This evidence is considered below. 
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Table 1.3 Summary of studies assessing role of adenosine in mediating hyperaemia in humans 
Study Muscle group Exercise Blood flow 
measurements 
Drug intervention Results 
Radegran & Calbet 
(2001) 
Quadriceps Dynamic knee 
extension - ~48% 
peak. 
Doppler ultrasound Intravenous 
theophylline 
(adenosine receptor 
antagonist) 
Theophylline reduces 
exercise hyperaemia 
by ~20%. 
Martin et. al. (2006b) Forearm Dynamic handgrip – 
21%, 14% & 7% MVC 
Doppler ultrasound Intra-arterial 
aminophylline 
(adenosine receptor 
antagonist) 
15% reduction in 
exercise hyperaemia 
at 21% MVC, but no 
change at 7 or 14%. 
Martin et. al. (2007) Forearm Dynamic handgrip – 
21%, 14% & 7% MVC 
Doppler ultrasound Dipyridamole 
(increases interstitial 
adnosine by blocking 
reuptake)  
No effect on 
hyperaemia. 
Mortensen et. al. 
(2009b) 
Quadriceps Dynamic knee 
extension - 30% 
peak. 
Doppler ultrasound Intravenous 
theophylline (in 
presence of NOS and 
COX blockade). 
Theophylline had no 
additive effect to the 
reduction in 
hyperaemia seen by 
dual NOS and COX 
blockade. 
Hellsten et al. (1998) Quadriceps Dynamic knee 
extension – 10, 20, 
30, 40 & 50W 
Doppler ultrasound N/A Interstitial adenosine 
increase strongly 
correlated with 
increased exercise 
hyperaemia. 
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1.2.3.5 Potassium ions (K+) and Endothelium derived hyperpolarising 
factor (EDHF) 
K+ has been implicated in mediating exercise hyperaemia since the 1970s with 
demonstration of a transient increase in venous plasma K+ following a brief 
electrically evoked contraction in dog hindlimb muscle (Mohrman & Sparks, 
1974). Although measuring venous plasma concentrations of K+ led to a time 
delay relative to any increases in release from the muscle capillary, the authors 
concluded that the timecourse of this increased release was sufficient to 
precede the vasodilatation which occurred. Thus they concluded that increased 
K+ could be causally related to the exercise hyperaemia caused by a brief 
tetanic contraction. The increase in K+ seen in this study was also similar to 
concentrations that have been shown to cause vasodilatation (Mohrman & 
Sparks, 1974; Kirby & Carlson, 2008). Similarly, K+ has been shown to be 
released in proportion to the magnitude of the exercise hyperaemia and work 
done (Hilton et al., 1978).  
A more robust case for a role of K+ in mediating the rapid vasodilatation induced 
by exercise has recently been made using an in situ hamster cremaster muscle 
preparation (Armstrong et al., 2007). In this study hamster cremaster muscle 
was stimulated at varying intensities (between 4 and 80Hz) for 250ms with the 
actions of K+ being inhibited by one of 3 drugs – 3,4-diaminopyridine (DAP – a 
KV channel blocker), ouabain (Na+/K+ ATPase inhibitor) or barium chloride 
(BaCl2 - KIR channel blocker). The diameter of arterioles running perpendicular 
to muscle fibres was visualised and any changes measured using intravital 
microscopy. Their major findings were that all 3 drugs blunted the rapid 
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vasodilatation (at 4 seconds) in response to muscle contraction by 60-65% at 
most stimulation frequencies (at all frequencies for DAP and ouabain and at all 
except 4 and 40Hz for BaCl2). These data suggest a significant role for K+ in 
mediating the rapid onset vasodilatation following a single short tetanic 
contraction.  
Although there is still a lack of evidence for a role of K+ in mediating the 
vasodilatation during and after more sustained exercise, it has been implicated 
in mediating the effects of endothelium derived hyperpolarising factor (EDHF) 
(Nagao & Vanhoutte, 1992).  
The existence of an unidentified substance or substances which caused 
hyperpolarisation of the vascular smooth muscle in porcine coronary artery in 
the presence of NOS and COX blockade was demonstrated by Nagao and 
Vanhoutte (1992). Since then, the consensus is that this EDHF actually consists 
of a number of substances which all cause hyperpolarisation of the vascular 
smooth muscle (for review see Feletou & Vanhoutte, 2006). Campbell et al. 
(1996) demonstrated that in bovine coronary arteries, inhibition of the 
cytochrome p450 enzyme with miconazole significantly reduced endothelium 
dependent relaxation induced by metacholine. This suggests that 
epoxyeicosatrienoic acids (EETs) produced from the metabolism of arachidonic 
acid by cytochrome p450 are candidates for being EDHF. It was then shown in 
human coronary arteries that EDHF hyperpolarises the vascular smooth muscle 
via Ca2+activated K+ channels (Miura & Gutterman, 1998; Miura et al., 1999). 
The contribution of EETs has since been investigated in vivo in the human 
forearm using the cytochrome p450 inhibitor miconazole (Halcox et al., 2001). 
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In the presence of a prior combined NOS and COX blockade with L-NMMA and 
aspirin, these researchers compared the vasodilatation seen in response to 
bradykinin infusions with and without miconazole infusion. Their findings were 
that p450 blockade reduced the vasodilatation caused by the endothelium 
dependent vasodilator bradykinin, but had no effect on the endothelium 
independent vasodilator sodium nitroprusside. This shows that in the human 
forearm in the absence of NO and prostaglandins, an endothelium dependent 
vasodilator is present. In the same study, the researchers were able to 
reproduce the effects of miconazole by using an intra-arterial infusion of 
potassium chloride to clamp the vascular smooth muscle membrane potential 
and thus eliminate any effect caused by hyperpolarisation. This indicates that in 
the human forearm, arachidonic acid metabolites such as EETs are able to play 
the role of EDHF.  
Of importance regarding exercise hyperaemia, Hillig et al. (2003) investigated 
the effects of inhibiting the cytochrome p450 2C9 enzyme with sulfaphenazole 
in healthy young men performing single leg knee extension for 10 minutes (the 
highest level of force all subjects could maintain for this time). They compared 
the effects of infusing sulfaphenazole alone with coinfusion of sulfaphenazole 
and L-NMMA, using a dose of L-NMMA they had previously shown had no 
effect on exercise hyperaemia in a similar protocol (Radegran & Saltin, 1999). 
Their findings were that cytochrome p450 2C9 inhibition alone had no effect on 
the increase in leg blood flow or vascular conductance during exercise 
compared to control. When combined with NOS blockade however, 
sulfaphenazole reduced the exercise hyperaemia by ~16%. Combined with the 
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results of their previous findings that NOS blockade alone had no effect on 
exercise hyperaemia, this suggests that NO and cytochrome p450 2C9 derived 
products act in an interdependent manner, such that inhibition of one can be 
compensated for by upregulation of the other. 
1.2.3.6 Interdependency and redundancy 
The discussion above has concentrated largely on the individual contributions of 
NO, prostaglandins, adenosine and ATP in mediating exercise hyperaemia. 
Individually the contributions of any one of these mediators is relatively modest. 
Recently however, there have been some studies which have shown evidence 
of interdependency between the vasodilator systems.  
In one of the first studies to demonstrate interdependency, intra-arterial 
indomethacin was given to block COX in moderately trained young subjects 
performing 5 minutes of 1-legged rhythmic knee extension exercise at 20% of 
their maximum workload, measuring blood flow with Doppler ultrasound 
(Mortensen et al., 2007). They found that single inhibition of COX had no effect 
on the increase in blood flow evoked by exercise, a finding that contrasts with 
the studies described above in section 1.2.3.3 in the forearm. However, when 
COX inhibition was combined with NOS inhibition, exercise hyperaemia was 
reduced by 33%, despite previous findings by the same group that the same 
dose of L-NMMA given as a single agent in a similar protocol did not lower 
blood flow (Radegran & Saltin, 1999). Similar findings were made in another 
recent study where positron emission tomography (PET) with radiolabelled 
water was used to measure the blood flow to metabolically active tissue 
(Heinonen et al., 2011). Healthy young men performed rhythmic single leg 
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extension at 40rpm at a force of 4.5kg after combined NOS and COX blockade 
(with L-NMMA and indomethacin). They found that combined blockade reduced 
exercise hyperaemia to the working quadriceps femoris muscle by 15-20%. 
NOS inhibition alone had no effect and blood flow to the resting posterior 
muscle group was unaffected by either single or double blockade. Thus both 
studies indicate that NO and prostaglandins act interdependently to mediate 
exercise hyperaemia. 
Further, in a relatively large study on 24 physically active young men performing 
knee extension at 30% of peak workload, systemic blockade of adenosine 
receptors using an intravenous infusion of theophylline and a local blockade of 
COX and NOS with indomethacin and L-NMMA infused into the femoral artery  
showed that dual blockade of COX and NOS and triple blockade of COX, NOS 
and adenosine receptors both reduced leg blood flow and vascular 
conductance by similar amounts (~30%) (Mortensen et al., 2009b). Additionally, 
they found that the vasodilator response to intra-arterial infusion of adenosine 
was reduced by both COX and NOS inhibition separately, these reductions 
being additive in dual blockade. These results raise the possibility that 
adenosine acts to mediate exercise hyperaemia by increasing levels of 
vasodilator prostaglandins and nitric oxide. Interestingly, in a separate protocol 
designed to assess the changes in plasma adenosine concentration, neither 
venous nor arterial adenosine levels were altered, suggesting that interstitial 
adenosine mediates exercise hyperaemia rather than plasma adenosine. 
A recent study by the same group in Copenhagen used microdialysis to 
measure changes in concentrations of adenosine, prostacyclin and NO in the 
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interstitium and plasma in response to both intra-arterial and interstitial infusions 
of adenosine (Nyberg et al., 2010). They found that intra-arterial adenosine 
infusion not only increased leg blood flow but caused an increase in both 
interstitial and venous plasma levels of NO and 6-keto PGF1. Further, when 
adenosine was infused into the interstitium, there was no effect on leg blood 
flow, but both interstitial NO and 6-keto PGF1 increased. In other studies 
cultured endothelial and skeletal muscle cells produced NO in response to 
adenosine, but only endothelial cells produced prostacyclin. Combined, the 
results of these studies indicate that adenosine mediates local vasodilatation by 
increasing production of prostacyclin and NO from the endothelium as well as 
NO from muscle fibres.     
Regarding interactions between ATP and other mediators, researchers have 
had mixed findings depending on which limb they have investigated. NOS 
inhibition with L-NMMA did not affect the forearm vasodilatation in response to 
ATP, but did reduce the vasodilatation caused by acetylcholine (Rongen et al., 
1994). This indicates that NO does not significantly contribute to ATP-induced 
vasodilatation in the human forearm. Further investigation found that individual 
blockade of COX and EDHF had no effect on ATP-induced vasodilatation, 
whereas combined blockade of COX, EDHF and NO reduced ATP-induced 
vasodilatation(van Ginneken et al., 2004). However, combined blockade also 
reduced vasodilatation evoked by the endothelium independent vasodilator 
SNP, thus we can conclude that the reduction in vasodilatation was a non-
specific effect due to the combined vasoconstrictor properties of the infused 
agents. 
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More recently however, another group has found evidence of interdependency 
in the leg of moderately trained young men (Mortensen et al., 2009a). The 
increase in leg vascular conductance in response to femoral artery ATP infusion 
was reduced by 12% and 26% by L-NMMA and indomethacin respectively. Dual 
inhibition reduced LVC by ~42%, indicating that both NO and prostaglandins 
mediate part of the vasodilator response to ATP, although they appear to work 
via separate pathways. Adenosine receptor antagonism had no effect on ATP-
induced vasodilatation, indicating that ATP breakdown to adenosine is not 
significantly responsible for mediating the vasodilatation. The authors speculate 
that any differences between this positive study in the leg and negative findings 
in forearm may either be due to vasodilatator differences between the limbs, or 
to the increased muscle mass in the leg resulting in a more visible response to 
pharmacological intervention. 
In summary, the current evidence suggests that both adenosine and ATP may 
mediate exercise hyperaemia through production of both vasodilator 
prostaglandins and NO. These vasodilator prostaglandins and NO likely work in 
an interdependent manner. The caveat is that the role of ATP cannot be tested 
due to the absence of an antagonist. 
1.2.4 Effects of age on hyperaemia 
In ageing there is a decrease in exercise capacity in humans that is partly due 
to a decreased VO2-max and cardiac output (Ogawa et al., 1992). It is also 
possible that decreased vasodilatation in aged humans affects skeletal muscle 
blood flow and thus limits exercise performance (Schrage et al., 2007). The 
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discussion below focuses on recent evidence that vasodilatation in exercise is 
impaired with ageing.  
Irion et al. (1987) first showed that exercise hyperaemia occurred to a lesser 
extent in old animals than in younger animals. Hind limb blood flow was 
assessed using injection of microspheres in 12 and 24 month old rats, 
corresponding to a human age of 40-50 and 70 years old respectively. Exercise 
hyperaemia following dynamic muscle contraction was impaired by ~30% in the 
older rats and this was associated with an increase in muscle fatigue. Resting 
blood flow did not differ between age groups, thus the source of impairment lies 
in the mechanisms of exercise hyperaemia.  
Regarding the effects of ageing on exercise hyperaemia in humans, the results 
have been more equivocal. Jasperse et al. (1994) measured FBF in sedentary 
or recreationally active subjects aged 19-29 and 60-74 years old. Peak forearm 
vasodilator capacity, assessed by the response to 10 minutes of ischemia with 
isometric handgrip for the last 2 minutes, was not affected by ageing. Similarly, 
the peak dynamic workload and the blood flow immediately following dynamic 
exercise were not significantly different in either age group at any workload from 
7%MVC to ~80% of MVC, thus indicating that ageing has no effect on exercise 
hyperaemia. This contrasts with a later study measuring leg blood flow during 
submaximal cycling exercise in endurance trained young and older men 
(Proctor et al., 1998). Older men had ~25% lower blood flow than younger 
subjects at any of the three workloads that were assessed (~40%, 65% and 
90% of VO2peak), although resting values of leg blood flow were not measured, 
therefore it is not clear whether the deficit in exercise blood flow represented the 
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continuation of a deficit which was present at rest. Similarly, sedentary older 
subjects had a reduced leg blood flow during cycling exercise compared to 
sedentary young subjects, both at an absolute work rate of 99W and at the 
relative maximum work rate for each group of subjects (Poole et al., 2003). This 
difference was not present at lower work rates of 15 and 30W. The authors 
postulated that the limited muscle perfusion in older subjects was directly 
responsible for the reduced maximum work rate compared to the younger 
subjects. 
More recently Donato et al. (2006) investigated the effects of ageing on limb 
blood flow during dynamic exercise in the forearm and the leg. Exercise 
hyperaemia in the forearm was not altered with age when levels of hyperaemia 
were expressed as an absolute value. It was also true when exercise 
hyperaemia was expressed relative to muscle mass or to maximum work rate, 
in order to account for any change in these values in older subjects. In the leg 
however, exercise hyperaemia was reduced in old subjects compared to 
younger subjects at comparable workloads (although absolute workload was 
lower as older subjects had a lower maximum force). As resting blood flow was 
unaffected by age this supports the concept that exercise hyperaemia is 
attenuated in the leg with ageing.  
Other groups have demonstrated ageing-related changes in the forearm 
exercise hyperaemia. Carlson et al. (2008) used single, one second 
contractions to effectively isolating any vasodilator mechanism. Exercise 
hyperaemia was maintained with age at 5% MVC, but at intensities greater than 
10% MVC both the immediate and peak vasodilatation were reduced in the 
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older subjects. Importantly, there were no significant differences between young 
and older subjects in terms of forearm muscle mass or the maximum force they 
were able to attain, thus the impaired exercise hyperaemia is purely explained 
by an attenuated vasodilator response. 
The mechanism for impairment of exercise hyperaemia in ageing may be 
attenuated endothelial function. In a study of 53 healthy adults (age 19-79), the 
magnitude of vasodilatation in response to ACh infusion was negatively 
correlated with the subjects age (r=-0.86), although there was no effect of age 
on the dilatation to sodium nitroprusside (Taddei et al., 1995). This indicates 
that the endothelial function is impaired with ageing, despite no significant 
impairment of the vascular smooth muscle. More recently, it has also been 
shown that infusion of prostacyclin resulted in a reduced vasodilatation from 
baseline in older subjects compared to younger subjects, although again the 
response to SNP was not altered (Nicholson et al., 2009). Interestingly, this 
group found that NOS inhibition had no effect on the older group but decreased 
the response to PGI2 in the young, such that there was no longer any difference 
between the young and older groups, suggesting a decreased role for NO in 
ageing.  
Similar findings for a decreased role of NO in ageing have been made looking 
at the blood flow response to handgrip exercise (Schrage et al., 2007). 15 
recreationally active subjects aged 55-81 performed dynamic handgrip exercise 
at 10% and 20% of MVC for 20 minutes. L-NAME and ketorolac were infused 
during steady state exercise in differing orders, such that the effect of single 
NOS and COX blockade could be assessed as well as the effect of dual 
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blockade. When compared to another study by the same group in which young 
subjects undertook the same protocol (Schrage et al., 2004), the effects of NOS 
blockade on reducing steady state exercise FBF were reduced by about 40% in 
older subjects and the 12% decrease in FBF seen in the young subjects during 
COX inhibition was completely absent in the older subjects. This shows a 
reduced role for both NO and prostaglandins in mediating exercise hyperaemia 
in older humans. In another study, infusing the antioxidant ascorbic acid during 
dynamic handgrip exercise at 10% MVC increased FBF by ~25% (Crecelius et 
al., 2010). The researchers then infused L-NMMA and ketorolac in a 
randomised order during steady state exercise with ascorbic acid infusion. 
Regardless of the order of blockade, they found that L-NMMA reduced the 
steady state blood flow with ascorbic acid by approximately 20%, i.e. nearly 
back to steady state exercise levels prior to ascorbic acid infusion. COX 
inhibition with ketorolac had no effect, either when infused first or second. This 
indicates that the reduced steady state blood flow seen in low intensity dynamic 
handgrip exercise in older subjects may be due to decreased NO bioavailability 
due to formation of reactive oxygen species.  
Of relevance to the findings of a role for vasodilator prostaglandins in exercise 
hyperaemia in young subjects, there is some evidence for a shift from 
vasodilator to vasoconstrictor prostanoids. Tang and Vanhoutte (2008) 
measured the levels of various prostanoid synthases in 36 week old and 72 
week old rats, corresponding to middle age and old age in humans. They found 
that expression of prostacyclin synthase was unchanged with ageing, but 
expression of thromboxane synthase was increased, indicating that production 
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of the vasoconstrictor thromboxane may be raised relative to the vasodilator 
prostacyclin. Importantly there is also evidence for this in aged humans with 
essential hypertension (Taddei et al., 1993). In this group of patients, infusion of 
the COX inhibitor indomethacin resulted in an increase in acetylcholine 
mediated vasodilatation, indicating that a COX-derived vasoconstrictor such as 
thromboxane is produced.  
In summary, there is substantial evidence of a reduction in exercise hyperaemia 
with ageing, which appears to be due to a complete loss of prostaglandin 
mediated vasodilatation and a reduction in NO mediated vasodilatation. This 
may be largely due to impaired endothelial function and an increase in reactive 
O2 species which decreases NO bioavailability. 
1.3 Mechanisms of Muscle Fatigue 
Fatigue has both a central neural and a peripheral muscular component [see, 
e.g. (McKenna & Hargreaves, 2008)]. The central component can be defined as 
a progressive exercise-induced failure of voluntary activation of the muscle and 
refers to processes taking place proximal to the neuromuscular junction (Taylor 
& Gandevia, 2008), i.e. at the levels of the motor neurone, spinal cord or brain.  
Evidence for the presence of central fatigue can be seen in experiments in 
which extra force is produced as a result of motor neurone or motor cortex 
stimulation whilst subjects perform a maximum voluntary contraction (for 
reviews see e.g. Gandevia, 2001; Taylor & Gandevia, 2008). Whilst the present 
studies will not consider central fatigue further, it is important to note that 
studies involving direct electrical stimulation of muscle or motor nerve supply 
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avoid central fatigue mechanisms contributing to observed responses whereas 
experiments involving voluntary contraction may be affected by them.  
Peripheral fatigue refers to any process which takes place at or distal to the 
neuromuscular junction (Amann & Calbet, 2008). A number of substances have 
been proposed to be involved in the development of peripheral fatigue. 
Traditionally, lactate ions produced as a result of anaerobic metabolism have 
been implicated in peripheral fatigue. However, experimental data show that 
muscle lactate levels do not correlate well with fatigue (Karlsson et al., 1975; 
Bangsbo et al., 1992a; 1992b) and thus lactate is not considered further. Briefly, 
the main substances that are currently implicated in the development of 
peripheral muscle fatigue are hydrogen (H+) ions, inorganic phosphate (Pi) and 
potassium ions (K+). Furthermore, previous work from this laboratory suggests 
that at least part of the mechanism of peripheral fatigue is O2-dependent (Fordy 
& Marshall, 2004). This study on young, recreationally active male subjects 
investigated the effect of breathing 40% O2 on the time to fatigue during 2 
periods of maximal voluntary forearm contraction, separated by 7 minutes 
recovery. It was found that breathing 40% O2 rather than air during the 7 minute 
recovery period from a period of maximum voluntary forearm contraction to 
exhaustion greatly improved the time to exhaustion during a second period of 
forearm contraction. By contrast, data in the same study showed that breathing 
supplemental O2 during the period of contraction only but not during the 
recovery period had no effect on muscle fatigue in the second period of 
contraction. When combined, these results show that the O2-dependent aspect 
of fatigue occurs during recovery and not during contraction. The following 
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discussion will analyse the evidence for and against the contributions of the 
substances mentioned previously and how they may be O2-dependent. 
1.3.1 Potassium ions 
In humans, the concentration of K+ within the muscle fibres ([K+]i) is 
approximately 165mM and has been shown to decrease to ~130mM during 
intense exercise (Sjogaard et al., 1985). Moreover, using microdialysis 
techniques, concentrations increasing from ~4mM at rest to greater than 10mM 
have been found in the muscle interstitium (Juel et al., 2000) and values of 
8mmol/L have been found in arterial  and venous blood of men performing 
exhaustive treadmill exercise (Medbo & Sejersted, 1990) even though the 
resting level in plasma is 4-5mmol/L. K+ is released from muscle fibres during 
exercise through KIR channels as a result of action potentials and via K+ATP 
channels, which respond to the decreased ATP by remaining open more 
frequently (Standen, 1992). K+ is taken back up by the cell via Na+/K+-ATPase 
(Clausen, 2003). 
A number of studies have shown a link between increased K+ efflux from 
skeletal muscle cells and fatigue. Thus, Juel et al (2000) used graded single leg 
extensor exercise to measure the interstitial concentration of potassium ([K+]int). 
Their results showed that the higher the intensity of the exercise, the greater the 
[K+]int. Further, Nielsen et al (2004) also used single leg extensor exercise to 
look at the effect of training on K+ concentrations and performance. The 
subjects trained one leg whilst using the other leg as an untrained control. It 
was found that following 6 weeks training, the time to fatigue was significantly 
longer in the trained leg than the untrained one and this was associated with a 
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greater, more rapid increase in [K+]int in the control leg than in the trained leg. In 
other studies performed in vitro, Clausen and Nielsen (2007) incubated rat 
skeletal muscle in a 4mM K+ solution. They demonstrated that pre-incubation 
with 10mM K+ caused a decrease in initial force and an increased rate of force 
decline in muscle relative to that seen in 4mM K+ solution. These changes 
became more pronounced with increasing periods of pre-incubation. Of 
particular interest, they showed an increased rate of force decline when they 
incubated muscle in 8mM K+ solution (Clausen & Nielsen, 2007), the level that 
has been found in arterial blood following exhaustive exercise.  
It has also been found that venous K+ concentrations were the same at the time 
of exhaustion when subjects exercised to exhaustion on two separate 
occasions on the same day, even though the time to exhaustion was shorter in 
the second exercise period (Bangsbo et al., 1992b). A final piece of evidence 
suggesting that potassium can cause fatigue comes from experiments in which 
subjects perform either leg exercise alone or leg exercise preceded by arm 
exercise. It was found that the [K+]Int measured in the leg during leg exercise 
were greater when arm exercise was performed first consistent with a rise in 
plasma K+ caused by arm exercise and this was associated with a decreased 
time to exhaustion (Nordsborg et al., 2003). It is thought that these changes in 
[K+] mediate fatigue by decreasing the action potential amplitude, thus 
decreasing the excitability of the skeletal muscle cell membrane (Sjogaard, 
1996). This results in a decrease in force development, which is measured as 
fatigue.  
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Interestingly, whilst it seems that increased [K+]Int from ~8mM and above is 
associated with a decreased time to fatigue in exercise, it appears that from the 
resting level of ~4mM up to a concentration of ~8mM it may actually increase 
the force generated (for review see McKenna et al., 2008). This raises the 
possibility that initially during exercise the rise in K+ improves muscle 
performance. When peak tetanic force is plotted against [K+]Int little decrease in 
force is seen as [K+]int increases from ~4mM to around 8-9mM, followed by a 
rapid decrease in force with little further increase in [K+]int (McKenna et al., 
2008). They describe the concentration where force rapidly decreases as the 
critical [K+]int. The [K+]Int at which force rapidly decreases can be shifted to the 
left or right depending on the actions of Na+/K+-ATPase (sodium/potassium 
pump or NKA), which clears K+ from the extracellular space by pumping 3 Na+ 
ions out of the cell and 2 K+ ions into the cell. Clausen and Nielsen (2007) 
investigated the effects of stimulating the Na+/K+-ATPase on fatigue in rat 
muscle. They found that the effect of 10mM K+ was reduced by stimulation of 
the Na+/K+-ATPase, whether by Na+ loading, salbutamol, adrenaline, rat CGRP 
or insulin. Additionally, K+ is released from muscle cells via the K+ATP channel, 
which responds to low ATP by remaining open more frequently (Standen, 
1992). This provides an interesting O2-dependent hypothesis as reduced O2 
may lead to reduced ATP and hence inactivation of the Na+/K+-ATPase and 
opening of the K+ATP channel, thus increasing net efflux of K+ (see Figure 1.3). 
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1.3.2 Inorganic Phosphate (Pi) 
Inorganic phosphate (Pi) increases in the interstitium during intense exercise 
when the rate of ATP (adenosine triphosphate) consumption is greater than the 
rate of supply from the mitochondria (Robergs et al., 2004). This is due to Pi 
release due to ATP hydrolysis outstripping the uptake by the mitochondria.  
ATP + H2O → ADP + Pi + H+ + energy 
As reviewed by Fitts (1994), the concentration of interstitial Pi ([Pi]i) in skeletal 
muscle at rest is quite variable, with values of between 3 and 41 mmol.kg-1 dry 
weight being reported and content being consistently higher in slow-twitch than 
fast-twitch muscles. As well as stores of Pi, phosphate is found in the cell in two 
important high-energy forms, adenosine triphosphate and phosphocreatine 
(PCr). ATP levels can be maintained during contractions by the creatine kinase 
reaction (PCr + ADP + H+ → Cr + ATP) and by the adenylate kinase reaction (2 
ADP → ATP + AMP). As can be seen from the creatine kinase reaction, PCr 
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breakdown is not the cause of the increase in Pi, as is sometimes mistakenly 
thought (Robergs et al., 2004). However, as during intense exercise ATP is 
constantly being synthesised from PCr and immediately broken down, the net 
reaction within the cell can be said to be PCr → Cr + Pi (Allen et al., 2008). 
Evidence to support the role of Pi in fatigue has been accumulating since the 
1980s. Cooke and Pate (1985) found that adding increased concentrations of 
extracellular Pi led to a reduction in isometric tension of single rabbit psoas 
muscle fibres. This correlates well with work by Westerblad and Allen (1996), 
who injected phosphate into mouse muscle fibres with and found that it caused 
a reduction in tetanic force. Despite these findings, the impact of Pi alone has 
been hard to investigate as injecting it into muscle fibres causes other metabolic 
changes. A solution to this problem has come from Westerblad and colleagues 
(Dahlstedt et al., 2000; 2001), who have used creatine kinase knockout (CK-/-) 
mice as a model to study the effects of increased Pi. In contrast with wild-type 
mice, the CK-/- mice have a higher myoplasmic concentration of Pi in fast twitch 
muscles at rest but show no increase in Pi following fatiguing contractions 
(Dahlstedt et al., 2000). These studies showed that the whole extensor 
digitorum longus muscle (EDL, a predominantly fast-twitch muscle) produced 
~25% lower force in the first contraction in CK-/- mice than wild-type mice 
suggesting that Pi has a force depressing effect. However, muscle fibres from 
CK-/- mice showed no decline in force production even over the course of 100 
contractions, compared to fibres from wild-type mice which showed a ~15% 
reduction in force after 10 contractions and ~30% after 100 contractions 
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(Dahlstedt et al., 2000). This supports the idea that increases in [Pi] mediate 
fatigue. 
The potential mechanisms by which increased Pi may mediate fatigue have 
been well reviewed (Westerblad et al., 2002; Allen et al., 2008). Fatigue is said 
to have three phases (for a review see eg. Allen, 2009). Briefly, phase one is a 
rapid drop to 80-90% of the initial force. In phase two the force is constant and 
in phase three the force drops again. Pi has been mainly implicated in phase 
one and three. In phase one, Pi is thought to inhibit cross-bridge formation, a 
theory that is supported by the studies described above on CK-/- mice which 
showed lower initial contractile force than wild type mice. In phase three, force 
is thought to decline due to a reduced release of calcium (Ca2+) from the 
sarcoplasmic reticulum and reduced sensitivity of contractile proteins to Ca2+, 
both of which have been linked to Pi. Firstly, an initial increase in intracellular 
Ca2+ ([Ca2+]i) occurs which has been attributed to Pi blocking Ca2+ reuptake 
(Duke & Steele, 2000). This may result in less Ca2+ being available for release 
in later stages of contraction (Westerblad et al., 2002). Secondly, it has been 
hypothesised that Pi enters the sarcoplasmic reticulum and causes precipitation 
of Ca2+ (Fryer et al., 1995; Kabbara & Allen, 1999; Dahlstedt et al., 2000). 
Finally, studies on skinned muscle fibres have shown that increased Pi reduces 
myofibrillar Ca2+ sensitivity (Millar & Homsher, 1990; Martyn & Gordon, 1992). 
This could have a greater effect when combined with reduced Ca2+ release due 
to the above mechanisms.  
A potential O2-dependent mechanism of Pi in fatigue can be hypothesised from 
work done by Haseler et al (1999; 2004) investigating the effects of 
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supplemental O2 on phosphocreatine resynthesis, a mechanism for removing Pi 
from the muscle fibre. 100% or 21% O2 was breathed before, during and after 
plantarflexion exercise. Using magnetic resonance spectroscopy, they found 
that the rate of phosphocreatine resynthesis following submaximal rhythmic 
exercise was only increased by breathing 100% O2 in active subjects and not in 
sedentary subjects. This implies that O2-delivery to muscle is more than 
adequate to supply muscle activity in sedentary subjects, with the authors 
hypothesising that an increase in mitochondrial number and efficiency allowed 
trained subjects to make better use of supplementary O2. This could therefore 
provide a mechanism for supplementary O2 to reduce the role of Pi in fatigue, at 
least in trained subjects (see Figure 1.4).  
 
1.3.3 Hydrogen ions 
The increase in hydrogen ions (H+) during exercise occurs when the rate of ATP 
breakdown exceeds the rate of mitochondrial respiration, not as a result of lactic 
acid production as is often assumed (Robergs et al., 2004). H+ has traditionally 
been thought to be involved in fatigue based on studies that have generally 
been performed on single fibres at room temperature or below and shown a 
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decrease in shortening velocity and isometric tension with decreasing pH 
(Metzger & Moss, 1987; Cooke et al., 1988). In more recent times this view has 
been questioned by a number of groups using different lines of investigation. 
Sahlin and Ren (1989) investigated the relationship between force and 
metabolic changes in the quadriceps femoris muscle following knee extension 
exercise in human subjects. The results showed that although force and pH 
both dropped, force recovered more rapidly than pH did, suggesting that 
hydrogen ions are not directly responsible for causing fatigue. The same 
findings were made in human first dorsal interosseous muscle (in the hand), 
where pH fell from about 7 to 6.5 and remained at 6.5 for at least 2 minutes, by 
which time force had recovered to ~85% of that of rested muscle (Cady et al., 
1989). In a similar model to Sahlin and Ren (1989), Bangsbo et al. (1996) used 
leg exercise performed on two separate occasions. On one day subjects 
performed arm exercise prior to leg exercise in order to increase blood and 
therefore leg muscle pH, and on the other they performed leg exercise without 
prior arm exercise. The findings of this study were that leg muscle fatigue 
occurred at a lower leg muscle pH following arm exercise than without, again 
suggesting that H+ is not directly implicated in fatigue.  
The reason for the seeming contradiction between results obtained in the 
original skinned muscle experiments and those on intact muscle would now 
seem to be due to temperature. Pate and colleagues (Pate et al., 1995) studied 
rabbit psoas muscle fibres with the sarcolemma chemically removed (“skinned 
fibres”) to allow the solution bathing the contractile apparatus to be precisely 
controlled. At 10C they found that reducing the pH from 7 to 6.2 caused a 30% 
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reduction in shortening velocity and a 50% reduction in isometric tension, 
findings in line with the original studies. However, when the temperature was 
increased to 30C, the reduction in pH only caused an 18% decrease in 
isometric tension and actually caused a 6% increase in shortening velocity. 
These findings suggest that at more physiological temperatures H+ does not 
cause fatigue and similar results have been found by other groups (eg. 
Westerblad et al., 1997).  
In summary, it is now considered unlikely that hydrogen ions are directly 
responsible for peripheral fatigue. If they are involved at all it is likely in an 
indirect role such as stimulating group III-IV afferent nerves to cause a 
sensation of discomfort as proposed by Westerblad et al (2002).  
As mentioned above, pH decreases as a result of H+ released when ATP 
breakdown exceeds mitochondrial respiration (Robergs et al., 2004). As a 
result, it is possible that pH could be a third theoretical O2-dependent 
mechanism of fatigue, as increased O2 delivery could delay the onset of H+ 
formation by increasing oxidative phosphorylation, which uses up H+ (see 
Figure 1.5). 
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1.3.4 Effect of age on muscle fatigue 
Despite the importance of fatigue in health and disease, the topic of whether the 
susceptibility of muscles to fatigue is altered with age is still an area of active 
research. Firstly we must consider whether any change in muscle function seen 
in older subjects is a physiological result of normal ageing or a functional result 
of reduced activity (Kirkendall & Garrett, 1998). Supporting a functional result of 
reduced activity, it has been demonstrated that habitual activity is inversely 
related to age (Aoyagi & Shephard, 1992) and it has been shown in cadavers 
that vastus lateralis cross-sectional area declines approximately 40% between 
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the ages of 20 and 80 years (Lexell et al., 1988). Additionally it has recently 
been demonstrated that older adults have a reduction in strength which is not 
totally accounted for by a loss in muscle volume (Goodpaster et al., 2006). 
Thus, it can be suggested that there is a loss of muscle quality with ageing.  
Even after controlling for reduced strength by matching subjects for strength or 
by assessing relative strength levels, there is a considerable spread of results 
as to whether older subjects have altered levels of fatiguability. A majority of 
studies find that older subjects are more fatigue resistant than younger subjects, 
with this result being shown in the thumb (Chan et al., 2000; Ditor & Hicks, 
2000), ankle (Kent-Braun et al., 2002; Lanza et al., 2004) and elbow (Hunter et 
al., 2005). Moreover, the aforementioned studies represent a range of different 
exercise protocols. However, other studies have found conflicting results, with 
for example Baudry, et.al. (2007) demonstrating increased fatiguability in 
response to repetitive maximal ankle dorsiflexion and Petrella et.al. (2005) 
finding that older adults are less capable of sustaining maximum knee extension 
contractions. A recent meta-analysis of the field suggests that the modality of 
exercise may play a role (Avin & Frey Law, 2011). They determined that older 
adults are more fatigue resistant than younger adults when performing relative 
intensity tasks when the exercise comprises of static exercise, but there is no 
change in fatiguability when subjects are performing dynamic contractions.  
A pattern of reduced maximal strength but maintained or improved fatigue 
resistance in the elderly may be explained by the histological findings of work by 
Lexell and colleagues (Lexell et al., 1986; Lexell et al., 1988). These studies 
examined slices of vastus lateralis muscle from the quadriceps, and discovered 
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firstly that ageing was associated with a reduction in muscle fibre number, 
which may explain an overall reduction in absolute strength. This could partly 
explain improved fatigue resistance, as reduced muscle strength and size may 
lead to reduced occlusion. Secondly they found that ageing was associated with 
a reduction in the number of fast twitch Type II fibres leading to a relative 
increase in the percentage of slow twitch Type I fibres which are generally able 
to produce less force but are more fatigue resistant (Kent-Braun, 2009). Similar 
studies have not been performed looking at fibre type change in the forearm to 
our knowledge. However, White and Carrington (White & Carrington, 1993) 
investigated the changes in twitch speed in calf and biceps muscle with ageing. 
They found that whilst calf twitch speed decreased in elderly subjects compared 
to younger subjects, there was no difference in biceps twitch speed. This could 
be used as a surrogate measure for fibre type, thus suggesting that leg muscle 
switches to slow twitch Type I fibres whilst arm muscle does not. 
In conclusion, overall the evidence points towards a reduction in absolute 
strength but an increase in fatigue resistance in older subjects, at least when 
performing static exercise. Whilst some of this is may be due to a reduction in 
muscle fibre number and a shift towards a Type 1 fibre type, there still remains 
research to be done investigating age-related alterations within the muscle, 
particularly in the arm.  
1.4 Methods of measuring blood flow 
The studies described above tend to measure blood flow using one of 3 
techniques, these being venous occlusion plethysmography, Doppler ultrasound 
and thermodilution. The discussion below concentrates on the advantages and 
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disadvantages of these techniques, and puts forward the reasoning for using 
venous occlusion plethysmography in the studies discussed in later chapters.    
Venous occlusion plethysmography is one of the oldest techniques used to 
measure limb blood flow (for reviews on methodology see e.g. Greenfield et al., 
1963; Wilkinson & Webb, 2001). Briefly, the technique relies on the fact that the 
veins in a limb supported at heart level are largely empty of blood. If venous 
outflow is blocked whilst arterial inflow remains unimpeded, this results in 
pooling of blood in these veins and a corresponding increase in limb volume, 
which can be measured using a strain gauge around the limb. Advantages of 
using venous occlusion plethysmography over other techniques are that it is 
cheap, widely available, non-invasive and does not require extensive training to 
obtain accurate, reproducible results. The major disadvantage of venous 
occlusion plethysmography is the fact that during the procedure the limb needs 
to be relaxed. This affects research on blood flow during exercise as readings 
can only reliably be taken during breaks in the contractions or on cessation of 
exercise.  
Thermodilution is an alternative to venous occlusion plethysmography and 
involves the insertion of a catheter with a thermistor into an artery or vein 
serving the tissue of interest. In one widely used protocol, the thermistor is 
advanced through the venous catheter until the tip is located 12cm prox to the 
entry hole (Andersen & Saltin, 1985). Saline is then infused into the vein at a 
constant temperature of 0C. Changes measured in the temperature at the 
thermistor are therefore due to dilution of this saline with blood, with increased 
blood flow resulting in a higher temperature than lower blood flows. Although 
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accuracy of thermodilution is reported to be comparable to plethysmography 
(Greenfield et al., 1963), disadvantages include the increased invasiveness of 
the protocol, as well as the interference caused by exercise, as reported by 
Humphreys and Lind (1963). 
A more recent technique for measuring blood flow uses a Doppler ultrasound 
probe to measure the velocity of the blood flow in the artery of interest whilst 
simultaneously or at set intervals measuring the diameter of the artery (see e.g. 
Shoemaker et al., 1996b; Schrage et al., 2004). Advantages of this technique 
include the ability to visualise both vessel diameter and blood velocity, the 
ability to observe changes in blood flow in real time and the fact that it is non-
invasive. However, the technique is limited in use to vessels with a diameter of 
over 1-2mm and requires expensive equipment and skilled operators (Wilkinson 
& Webb, 2001). 
Much research has been performed on the reproducibility and validity of venous 
occlusion plethysmography. The importance of maintaining a consistent forearm 
position at heart level has been underlined by recent research by Rojek et. al. 
who found that blood flow was significantly lower when the forearm was 
positioned ten centimeters below heart level than when positioned ten 
centimeters above heart level (Rojek & et al., 2007). Conversely the same study 
found that blood flow following exercise was actually increased when measured 
below compared to above heart level. There is also variation between research 
groups concerning whether blood flow is reported in one arm only or as a ratio 
of blood flow between both arms. Roberts et. al. performed six repeated 
measures of blood flow using strain gauge plethysmography in the forearm and 
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calf over a one month period (Roberts et al., 1986). At rest they found a 
coefficient of variation of 10.5% and 11.5% in the forearm and calf respectively, 
with variation increasing slightly to 11.5% and 13% post-exercise. They 
concluded that this is a suitable accuracy for repeated measures within the 
same individual. This compares favourably to a similar study on the repeatability 
of Doppler ultrasound (Shoemaker et al., 1996b), which found a coefficient of 
variation of 13.2% when measuring mean blood velocity at rest, which 
increased to 20.2% in the last minute of exercise. 
A recent study investigated the accuracy and reproducibility of plethysmography 
when measuring high levels of blood flow (Wood & Stewart, 2010). Seven 
subjects were asked to perform five-minute periods of rhythmic handgrip 
exercise at various workloads and blood flow was measured using strain gauge 
plethysmography at rest and after exercise. The slope obtained by venous 
occlusion plethysmography was analysed separately over the first one, two, 
three and four cardiac cycles to assess whether measuring analysis over 
multiple cardiac cycles resulted in an underestimation of blood flow. There was 
no significant difference in values obtained at rest. However, after exercise at 
intensities over 30% of maximum voluntary contraction, forearm blood flow was 
significantly reduced when measured over 2-4 cardiac cycles compared to 
when measured for a single cycle. This indicates that when measuring high 
levels of blood flow, researchers should use small timeframes of measurement. 
Given the independent evidence that venous occlusion plethysmography is still 
a reliable and accurate technique compared to alternatives, combined with the 
fact that it has been used successfully in this laboratory previously (Fordy & 
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Marshall, 2004; Win & Marshall, 2005), it was decided to continue with this 
methodology in the present studies. It is however recognised that the use of 
plethysmography measures post-exercise hyperaemia and therefore may not 
fully reflect the effect of interventions on exercise hyperaemia. 
1.5 Aims and hypotheses of the present study 
This study aims to investigate the role of O2-dependent substances in exercise. 
1. We hypothesise that in recreationally active young subjects, substances 
such as prostaglandins or adenosine act in an O2-dependent manner to 
mediate a portion of the vasodilatation seen in exercise hyperaemia 
following both static and dynamic exercise. 
2. We hypothesise that in older subjects, the magnitude of exercise 
hyperaemia will be comparable to that seen in young subjects, but the 
role of O2-dependent substances will be reduced. 
3. A substance or substances that acts in an O2-dependent manner during 
recovery mediates a component of fatigue.  
The above hypotheses were tested by investigating the vasodilator and fatigue 
response to handgrip exercise in groups of recreationally active young and 
older subjects. We used supplementary 40% O2 as compared to air to 
investigate O2-dependence and aspirin and aminophylline to investigate the 
contribution of prostaglandins and adenosine respectively. Venous blood 
samples were be taken for analysis of metabolites produced in exercise and to 
test for changes that occur following interventions. 
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  CHAPTER 2: GENERAL METHODS
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2.1 Subjects 
All experiments were carried out on healthy males aged 18 to 30 years of age 
for the younger groups and 50 to 70 years of age for older groups. Subjects 
activity levels were assessed using a self-reporting screening questionnaire 
(Appendix 1). The questionnaire was also used to confirm that subjects were 
non-smokers (classed as never smoked for young group and non-smoker for 
>20 years for the older group), healthy, on no medication and had no history of 
cardiovascular disease. Subjects were required to refrain from alcohol and 
strenuous exercise for 24 hours prior to the study and from caffeinated drinks 
such as coffee, tea and coke for 12 hours before. Females were not included in 
the experiment to exclude any effect of the menstrual cycle or oral contraceptive 
pill. 
The experiments were approved by the University of Birmingham Life and 
Health Sciences Ethical Review Committee. Procedures were explained to the 
subjects before they agreed to participate and gave informed consent. 
2.2 General experimental conditions and equipment 
All experiments were performed in a room with a constant temperature of 21-
24C, with noise and visual distractions kept to a minimum. Subjects were 
seated facing away from the data acquisition equipment so as to minimise any 
distractions. 
Subjects were seated on a clinical examination couch with the backrest at 
approximately 45 to the horizontal with both upper limbs resting on a pillow at 
around heart level. Exercise was carried out using the subject’s dominant arm. 
Where required, venous occlusion plethysmography was also performed on this 
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arm to measure forearm blood flow (FBF) and a cannula was inserted in an 
antecubital vein to obtain venous blood samples (see below). The contralateral 
arm was used to measure blood pressure, heart rate and skin blood flow (see 
below). 
2.2.1 Exercise 
Each subject performed exercise by using a hand-grip dynamometer with a 
voltage output (Lafayette 70718, Loughborough, UK), which was linked to a 
computer to give accurate measurements of peak force and duration of the 
contraction. The 100% maximum voluntary contraction (MVC) for each subject 
was determined at the start of the first experimental day by asking the subject to 
grip the dynamometer as hard as possible for 2 seconds and 100% MVC was 
taken as the force at the end of this 2 second contraction to remove any effect 
of the initial snatch of the dynamometer. An average of 3 such readings was 
taken as 100% MVC for the remainder of the protocol.  
For the studies in Chapters 4 and 5, a pilot study showed that our subjects were 
unable to maintain a static contraction at 60% MVC for 2 minutes as used 
previously in this laboratory (Win & Marshall, 2005), therefore 50% MVC was 
chosen for the exercise protocol in these studies. 
2.2.2 Measurement of blood flow 
Forearm blood flow was measured by using venous occlusion 
plethysmography, as has been used in previous experiments in this laboratory 
(Fordy & Marshall, 2004; Win & Marshall, 2005). To this end, a mercury-in-
silastic strain gauge was placed around the forearm at the point of the largest 
circumference to measure changes in the forearm circumference. A paediatric 
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sphygmomanometer cuff was placed around the wrist and inflated to 
>150mmHg to occlude blood flow to the hand just prior to measurement of FBF. 
This excludes a large component of the cutaneous circulation thereby focussing 
measurements on the skeletal muscle of the forearm. A second, adult 
sphygmomanometer cuff, which was placed around the upper arm, was inflated 
to 50mmHg to occlude venous return from the forearm but still allow arterial 
inflow in order to obtain a recording of FBF. The wrist cuff was inflated manually 
using a hand-pump (Mityvac, St. Louis, USA) approximately 10 seconds prior to 
measurements being taken and the upper arm cuff was inflated using an 
automatic cuff inflator and air source (Hokanson E20 and AG101 respectively, 
Washington, USA).  
At the beginning of each experimental session, with the strain gauge in place, 
the plethysmography was calibrated 3 times by producing a deflection on the 
trace equal to a change of 1% of forearm volume.  
Blood flow was calculated offline by calculating the average slope for the initial 
linear portion of the plethysmography trace following inflation of the upper arm 
cuff. This value was then divided by the average of the 3 calibration deflections 
and multiplied by 60 to give a value of blood flow in units of ml.100ml tissue-
1.min-1. Forearm vascular conductance (FVC) was also calculated as a measure 
of vasodilatation by dividing FBF by mean arterial blood pressure, which was 
averaged over 10 seconds at same time as plethysmography trace was 
analysed for FBF. The recording of arterial blood pressure is described below.  
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2.2.3 Delivery of 40% oxygen or room air 
Subjects were given either 40% O2 or room air through a secure facemask 
(Intersurgical, Wokingham, UK), with all protocols designed so that the subject 
was unaware which gas he was breathing. The 40% O2 mixture was obtained 
by using two commercially available O2 concentrators (Oxygen Leisure 
Products Ltd, London, UK). Briefly, they each concentrate room air and produce 
5L.min-1 of 95% O2. This was directed through rubber tubing to a Venturi valve 
attached to the facemask. The valve is designed so that when 10 L.min-1 
oxygen is pumped through it draws ~25 L.min-1 of room air into it giving a total 
flow of 35 L.min-1 at a final O2 concentration of ~40%. As a control intervention, 
room air was pumped through a similar mask and Venturi valve system by a 
Reciprocator Pump (Stanhope Seta Ltd, Denmark). The gas delivery was set up 
before the subject arrived so he was unaware which mixture he was breathing. 
When no gas intervention was being administered, the mask remained in place 
with the subject breathing ambient room air (i.e. there was no flow through the 
mask). 
2.2.4 Measurement of heart rate and blood pressure 
Arterial blood pressure (ABP) was monitored continuously using a Finapres cuff 
connected to a Finapres monitor (Ohmeda 2300, Englewood, USA), which was 
placed on the middle finger of the non-exercising hand and connected to a PC 
via a Maclab (Maclab, AD instruments, Hastings, UK). From the ABP trace, 
heart rate (HR) was calculated on-line by ChartPro 5 software (AD instruments, 
Hastings, UK) using the time interval between consecutive systolic peaks. All 
data was collected on a PC via Maclab hardware. 10 seconds traces were 
taken at the same point as each FBF measurement for calculation of FVC as 
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described above. HR and MABP were also measured in 30 second blocks 
before, during and after exercise. 
2.2.5 Blood sampling 
A 20 gauge IV cannula (BD Venflon, Becton Dickinson Infusion Therapy, 
Helsingborg, Sweden) was inserted into a vein in the antecubital fossa of the 
exercising arm. The cannula was placed proximal enough that it would not 
interfere with the placement of the mercury-in-silastic strain gauge used for 
venous occlusion plethysmography. A 3-way extension valve (BD Connecta, 
Becton Dickinson Infusion Therapy, Helsingborg, Sweden) was attached to the 
cannula. The procedure used for blood sampling was that 2.5ml blood was 
quickly removed and disposed of to ensure the blood actually sampled was 
representative of the venous blood at the intended moment in time. 5ml blood 
was then drawn into a 10ml syringe (using a larger syringe reduces the 
withdrawal pressure required and therefore reduces the risk of haemolysis). 
This sample was used to anaerobically fill a 170l heparinised capillary tube 
which was capped on either end; a metal flea was placed in the tube to allow 
mixing and stop clotting. This tube was placed on ice for blood gas analysis 
after the experiment had finished (see below). The remainder of the 5ml blood 
was transferred to a vacutainer (yellow-capped Vacuette, Kremsmuenster, 
Austria) and placed on ice. The cannula was then flushed with 7ml 0.9% sodium 
chloride solution (Maco Pharma, Twickenham, UK) to prevent clotting. At the 
end of the experiment, the 5ml vacutainer of blood was centrifuged for 15 
minutes at ~3500rpm to separate the blood components and the serum was 
extracted and snap frozen in liquid nitrogen before being stored at -80C for 
later analysis. 
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2.3 Analysis of venous blood samples 
Blood samples were stored in heparinised capillary tubes on ice as described 
above until the subject finished the protocol. Following this samples were 
analysed using an automated blood gas analyser (GEM Premier 4000, 
Instrumentation Laboratory Ltd.) to obtain measurements for pO2, pCO2, K+ and 
lactate concentrations and pH. A pilot study was performed to investigate the 
effect of storing blood samples on ice. A venous blood sample was taken from a 
cannula and transferred to five separate capillary tubes. One tube was analysed 
immediately, whilst the remaining four were placed on ice, with one sample 
analysed every 30 minutes until 2 hours post-sampling. This was repeated with 
5 separate venous blood samples. This pilot study showed no change in any of 
the variables measured in blood gas analysis over the course of 2 hours, 
compared to when analysed immediately after sampling. 
2.5 Statistical analysis 
All data are expressed as the meanS.E.M. of the subjects. Statistical analysis 
was carried out using SPSS 17.0 for Mac.  
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CHAPTER 3: FOREARM SKELETAL MUSCLE BLOOD FLOW IS NOT 
COMPLETELY OCCLUDED BY STATIC HANDGRIP EXERCISE AT 100% 
MAXIMUM VOLUNTARY EFFORT 
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3.1 Introduction 
It has long been hypothesised that the mechanical forces developed within the 
muscle during contraction may act to constrict the blood vessels, thus reducing 
the O2 delivery. However, efforts to investigate this effect have been hampered 
by experimental difficulties and by apparent differences in the muscle group 
examined. One of the most frequently cited references is that of Humphreys 
and Lind (1963), who investigated forearm blood flow during sustained handgrip 
exercise. Four subjects performed exercise until fatigue at intensities from 30-
70% MVC, in 10% increments. Gross limb blood flow was measured using 
venous occlusion plethysmography, a technique unsuited to use during 
exercise, as discussed in Chapter 1. Their results showed a clear graded 
increase in blood flow with increasing exercise intensity until 60% MVC, but 
found that artefacts from muscle tremors precluded accurate measure of blood 
flow at 70% MVC. By extrapolating the levels of hyperaemia at lower intensities, 
the authors concluded that forearm occlusion would occur at some point greater 
than 70% MVC. Similarly Barnes (1980) also used venous occlusion 
plethysmography to measure blood flow 15 seconds into handgrip exercise at 
intensities from 10-80% MVC. He reported that exercise blood flow increased 
above resting values until 20% MVC, then began to decrease, with intensities 
over ~30% MVC resulting in sub-resting values. This supports other findings 
that contractions of greater than 60% MVC completely occlude intramuscular 
circulation (Royce, 1958; Clark, 1962).  
More recently, Kagaya and Homma (1997) used pulse-echo Doppler ultrasound 
to measure brachial artery blood flow during handgrip exercise in 7 young 
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women. They observed no change in brachial artery blood flow at any load from 
10-70% MVC (20% increments), although they did find that post-exercise blood 
flow increased at intensities above 10% MVC and further increased at 70% 
compared to 50% MVC. They interpreted this to show an increasing imbalance 
between O2 supply and demand within the forearm musculature, possibly due to 
partial occlusion. In contrast to the forearm, it has been reported that blood flow 
in calf muscle is occluded at much lower relative intensities, with Richardson et 
al. (1981) reporting that occlusion occurs as low as 30% MVC . However, these 
results were obtained with the calf below heart level, thus casting the validity of 
results obtained using plethysmography into doubt (see Section 1.4).  
In recent years newer methodologies have been utilised in an attempt to control 
for some of the difficulties inherent with using plethysmography during exercise. 
Wigmore et al. (2004) used functional MRI (fMRI) to investigate the relationship 
between intramuscular pressure and perfusion during ankle dorsiflexion. This 
technique allows visualisation of perfusion in regions of the muscle rather than 
global observations. They observed a plateau in hyperaemia at around 60% 
MVC and therefore suggested that this is the force at which complete occlusion 
occurs. 
Previous work from our laboratory seems to contrast with the idea of occlusion 
occurring at high intensities of exercise (Fordy & Marshall, 2004; discussed fully 
in Section 1.2.3.1). This study demonstrated that breathing supplementary O2, 
only during a bout of handgrip exercise at 100% maximum voluntary effort 
(MVE), attenuated post-contraction hyperaemia. Thus we can infer that there 
was at least adequate perfusion of the muscle. Moreover, given that the O2 
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reduced the level of exercise hyperaemia, we can conclude that the O2 is 
specifically reaching areas of active muscle. This is not due to any effect of 
supplementary O2 reducing levels of fatigue as peak force and rate of force 
decline were unaffected. Further, it has been shown that even when force 
declines due to fatigue, there is no effect on levels of hyperaemia measured 
immediately post-contraction (Wigmore et al., 2006). 
Recently a number of groups have investigated the usefulness of Near Infra-
Red Spectroscopy (NIRS) in monitoring blood flow to active skeletal muscle 
(Boushel & Piantadosi, 2000; van Beekvelt et al., 2001a; van Beekvelt et al., 
2002). NIRS is non-invasive, continuous and can operate in real time (Boushel 
& Piantadosi, 2000) and has been used to measure changes in skeletal muscle 
tissue oxygenation (Abozguia et al., 2008). It works by measuring the 
absorption of near infrared light by the iron content of haemoglobin and 
myoglobin. Work by van Beekvelt and colleagues (van Beekvelt et al., 2001a; 
van Beekvelt et al., 2002) has demonstrated that NIRS works well even during 
handgrip exercise.  
The rationale for the study in this chapter was to determine whether skeletal 
muscle circulation is occluded during maximum handgrip exercise. We felt that 
NIRS would be well suited to investigating this question. This is important in 
relation to the studies in this thesis, as if it was shown that skeletal blood flow is 
totally occluded during exercise this would invalidate the methodology of 
administering supplemental O2 during the period of contraction only. However, if 
the muscle is not occluded at 100% MVE as used in previous studies from this 
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laboratory (Fordy & Marshall, 2004), it is a reasonable assumption that it is not 
occluded at 50% MVC.  
3.1.1 Hypotheses 
1. Muscle blood flow still occurs in active muscle, even during the initial 
stages of handgrip exercise at 100% MVE. 
We tested this hypothesis by using NIRS to measure the oxygenation of the 
flexor digitorum superficialis muscle, which is one of the major muscle groups 
active during handgrip exercise (Humphreys & Lind, 1963; van Beekvelt et al., 
2002). We compared the level of oxygenation during sustained contraction at 
100% MVE and during complete forearm circulatory occlusion at rest with a 
sphygmomanometer inflated to 200mmHg. We anticipated that if muscle 
circulation were occluded during contraction, the change in haemoglobin O2 
saturation in muscle would be greater than that seen in arterial occlusion, due to 
the increased metabolic demand of the active muscle compared to resting 
muscle.  
3.2 Methods 
10 healthy young subjects attended the laboratory on two separate occasions. 
At the beginning of the first visit, the subject was familiarised with the equipment 
and given an opportunity to ask any questions. Subjects were seated 
comfortably on an examination couch at an angle of ~45 with their forearms 
supported in front of them on a pillow. Forearm circumference was measured 
around the thickest part of their forearm and MVC was measured as described 
in Chapter 2. An OxiplexTS NearInfrared tissue oximeter (ISS Inc., Champaign, 
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IL, USA) was used for measurement of skeletal muscle oxygenated 
haemoglobin (Oxy-Hb), deoxygenated haemoglobin (deoxy-Hb) and total 
haemoglobin (HbT). The source-detector distance was 30-44mm to limit the 
contribution of skin and non-muscular subcutaneous tissue to measurements 
taken. The probe was fitted securely over the flexor digitorum superficialis 
muscle of the dominant forearm. 
A facemask was fitted to the subject, although initially no gas was switched on. 
Following a 15 minute rest period subjects were required to perform a single 
static handgrip contraction at maximum voluntary effort (i.e. gripping as hard as 
possible) for 2 minutes or until exhaustion if sooner. During the period of 
contraction only, subjects breathed either 40% supplemental O2 or room air 
such that they were unaware of the experimental gas mixture. Study days were 
randomised in a single blinded manner. The 2 minute cut-off was chosen as this 
had been found to be greater than the time to voluntary exhaustion in the 
majority of young subjects (data discussed in Chapter 6). Subjects then 
recovered for 7 minutes to allow perfusion to return to baseline before a 
sphygmomanometer cuff was inflated around the upper arm at 200mmHg for 3 
minutes at rest. This timescale was chosen in line with the protocol used by 
other members of the laboratory. NIRS recordings were made throughout. 
3.2.1 Analysis 
Data was analysed using SPSS for mac (version 17.0). Baseline for exercise 
was taken as the average of the resting measurements and baseline for 
occlusion was taken as the peak reached during recovery. Changes from 
baseline were measured to the greatest change during exercise and occlusion. 
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Changes from baseline, differences between changes in exercise and occlusion 
and differences between air and O2 breathing in exercise were analysed using 
repeated measures ANOVA. Two comparisons were made for time (exercise 
and occlusion against baseline) and one comparison for exercise vs. occlusion. 
Correlations were analysed using a two-tailed bivariate correlation with 
Pearson’s correlation coefficient. 
3.3. Results 
3.3.1 Subject characteristics 
Subjects were aged 28.6±1.6 (mean±S.E.M). They had an average forearm 
circumference of 26.1±0.9cm and were able to produce a mean maximum force 
of 28.6±3.3kg. 
3.3.2 NIRS changes in exercise 
On commencing handgrip exercise, haemoglobin O2 saturation and 
oxyhaemoglobin concentrations rapidly decreased, reaching a nadir by 30 
seconds. Levels then remained around this level or slightly higher for the 
remainder of exercise. Deoxyhaemoglobin concentrations followed an inverse 
of this pattern, reaching a peak by 30 seconds and then falling slightly for the 
remainder of exercise. Force produced during exercise remained at peak force 
for 10-15 seconds before gradually declining over the remainder of the exercise 
period.  
Table 3.1 shows the mean ± SEM values for variables measured by NIRS in 
rest, exercise, recovery and occlusion. Figure 3.1 shows the maximum change 
in deoxyhaemoglobin and oxyhaemoglobin concentration during handgrip 
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exercise at 100%MVE until exhaustion and during complete occlusion for 3 
minutes. There was a large variation in the maximum change of 
deoxyhaemoglobin from baseline between subjects, with the mean±S.D. being 
25.4±20.7 for exercise and 34.7±21.7 for occlusion. Due to this variation, the 
increase from baseline and the difference between exercise and occlusion was 
not significant (p=0.325). However, levels of oxyhaemoglobin decreased 
significantly (p<0.001) from baseline in both exercise and occlusion. There was 
no significant difference in oxyhaemoglobin during forearm circulatory occlusion 
compared to during exercise (p=0.088). 
Changes in haemoglobin O2 saturation are shown in figure 3.2. O2 saturation 
fell significantly during both static handgrip exercise and during forearm 
circulatory occlusion (p<0.001). The decrease during occlusion was greater 
than that seen in handgrip exercise (p=0.043), despite the O2 requirements in 
exercise being greater than the requirement during occlusion at rest.  
Breathing supplemental 40% O2 during contraction compared to room air had 
no effect on changes in any NIRS measurements. Peak exercise change in 
haemoglobin O2 saturation was 25.7±4.7% in air (mean±S.E.M.)  vs. 20.1±3.5% 
when O2 was breathed (p=0.16). Similarly, peak changes in oxyhaemoglobin 
concentration were 17.7±2.7% in air vs. 18.0±3.8 in O2 (p=0.94) and peak 
changes in deoxyhaemoglobin concentration were 25.4±6.6 in air vs. 22.0±4.8 
in O2 (p=0.68). 
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3.3.3 Correlations between forearm circumference, strength and change in 
haemoglobin O2 saturation 
Figure 3.3 shows the relationship between forearm circumference and peak 
force in handgrip exercise. There was a highly positive relationship, such that 
subjects with an greater forearm circumference produced a greater peak force 
(Pearson correlation coefficient = 0.919; p<0.001).  
Figure 3.4 shows the relationship between peak force in handgrip exercise and 
the maximum change in haemoglobin O2 saturation seen during handgrip 
exercise at 100% MVE. There is a weakly positive correlation (Pearson 
correlation coefficient = 0.291) which does not reach statistical significance. 
Similarly, the relationship between forearm circumference and the maximum 
change in haemoglobin O2 saturation seen during handgrip exercise at 100% 
MVE (not shown) was positive but not significant (Pearson correlation 
coefficient = 0.328). 
3.4. Discussion 
The main findings of this study were that the change in haemoglobin O2 
saturation did not decrease as much during static handgrip at 100% MVE until 
exhaustion as it did during total forearm circulatory occlusion. This was despite 
the fact that we can expect the O2 requirement during exercise to be greater 
than that during occlusion at rest. In agreement with our hypothesis, this 
indicates that blood flow to active muscle must continue even during exercise at 
maximal voluntary effort. Breathing supplemental O2 during exercise had no 
effect on changes in any of the variables measured by NIRS. In addition, our 
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data show a highly positive correlation between forearm circumference and 
muscle strength. Although the study was not designed to investigate this effect 
and therefore was underpowered, there was a positive correlation between both 
forearm circumference and peak force and the maximum change seen in 
haemoglobin oxygen saturation. This suggests that there may be greater levels 
of circulatory occlusion in subjects who are able to produce greater force.  
3.4.1 Circulatory occlusion during exercise 
Previous research investigating whether skeletal muscle circulation is occluded 
has had differing results depending on the technique used and the muscle bed 
investigated. It appears that in calf muscle, occlusion occurs at relatively low 
intensities of exercise (Richardson, 1981). Early studies investigating forearm 
muscle during handgrip used venous occlusion plethysmography. Royce (1958) 
and Clark (1962) calculated the level of complete occlusion as occurring at 60% 
MVC, whereas Humphreys and Lind (1963) extrapolated data measured up to 
60% MVC and calculated that occlusion would occur at around 70% MVC. 
Finally Barnes (1980) calculated that in contractions greater than 30% MVC the 
blood flow had decreased to levels below resting values. Venous occlusion 
plethysmography has the advantage that it measures blood flow primarily to 
skeletal muscle in the forearm. However, due to the fact that the variable 
measured is the change in circumference of the limb under investigation, it is 
not ideally suited to measurements taken during periods of contraction.  
More recently the technique of pulse echo Doppler ultrasound has been utilised 
(Kagaya & Homma, 1997). This technique calculates the diameter of the artery 
supplying a limb (in this case the brachial artery) and the velocity of the blood 
 89 
flowing through it to give a measure of limb blood flow. Kagaya and Homma 
(1997) found no change in blood flow through the brachial artery at exercise 
intensities of between 10% and 70% MVC. However, this is possibly to be 
expected as there would need to be significant force production to occlude the 
brachial artery. Therefore it seems likely that any occlusion that does occur will 
occur locally at the level of the active muscle rather than the entire limb.  
Local muscle occlusion has been measured to some extent using the new 
technique of functional MRI with Wigmore (Wigmore et al., 2004) using it to 
investigate blood flow in the ankle dorsiflexors. They observed an increasing 
hyperaemia at intensities up to 60% MVC before it plateaued at around 50% of 
the reactive hyperaemia seen after 5 minutes of occlusion. They interpreted this 
as being the level at which complete occlusion occurs, although given that they 
still observing these maximal levels of blood flow at 90% MVC, it is equally 
probable that the hyperaemia seen at 60% MVC represented the maximum 
level of hyperaemia in response to ankle dorsiflexion. 
To our knowledge, there have not been any studies that have used reliable 
techniques to investigate local levels of occlusion in forearm muscle during 
handgrip exercise. Previous work from our laboratory has provided some 
indirect evidence that there is not complete occlusion of forearm vasculature to 
the active muscles (Fordy & Marshall, 2004). In that study, 40% O2 breathed 
during the period of contraction only was able to have an effect on the 
magnitude of post-exercise hyperaemia, therefore blood flow must have been 
reaching the active muscle. As noted above (section 3.1), this was not due to 
any effect of O2 on force production or fatigue levels. 
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The present study repeated the handgrip exercise protocol used by Fordy 
(2004) using NIRS to investigate blood flow. This is a technique which has been 
used to measure forearm blood flow and found to be reproducible (van Beekvelt 
et al., 2002). Advantages of using this technique were that it allowed real time 
visualisation of the active flexor digitorum superficialis muscle. By using a 
source-detector distance of 30-44mm we limited the contribution made by skin 
and non-muscular subcutaneous tissue to the measurements made. We 
demonstrated that the magnitude of the decrease in haemoglobin O2 saturation 
that occurred during exercise was not as great as that seen during forearm 
occlusion. This indicates that blood flow to the active muscle was not 
compromised during handgrip exercise at 100% MVE. Indeed, the results 
presented in figure 3.2 do not show the entire picture, as we can expect the rate 
of O2 uptake to be greater during the exercise protocol than the occlusion 
protocol.  
3.4.2 Impact of force production on levels of occlusion 
It would appear logical that if there is any occlusion taking place within active 
muscle, greater force production by the muscle would produce greater levels of 
occlusion. In the studies described above, there is some evidence that this is 
the case. Barnes (1980) examined 20 active young men performing static 
handgrip exercise. He then split them into the ten strongest and ten weakest 
and found evidence that occlusion was occurring at lower levels of MVC in the 
10 stronger subjects, thus levels of occlusion were dependent on absolute force 
rather than relative force. This supported earlier findings that stronger subjects 
occluded at 45% MVC compared to 60% in weaker subjects (Heyward, 1975). 
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However, Wigmore and colleagues (2006) more recently used levels of fatigue 
as a surrogate for blood flow, determining that occlusion of blood flow would 
produce greater levels of fatigue. They observed no correlation between levels 
of fatigue and either muscle volume or initial peak strength. Although this study 
was not designed to investigate the relationship between muscle size and 
strength and the levels of occlusion, the results shown in figure 3.4 and 
discussed above do give us some insight. Although the results did not reach 
statistical significance, the data show a small positive correlation between 
muscle strength and the decrease in haemoglobin O2 saturation and a medium 
positive correlation between forearm circumference and the decrease in 
haemoglobin O2 saturation. As the current study used the magnitude of the fall 
in haemoglobin O2 saturation as a measure of occlusion, this indicates that 
there is likely to be an effect of muscle size and strength on the relative level of 
occlusion seen, although as discussed above we have no evidence of a total 
occlusion occurring. 
3.4.3 Effect of supplemental O2 on NIRS variables 
This study found no evidence of any difference in changes in haemoglobin O2 
saturation, oxyhaemoglobin or deoxyhaemoglobin concentrations during 
exercise when 40% supplemental O2 was breathed during contraction 
compared to air breathing. This concurs with findings by Ekblom et al. (1975) 
showing that there is only a small change in haemoglobin O2 saturation from 
98-99% to 100% when 50% O2 is breathed. In their study they found that the 
majority of the changes which occur are a result of PaO2 rising from ~98 to 
240mmHg, which would not be picked up by NIRS which concentrates 
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specifically on haemoglobin and myoglobin O2 saturation. Of interest in the 
context of the studies described in the following chapters is the finding that this 
presumed increase in PaO2 caused by breathing 40% O2 did not appear to have 
any effect on levels of tissue oxygenation. The possible implications of these 
results are discussed in detail in Section 4.4.2.  
3.4.4 Critical evaluation of experimental protocol 
Although the NIRS methodology was chosen due to the ability to measure 
changes in haemoglobin and myoglobin in real time, some limitations are 
caused due to the small sample area. Firstly, measurements made with NIRS 
correspond to local changes within an area of the active muscle, not to changes 
within the whole muscle. Therefore, we cannot rule out the possibility that the 
measurements taken in this study miss the most active areas of muscle and 
that there may be small local areas of occlusion. Secondly, it is possible that the 
changes shown during exercise are underestimated due to the area of 
measurement encompassing areas of muscle not actively involved in 
contraction as well as contracting muscle. Finally, the data in the present study 
was was based on measurements of the flexor digitorum superficialis muscle. 
This was based on data showing that this muscle is active during handgrip 
exercise (Humphreys & Lind, 1963). However, we again cannot rule out the 
possibility that other muscles involved in handgrip are more effected by 
occlusion. 
 A further limitation of the current protocol concerns the appropriateness of 
comparing the exercise and occlusion interventions. This protocol was chosen 
in an attempt to answer whether forearm occlusion occurred during an exercise 
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protocol used previously in this laboratory (Fordy 2004). The first potential 
limitation concerns the use of 100% MVE handgrip exercise. Although the force 
is the maximum the subject is able to achieve throughout the entire contraction, 
the absolute force achieved begins to drop from approximately 10 seconds into 
the protocol. The possibility remains that the level of occlusion seen during 
exercise is underestimated due to the reduction in absolute force during the 
protocol. The second limitation concerns differences in time between exercise 
and occlusion, as the timescale for peak changes in NIRS variables to occur 
was different between the two interventions. This potentially confounds 
interpretation of data as it may be that a small level of occlusion occurs during 
the initial stages of exercise, but is missed by comparing NIRS changes with 
those seen after 3 minutes occlusion. For future work, both potential limitations 
could be alleviated by picking an exercise protocol that involves subjects 
maintaining a set force for a given time, then matching the length of occlusion to 
this. A different approach to answering the question of whether occlusion occurs 
during exercise could be to compare NIRS changes during exercise at the same 
force, with and without forearm occlusion.  
3.4.5 Summary 
In conclusion, the present study has demonstrated that significant blood flow 
occurs to active muscle even during the initial stages of maximal static handgrip 
exercise, when peak force is achieved. This validates our method of 
administering supplementary O2 during the period of contraction only (as used 
in Chapters 4 and 5), as we can reasonably assume that there will also be 
significant blood flow when performing exercise at 50% MVC.
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CHAPTER 4: THE O2-DEPENDENCE OF PROSTAGLANDINS IN MEDIATING 
EXERCISE HYPERAEMIA 
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4.1 Introduction 
As described in Chapter 1, vasodilator prostaglandins produced by the COX 
enzyme have been found to play a role in hyperaemia during and after exercise 
by some groups (e.g. Kilbom & Wennmalm, 1976; Duffy et al., 1999; Win & 
Marshall, 2005), but not all (Shoemaker et al., 1996a). For a summary see 
Table 1.2. Other groups have found evidence of vasodilator COX products 
playing an interdependent role with other substances such as NO (Mortensen et 
al., 2007), adenosine (Mortensen et al., 2009b; Nyberg et al., 2010) and ATP 
(Mortensen et al., 2009a).  
Previous findings from this laboratory showed that in fit recreationally active 
young male subjects, COX inhibition with aspirin reduced the vasodilatation 
caused by 2 minutes of static handgrip exercise at 60% MVC by 40-50% (Win & 
Marshall, 2005). This reduction in post-exercise hyperaemia could be replicated 
by administering 40% supplementary O2 before, during and after the exercise 
and there was no additive effect when COX inhibition and hyperoxia were 
combined. This implies that a vasodilator COX product produced or acting in an 
O2-dependent manner mediates a portion of post-exercise hyperaemia (see 
Figure 1.1). Since venous blood samples were not collected in this study these 
possibilities could not be differentiated. In previous studies, PGI2 and PGE2 
have been assayed in venous efflux and interstitium and have been implicated 
in exercise and post-exercise hyperaemia (Symons et al., 1991; Wilson & 
Kapoor, 1993b; Karamouzis et al., 2001a; Karamouzis et al., 2001b). Recent 
data also suggests that the site of production of PGI2 and PGE2 may be 
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different, with PGI2 being produced by the endothelium and PGE2 produced by 
the skeletal muscle (Testa et al., 2007; Nyberg et al., 2010).  
In their discussion, Win and Marshall (2005) proposed that the stimulus for 
prostaglandin production is a fall in pO2 at the level of the endothelium. This 
seemed the most likely explanation, for in healthy young subjects haemoglobin 
saturation would be ~98-99% and so supplementary O2 would only increase the 
arterial partial pressure of O2 (PaO2) from ~100mmHg to ~240mmHg without 
having a significant effect on O2 carriage. It was judged that a relatively small 
increase in arterial O2 content would be unlikely to have much effect on the pO2 
at the level of the skeletal muscle fibre. However, recent data (see Chapter 
1.2.3.1) showed that the pO2 within muscle fibres is ~34mmHg at rest 
(Richardson et al., 2006). In light of earlier findings that muscle fibre pO2 falls to 
~3mmHg when performing increasing dynamic leg exercise and capillary pO2 is 
~37mmHg at maximal exercise (Richardson et al., 1995; 2001), it is now clear 
that a large O2 gradient develops between the capillary and the skeletal muscle 
fibre in exercise. Thus we hypothesise that increasing the pO2 in the capillary by 
administering hyperoxic gas would increase this gradient and could lead to 
greater diffusion of O2 into the muscle. Based on the findings that skeletal 
muscle produces PGE2 (Testa et al., 2007; Nyberg et al., 2010), we can 
hypothesise that this will be the prostanoid affected. Indirect evidence of 
whether supplementary O2 is effective at the level of the muscle fibre could be 
obtained with blood gas analysis of venous blood samples. If supplementary O2 
does ameliorate hypoxia, it is a reasonable hypothesis that this would result in a 
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reduction in lactate production and a reduction in the acidosis which occurs 
when ATP breakdown exceeds resynthesis (Robergs et al., 2004).  
Further work from this laboratory has investigated the timing of supplementary 
O2 which causes this attenuation of post-exercise hyperaemia (Fordy & 
Marshall, 2004). The major findings of this research (see Chapter 1.2.3.1) were 
that O2 only has this effect when administered during the period of contraction, 
and that administration during recovery or preloading the muscle with O2 prior to 
exercise had no effect on the levels of post-exercise hyperaemia. Therefore we 
hypothesise that an O2-dependent mediator of post-exercise hyperaemia is 
produced during the period of exercise. 
Regarding the effect of ageing on exercise and post-exercise hyperaemia, 
some groups have shown a reduced vasodilatation during or after exercise 
(Proctor et al., 1998; Carlson et al., 2008), whilst others have found no 
alteration compared to younger subjects (Jasperse et al., 1994) (See Chapter 
1.2.4). In the context of prostaglandin mediated exercise hyperaemia, Schrage 
et al. (2004; 2007) showed that COX inhibition in young subjects reduced 
exercise hyperaemia evoked by dynamic forearm exercise at 10% MVC  by 
~12%, whereas it has no effect in older subjects, thus ageing completely 
abolishes prostaglandin mediated exercise hyperaemia. In addition, there is 
evidence that production of vasodilator prostaglandins is switched to production 
of vasoconstrictor prostanoids in older rats (Tang & Vanhoutte, 2008), as well 
as humans with hypertension (Taddei et al., 1993). However, neither of these 
studies directly measured production of vasodilator and vasoconstrictor 
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prostanoids and this switch in prostanoid production has not been investigated 
in young and older healthy human subjects. 
4.1.1 Hypotheses 
1. In recreationally active young men, prostaglandins contribute to post-
exercise hyperaemia in an O2-dependent manner following both static 
and dynamic handgrip exercise.  
2. This O2-dependence is mediated by hypoxia within the skeletal muscle.  
3. The contribution of dilator prostaglandins to mediating post-exercise 
hyperaemia is reduced in older subjects.  
4. The magnitude of hyperaemia is not altered by ageing .  
We tested these hypotheses by measuring blood flow before and after handgrip 
exercise in healthy young and older subjects. Over four separate visits subjects 
were randomly assigned to COX inhibition with aspirin or placebo and breathed 
either 40% O2 or room air through a facemask during the period of exercise 
only. Venous blood samples were obtained for measurement of venous PGE 
metabolites and venous blood gases. 
We anticipated that both aspirin and breathing supplementary O2 would reduce 
the magnitude of post-exercise hyperaemia and the venous efflux of PGE 
metabolites in young subjects but not in older subjects. We anticipated that 
ameliorating hypoxia within skeletal muscle with supplementary O2 would result 
in a reduction in the venous concentrations of lactate and hydrogen ions. 
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4.2 Methods 
12 young (21.5+/-0.4 years) and 12 older (60.5+/-5.7 years) subjects attended 
the laboratory on 4 separate days, at least a week apart. Subjects were set up 
and MVC was measured on the first visit as described in chapter 2. Either 40% 
O2 or room air was breathed through a mask during the period of contraction 
only, for the rest of the protocol, subjects breathed room air without a mask. 
Once the subject was seated comfortably, 600mg aspirin in 250ml orange 
squash or 250ml orange squash alone as a placebo was administered. Subjects 
then rested for 30 minutes prior to the first period of exercise, as this has been 
shown to cause maximal inhibition of the COX enzyme (Heavey et al., 1985). 
The order of all interventions was randomised in a single-blinded manner, such 
that upon completion of the study all subjects had received air/placebo (i.e. 
control), air/aspirin, O2/placebo and O2/aspirin.  
On the first visit to the laboratory, the subject was familiarised with the 
equipment and given an opportunity to ask any questions. The activity 
questionnaire was administered at this point. 30 minutes after administration of 
the aspirin or placebo a venous blood sample was taken and three recordings 
of baseline FBF were made by venous occlusion plethysmography. The 
facemask was then fitted to the subject although the gas was not switched on. 
The subject then began the period of static exercise at 50% MVC for two 
minutes, with the experimental gas mixture pumped through the facemask 
during the exercise period only. Immediately after the subject released the 
dynamometer another recording of FBF was taken. By inflating the wrist cuff in 
the last 10 seconds prior to cessation of exercise, it was possible to consistently 
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take these measurements at ~1 second after relaxation of the contraction. This 
therefore allowed as close an estimation of true exercise hyperaemia as 
possible using venous occlusion plethysmography. A venous blood sample was 
taken immediately following the measurement of FBF (approximately 10-15 
seconds after completion of the exercise). Further venous blood samples and 
FBF recordings were taken at 3 and 6 minutes after the end of the exercise. 30 
minutes following the first period of exercise this protocol was repeated with the 
subject performing two minutes of rhythmic exercise at 50% MVC, at a rate of 1 
second contraction/1 second relaxation.  
4.2.1 PGE metabolite assay 
Serum was extracted from venous blood samples and stored as explained in 
the general methods (section 2.2.5). Samples taken at rest and immediately 
following static exercise from all subjects were assayed using a Prostaglandin E 
metabolite EIA Kit (Cayman Chemicals, Ann Arbor, MI). Due to the rapid 
metabolism of PGE2, this assay converts the metabolites of PGE into a single 
stable derivative, which can then be quantified.  
The assay was performed as per the manufacturer’s instructions. Briefly, 
samples were derivatized overnight with carbonate buffer, before being 
phosphate buffer and EIA buffer were added (all buffers were supplied with the 
kit). Samples were not diluted as typical values for PGE2 given by the 
manufacturer were 3-12pg/ml (based on findings by Granstrom et. al. (1980)) 
and these values would occur in the most sensitive range of the assay. 50l of 
sample were combined with tracer and antibody and incubated for 18 hours; 
absorbance was then read using a colorimeter. These values were then used to 
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calculate the concentration based on the absorbance of known concentrations 
of assay standard. 
4.2.2 Analysis 
All data was analysed using SPSS for mac (version 17.0). Data are presented 
as mean  S.E.M.  
Differences between subject characteristics were analysed using an 
independent sample T-test, with the exception of activity levels and hours per 
week of activity due which were analysed using a Mann Whitney U test. 
FBF and FVC were analysed using 3-way repeated measures ANOVA with 
within-subject factors for gas breathed, drug intervention and time. Differences 
in FBF and FVC between young and old subjects were analysed using mixed 
between/within ANOVA using an additional between-subjects factor of age. 
Main factor effects are presented using Huyne-Feldt correction to control for any 
differences in variance between groups. In cases where significance was 
detected, Bonferroni adjustment was performed in order to locate where 
differences occurred within or between groups. 3 comparisons were made for 
time (3 post-exercise timepoints vs. rest), 1 comparison was made for gas (O2 
vs. air) and 1 for drug (aspirin vs. placebo).  
Heart rate and mean arterial blood pressure were analysed using repeated 
measures ANOVA with special contrasts defined to perform 3 pairwise 
comparisons of the 3 groups of time points (baseline, exercise and recovery).  
pO2, pCO2, pH and lactate were analysed using Generalised Estimating 
Equations to correct for data missing due to failure of cannulation (missing 
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values for entire experimental visit) or malfunction of the blood gas analyser 
(missing single values within visit). A table showing proportions of missing data 
points is included in Appendix 2. 
Tables showing data as Mean±S.E.M. are included in Appendix 3 for reference. 
4.3 Results 
4.3.1 Subject characteristics 
Subject characteristics are shown in Table 4.1. Young subjects were aged 
21.5±0.4 (mean +/-SEM) years old compared to 60.5±5.7 years for the older 
subjects. Young subjects had a mean forearm circumference of 25.7±0.7cm, a 
mean peak force of 32.6±2.1kg. This was similar to the older group, with a 
mean forearm circumference of 26.1±0.5cm and peak force of 32.8±1.8kg. 
Young subjects rated themselves as less active than older subjects on a 
subjective scale, although this difference was not significant (p=0.075). They 
also reported less hours of activity per week than the older subjects although 
this was not statistically significant (p=0.17). Both young and old subjects 
reported predominantly leg-based activity. 
4.3.2 Heart rate and MABP 
The heart rate and MABP responses for both young and old subjects in 
response to 2 minutes handgrip exercise are shown in Figure 4.1 (response to 
static exercise) and 4.2 (response to dynamic exercise). In young subjects, both 
heart rate and MABP were significantly greater during static exercise than 
during baseline or recovery (p<0.001). There was not a significant increase in 
heart rate from baseline during dynamic exercise (p=0.114) but there was a 
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significant decrease from exercise levels during recovery (p=0.03). MABP was 
raised in exercise compared to both baseline and recovery (p<0.001). There 
was no significant effect of breathing supplementary O2, aspirin or the two in 
combination on either heart rate or MABP. 
In older subjects, both heart rate and MABP were higher during exercise than 
baseline or recovery (static: all p<0.01; dynamic: all p<0.001). There was an 
interaction of gas and drug on MABP during the static exercise protocol 
(p=0.004), such that supplementary O2 and aspirin given in combination 
resulted in a lower MABP over the whole time course than the air/placebo 
control. There was otherwise no effect of either supplementary O2 or aspirin or 
combination on heart rate or MABP in older subjects. 
4.3.3 FBF and FVC 
Figure 4.3a and b show the FBF and FVC respectively for both young and older 
subjects before and after static exercise. There was no significant difference 
between resting blood flow with age (p=0.178). Static handgrip exercise at 
50%MVC for 2 minutes resulted in a significant rise in FBF measured 
immediately post-exercise in young subjects (Fig 4.3a; p<0.001). This rise was 
comparable in the older subjects (Fig 4.3a; p<0.001), with no significant 
differences in the peak values measured in the young or older subjects. Figure 
4.3a shows that in both groups the FBF fell from these peak values at 3 minutes 
and further at 6 minutes, although still remained increased from baseline 
(p<0.001 for young; p=0.027 for older). In young subjects there were no 
significant main effects of breathing supplementary O2 (p=0.63), taking aspirin 
(p=0.804) or the two combined (p=0.616). Similarly, there was no individual 
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effect of 40% O2 (p=0.278) or aspirin (p=0.897) in older subjects, although there 
was a significant interaction of gas and drug (p=0.047) for FBF following static 
handgrip exercise, which is attributable to the data for all the interventions being 
lower than the air/placebo control.  
Figure 4.3b demonstrates that the trend for changes in FVC was similar to that 
for FBF, indicating that the changes in FBF were due to changes in vascular 
tone. Similarly there were no significant main effects of 40% O2, aspirin or the 
two in combination in young (respectively p=0.843; p=0.899; p=0.725) or older 
subjects (respectively p=0.236; p=0.565; p=0.386). 
Dynamic handgrip exercise (Figure 4.4 a and b) elicited a similar pattern to 
static exercise; both FBF and FVC were increased immediately after exercise 
and fell by 3 and 6 minutes, whilst remaining higher than baseline. Similarly, 
there were no significant main effects of supplementary O2, aspirin or both 
combined in either young or older subjects. 
4.3.4 Venous blood gas analysis 
4.3.4.1 pO2 
Figure 4.5a&b show the values for venous pO2 before and after static and 
dynamic exercise. In young subjects both static and dynamic exercise resulted 
in a peak venous pO2 at 3 minutes post-exercise, such that pO2 was 
significantly elevated from both baseline and from immediately post-exercise 
(Fig. 4.5a; p<0.001); pO2 then began to return to baseline by 6 minutes post-
exercise. There were no significant main effects of breathing 40% O2 (static 
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p=0.968; dynamic p=0.647), aspirin (static p=0.549; dynamic p=0.566) or the 
two in combination (static p=0.265; dynamic p=0.926).  
As can be seen from Fig. 4.5b the pattern was similar in older subjects, with 
pO2 significantly peaking at 3 minutes post-exercise (p<0.001); the rise from 
baseline was also significant immediately post-exercise (p<0.001). As with 
young subjects, there were no significant main effects of supplementary O2, 
aspirin or both in combination. 
4.3.4.2 pCO2 
Figure 4.5c&d show the values for venous pCO2 before and after static and 
dynamic handgrip exercise. In both young (Fig. 4.5c) and older subjects (Fig. 
4.5d), both modes of exercise resulted in a peak venous pCO2 immediately 
post-exercise and returned to baseline by 3 minutes post-exercise (p<0.001 
compared to baseline and 3 minutes post-exercise).  
There were no significant main effects of supplementary O2, aspirin or both 
combined in either mode of exercise in both young and older subjects.  
4.3.4.3 Lactate 
Figure 4.6a&b show venous lactate concentrations before and after static 
handgrip exercise. In young subjects (Fig. 4.6a), venous lactate concentrations 
were raised from baseline at all time points following both static and dynamic 
exercise (p<0.001). There were no significant main effects of breathing 40% O2 
(static p=0.195; dynamic p=0.688), aspirin (static p=0.996; dynamic p=0.253) or 
the two in combination (static p=0.485; dynamic p=0.064).  
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The time-course of changes in venous lactate concentrations was the same in 
older subjects for both static and dynamic exercise (Fig. 4.6b; also p<0.001). As 
with young subjects, there were no significant main effects of supplementary 
O2, aspirin or both in combination. 
4.3.4.4 pH 
Both young (Fig. 4.6c) and older subjects (Fig. 4.6d) demonstrated similar 
changes in venous pH in response to static and dynamic exercise, such that pH 
was significantly decreased from baseline immediately post exercise (p<0.001), 
with pH returning towards baseline at 3 minutes and further recovered by 6 
minutes.  
There were no significant main effects of supplementary O2, aspirin or both 
combined in either mode of exercise in both young and older subjects.  
4.3.5 Venous serum PGE metabolite assay 
Figure 4.7 shows the concentrations of the PGE2 metabolites assayed in serum 
taken before and after static handgrip exercise. In young subjects (Fig. 4.7a), 
levels of PGE metabolites measured from venous serum remained unchanged 
after exercise compared to resting levels. The same pattern occurred in the 
older subjects (Fig. 4.7b). As would be expected from COX inhibition, Figure 4.7 
demonstrates a reduction in the resting concentration of PGE metabolites on 
the 2 experimental occasions involving aspirin administration 30 minutes prior to 
blood sampling, with a non-significant decrease in the young subjects (p=0.092) 
and a significant reduction in the older group (p=0.027). Breathing 
supplementary O2 in recovery had no effect (young p=0.988; older p=0.763). 
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Analysis by repeated measures ANOVA shows no significant effect of age on 
PGE metabolite levels (p=0.134) or the effect of aspirin (p=0.623). 
4.4 Discussion 
The studies presented in this chapter were the first to investigate the O2-
dependence of vasodilator prostaglandins in mediating post-exercise 
hyperaemia in both static and dynamic exercise in the forearm. The data also 
add to the literature concerning the effects of ageing on the mediation and 
magnitude of post-exercise hyperaemia.  
The main findings of this study were: 
1. In contrast with our first hypothesis, neither COX inhibition nor hyperoxia 
had any effect on FBF or FVC following static exercise at 50% MVC for 2 
minutes in young subjects. 
2. Similarly in young subjects, neither aspirin nor 40% O2 had an effect on 
FBF or FVC following dynamic exercise at 50% MVC for 2 minutes at a 
rate of 0.5Hz; this was also in opposition to our first hypothesis. 
3. Breathing supplemental O2 had no effect on the pH or lactate measured 
in venous blood, suggesting that O2 delivery to muscle was not increased 
by this protocol. 
4. In agreement with our third hypothesis, COX inhibition and 40% O2 had 
no effect on FBF or FVC following exercise in older subjects.  
5. In agreement with hypothesis four, there was no difference in FBF or 
FVC evoked following static or dynamic exercise between young and 
older groups.   
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6. Venous efflux of PGE2 was not increased by exercise in either young or 
older subjects. 
4.4.1 Control findings in young subjects 
As expected, both static and dynamic exercise resulted in an increase in FBF 
immediately post-exercise, attributable to a decrease in vessel tone, which 
decreased steadily over the next 6 minutes (Fig. 4.3 and 4.4). This contrasts 
with venous pO2 levels (Fig. 4.5), which rose immediately post-exercise and 
peaked at 3 minutes. Given that levels of exercise and post-exercise 
hyperaemia are widely considered to be tightly coupled to metabolic demand 
(Clifford & Hellsten, 2004), the finding that the level of FBF is more than 
adequate to meet the O2 demands of the muscle suggests that, in the post-
exercise period, pO2 is not a factor in mediating FBF. Secondly, the disconnect 
in the time course of changes in FBF and pO2 suggests that alterations in pO2 
are not obligatory for changes in FBF. This refutes our second hypothesis, 
although it supports the present findings that there is no O2-dependent mediator 
of FBF, discussed further below. In contrast to venous pO2, the peak changes in 
venous pCO2, pH and lactate concentration all occur immediately post exercise, 
indicating that anaerobic metabolism is occurring within the skeletal muscle. 
Contrary to our third hypothesis, results of the present PGE metabolite assay 
indicates that exercise did not cause release of PGE from forearm muscle into 
the venous efflux. This contrasts with findings by Boushel et al. (2002) that 
PGE2 has been shown to play a role in the hyperaemia of intense dynamic 
quadriceps exercise. In that study however, PGE2 had no role in mediating the 
hyperaemia in lighter exercise, with the change in concentration of PGE2 
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occurring between 30 and 45W of exercise. Therefore we can hypothesise that 
the 50%MVC used in the present study is below the threshold at which PGE2 is 
released and mediates post-exercise hyperaemia. A further possibility is that an 
increase in PGE2 occurs within the interstitium, but release into the venous 
efflux is not sufficient to detect. 
4.4.2 Effect of hyperoxia on FBF and FVC in young subjects 
In young subjects, breathing 40% O2 during the period of contraction only had 
no effect on FBF or FVC after either static or dynamic handgrip exercise at 50% 
MVC for 2 minutes. This is consistent with results using dynamic leg exercise at 
40% MVC (MacDonald et al., 2000), where subjects were also classified as 
physically untrained by the researchers. In that study, leg blood flow measured 
by doppler ultrasound was unchanged by either hyperoxia at 70% O2 or hypoxia 
at 14% O2 compared to the response in normoxia. 
However, the findings of the present study and that of MacDonald et al. (2000) 
contrast with those of other groups (summary of all studies assessing effect of 
altering O2 can be found in Table 1.1). Briefly, researchers assessing the effect 
of hyperoxia on the hyperaemia in leg exercise at 55-70%MVC (Welch et al., 
1977) and 70%MVC (Pedersen et al., 1999) found a modest decrease in 
hyperaemia of 11-12% whilst using higher levels of O2 than the present study. 
In the forearm, decreases in post-exercise hyperaemia of 25-40% have been 
shown when administering 40%O2 to subjects performing static handgrip 
exercise at 100%MVE until exhaustion (Fordy, 2007) and 60%MVC for 2 
minutes (Win & Marshall, 2005).  
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When analysing the exercise intensities used in the literature, it seems likely 
that part of the discrepancy between findings is due to levels of exercise 
performed. In the studies (including our data presented herein) finding no effect 
of supplemental O2 on blood flow, exercise intensity was 50%MVC or lower. 
Conversely, all of the studies that reported an effect of hyperoxia used exercise 
intensities greater than 60%MVC. On this basis we can hypothesise that in 
intense exercise, an O2 deficit occurs which leads to the production of O2-
dependent mediators of hyperaemia. Supplemental O2 would alleviate this 
deficit and thus reduce production of an O2-dependent vasodilator. In less 
intense exercise this O2 deficit does not occur, therefore supplemental O2 has 
no effect. Based on the previous literature and the current data, we can 
hypothesise that the threshold at which this occurs is greater than 50% MVC. 
A further explanation for the opposing observations seen in the literature may 
be differences in the training status of the subjects used in the various studies. 
The present study and that of MacDonald et al. (2000) both used sedentary, 
untrained subjects. The above studies by Welch and Pedersen both stated that 
they used active subjects. Similarly, comparisons between the present study 
and that of Fordy (2007) suggest a difference in training status between 
subjects. For example, in the present study, the mean force exerted at MVC 
was ~33kg and forearm circumference was ~26cm in subjects with a mean 
bodyweight of 70kg. In comparison, the subjects used in a Fordy’s study (Fordy, 
2007) had a mean forearm circumference of 28.4cm, mean bodyweight of 74kg 
and force exerted at MVC was 50kg. Anthropometric measurements performed 
on male cadavers suggests that forearm circumference is highly correlated with 
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total muscle mass (Martin et al., 1990). It therefore seems likely that the study 
population used by Fordy was more physically active than the population 
selected in this study. On the face of it the study by Win and Marshall (2005) 
seemed to follow an identical protocol to that described herein. Although the 
forearm circumference and weight were similar in the two studies, Win and 
Marshall (2005) made no report of the peak force obtained for the subjects or 
stated sports participation as an exclusion criterion. Furthermore, our pilot study 
showed that subjects were unable to hold 60%MVC for 2 minutes (Section 
2.2.1), hence why we selected the 50%MVC in the current protocol. Thus it 
suggests that Win and Marshall (2005) investigated more active subjects than in 
the present study.  
Evidence for an activity related difference in O2 dependence can be seen in 
studies performed by Haseler et al. (1999; 2004) investigating the effects of 
supplementary O2. Using magnetic resonance spectroscopy, they found that the 
rate of phosphocreatine resynthesis following submaximal rhythmic exercise 
was only increased by breathing 100% O2 in active subjects and not in 
sedentary subjects. This implies that O2-delivery to muscle is more than 
adequate to supply muscle activity in sedentary subjects, with the authors 
hypothesising that an increase in mitochondrial number and efficiency allowed 
trained subjects to make better use of supplementary O2.  
On the basis of the present data and the previous literature, we can hypothesise 
that in active subjects with more efficient muscles, supplementary O2 can be 
utilised to reduce production of vasodilator metabolites which are produced 
during normoxic exercise; in less active or sedentary subjects, the reduced 
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efficiency of the muscle means that the supplementary O2 can not be utilised 
and so the increase in vasodilatation is not affected. This could also tie in with 
the suggestion made above, that force of contraction could explain some of the 
differences in findings between the present and previous studies, if there is a 
threshold of intensity above which forearm muscles become O2-dependent. 
A further consideration with the present study is the success of supplemental 
40% O2 in relieving muscle hypoxia. Whilst haemoglobin O2 carriage is unlikely 
to be affected significantly by supplemental O2, going from 98-99% to 100%, the 
main effect of hyperoxia in the present methodology is likely to be the increase 
in PaO2 from ~98 to 240mmHg (Ekblom et al., 1975; discussion of methodology 
in Win & Marshall, 2005). On the basis of this, previous work from this 
laboratory hypothesised that any effect of supplemental O2 was at the level of 
the endothelium (Win & Marshall, 2005). Following recent data showing an O2 
gradient from blood to skeletal muscle (Richardson et al., 1995; 2001; 2006) the 
present study hypothesised supplemental O2 acted by ameliorating hypoxia 
within the skeletal muscle (see Figure 1.1 for possible sources of 
prostaglandins). Whilst there were no direct measurements of PO2 within the 
skeletal muscle in this study, peak venous lactate or H+ levels seen post-
exercise could be used as a surrogate marker of hypoxia. It is of note that 
administration of supplementary O2 had no significant main effect on either of 
these values, suggesting that O2 delivery to the skeletal muscle was not 
sufficient to ameliorate any hypoxia within the muscle. Further evidence for this 
can be found in results shown in Chapter 3. In that study the change in tissue 
haemoglobin O2 saturation during exercise at 100%MVE was not significantly 
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altered by breathing 40% O2 during contraction compared to room air, as 
measured using Near Infra-red Spectroscopy. This would appear to 
demonstrate that despite findings of an increased O2 gradient from blood to 
muscle tissue (Richardson et al., 1995; 2001; 2006), increasing the PaO2 in the 
present manner does not significantly affect tissue oxygenation. Thus, it would 
seem that our second hypothesis was incorrect and that effects of hyperoxia 
seen in previous studies may have been due to increased O2 delivery to the 
endothelium and not to the skeletal muscle. The methodology in the current 
study cannot rule out the presence of an O2-dependent mediator produced from 
within the muscle fibres as supplemental O2 did not reach the level of the 
muscle. 
4.4.3 Effect of COX inhibition on FBF and FVC 
In contrast with our first hypothesis, COX inhibition with oral aspirin had no 
effect on either FBF or FVC immediately following either static or dynamic 
exercise. These findings agree with previous investigators who have found no 
effect of COX inhibition. For example, Shoemaker et al. (1996) found no effect 
of oral ibuprofen on the vasodilatation caused by dynamic handgrip at 10%MVC 
and Mortensen et al. (2007) observed no effect of intra-arterial infusion of 
indomethacin during light dynamic knee extension, although there was an effect 
when combined with NOS inhibition.  
However, other studies have found differing results (summarised in Table 1.2) 
Vasodilator prostaglandins such as PGI2 and PGE2 have both been implicated 
in mediating exercise hyperaemia due to the observed increase of both in the 
venous efflux (Karamouzis et al., 2001a; 2001b). Kilbom and Wennmalm (1976) 
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were the first to use indomethacin to reduce post-exercise hyperaemia following 
5 minutes static exercise at 15% MVC. Later, Wilson and Kapoor (1993) 
observed an attenuation of the post-exercise hyperaemia in response to 
dynamic wrist exercise to the magnitude of ~20%, also using ibuprofen. Similar 
findings have been made using a similar exercise protocol by another group 
using aspisol (Duffy et al., 1999) and an attenuation of post-exercise 
hyperaemia of approximately 35% has been observed using oral aspirin (Win & 
Marshall, 2005).   
As discussed in the General Introduction (Section 1.2.3.3), recent research has 
suggested that these discrepancies in the literature may be caused by 
differences in the intensity of the exercise used and the timing of interventions. 
Evidence for a role of vasodilator prostaglandins in exercise and post-exercise 
hyperaemia of intense exercise but not in less intense exercise has been 
discussed above in section 4.4.1. In terms of timing of drug administration, 
Schrage et al. (2004) showed that intra-arterial administration of the COX 
inhibitor ketorolac during exercise resulted in a transient 12% attenuation of 
exercise hyperaemia which was recovered by 2 minutes post-infusion. When 
designing the protocol for the present study, the 30 minute lag time between 
oral aspirin administration and full COX inhibition was not considered an issue 
in light of the previous findings from our group (Win & Marshall, 2005). 
However, given that vasodilator mechanisms to exercise appear to be different 
in the present group than previous groups studied in this laboratory, it may be 
the case that any contribution of vasodilator prostaglandins has been 
compensated for by another mechanism here.  
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In light of the current findings and other studies in the literature, it would seem 
that vasodilator prostaglandins do not play an obligatory role in mediating the 
hyperaemia immediately post-exercise, although on the basis of previous 
literature they may play a role in exercise of an increased intensity. 
4.4.4 PGE metabolite assays 
Although PGE2 was the target prostaglandin in the present study, 90% is 
broken down in the first pass through the lungs (Granstrom et al., 1980; 
Bothwell et al., 1982). As a result we assayed levels of the stable PGE 
breakdown products. Our control resting levels of PGE metabolites were 
comparable to the values reported by Granstrom et. al. (1980), thus validating 
our technique for collecting and assaying venous plasma samples.  
30 minutes following oral administration of aspirin, the present study found a 
non-significant fall in levels PGE metabolites compared to control exercise. 
However, the ~32% decrease in resting PGE metabolites seen in young 
subjects is not as great a decrease as that seen in previous studies by other 
groups. Wilson and Kapoor (1993) demonstrated a near abolishment in venous 
efflux of PGE2 following intra-arterial indomethacin. Similarly, oral indomethacin 
has been shown to cause a decrease in interstitial PGE2 from 4.3 to 0.4ng.ml-1 
in the vastus medialis (Boushel et al., 2002). It is thus unclear whether aspirin 
has had the desired effect of reducing prostaglandin production in normoxia. 
However, the protocol of aspirin administration that we used has previously 
been shown to lead to complete COX inhibition 30 minutes post-administration 
(Heavey et al., 1985). Further, the same protocol has also been shown to have 
an effect on blood flow (Win & Marshall, 2005). Given the previously shown 
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efficacy of the current aspirin administration, we propose that it is likely that the 
smaller decrease in PGE metabolites is due to the longer half-life of the more 
stable breakdown products, rather than failure of COX inhibition. In light of this 
we can question the appropriateness of assaying a stable PGE metabolite in 
this protocol as it would seem likely that dynamic changes in PGE release from 
forearm skeletal muscle may be missed due to the high background presence 
of stable breakdown products from tonic PGE2 production.       
Contrary to our hypothesis, we found no change in the levels of PGE 
metabolites in plasma following static exercise compared to baseline in either 
young or older men. This contrasts with work Wilson and Kapoor (1993) in 
which they demonstrated a fivefold increase in forearm release of PGE2 
following dynamic wrist flexion at 0.2 and 0.4W. Similarly, more recent work 
from other groups has shown an intensity-related increase in PGE2 in muscle 
interstitium following exercise. Karamouzis and colleagues (2001a) used 
radioimmunoassay to measure levels of PGE2 in 30 minutes worth of 
microdialysis fluid from the interstitium of the vastus lateralis. They found that 
there was an increase in PGE2 in fluid collected over 30 minutes of cycling 
exercise at 100W compared to fluid collected at rest. Additionally, they showed 
that the levels of PGE2 measured increased further when exercise was 
performed at 150W. Another study from the same group also observed that 
increases in PGE2 are dependent on the intensity of exercise (Karamouzis et 
al., 2001b). That study observed no increase in PGE in microdialysis fluid 
collected from the gastrocnemius (calf) during intermittent static calf exercise 
designed to mimic walking, and reported as being a light exercise protocol. 
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However, the same study reported an increase in PGE2 in the interstitium of the 
vastus lateralis during single knee leg extension exercise, used as a more 
severe exercise protocol.  
A similar graded release of PGE2 with increasing intensity has also been 
reported by Boushel et. al. (Boushel et al., 2002). They again measured PGE2 
from the muscle interstitium (vastus lateralis and medialis) using 
radioimmunoassay. Following knee extensor exercise, they observed no 
change in PGE2 from baseline following moderate exercise at 15 and 30W, but 
there was a significant increase following exercise at higher intensities (45 and 
60W). Unfortunately they did not report the maximum values subjects were able 
to achieve. Thus, we can hypothesise that the 50% MVC exercise used in the 
present study was not of sufficient intensity to produce a measurable increase 
in PGE metabolites in the forearm venous efflux. Alternatively, as discussed 
above, any changes in PGE release from forearm muscle may be hidden by the 
background levels of stable PGE metabolites. 
Finally, the present study found no effect of supplementary O2 on PGE 
metabolite levels. Considering the lack of effect of supplementary O2 on FBF 
and the lack of change in PGE metabolites post-exercise, we can conclude that 
PGE2 does not play an O2 dependent-role in mediating vasodilatation in 
exercise in the present protocol. 
A further question that can be raised is the possibility that COX inhibition 
affected the production of COX products other than PGE2, such as the 
vasodilator PGI2 or vasoconstrictor thromboxane (TXA2). Although neither of 
these substances were directly assayed, it seems unlikely that they were 
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significantly affected, as there were no changes in either resting or post-
exercise FBF following aspirin compared to placebo. We also consider it 
unlikely that aspirin could have had simultaneous effects on the cytochrome 
P450 pathway, a source of EDHF. Work investigating the contribution of EDHF 
in the human forearm used the cytochrome P450 inhibitor miconazole to 
demonstrate the presence of EDHF dependent vasodilatation (Halcox et al., 
2001). Importantly for this study, this was performed in the presence of COX 
inhibition with aspirin, demonstrating that aspirin does not inhibit the cytochrome 
P450 pathway. 
4.4.5 Effect of ageing 
We hypothesised that prostaglandins would play a reduced role in mediating 
post-exercise hyperaemia in older subjects compared to young subjects. Our 
data support this hypothesis in that we also found no role for them in older 
subjects. Also of interest is the observation that the magnitude of hyperaemia is 
not significantly different from that observed in the younger subjects.  
Previous literature concerning the effect of ageing on the gross changes in 
exercise hyperaemia gives mixed results and is discussed in the general 
introduction (section 1.2.4). In human leg muscle there is a general consensus 
that exercise hyperaemia is reduced with ageing (Proctor et al., 1998; Poole et 
al., 2003; Donato et al., 2006). Current data concerning the effect of ageing on 
forearm exercise hyperaemia is more equivocal, with Jasperse et. al. (1994) 
concluding that the maximum vasodilator capacity was not altered with age. In 
the same study, different intensities of exercise were also compared and no 
differences in blood flow were seen at any workload from 7-80%MVC. Similarly 
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the study by Donato et al. (2006) that observed attenuated blood flow in the leg 
found no evidence was found of a similar age-related decline in exercise 
hyperaemia in the forearm. In contrast, Carlson et al (2008) observed an 
attenuated peak blood flow in older subjects at intensities greater than 
10%MVC.  
The present study concurs with the evidence that there is no age-related 
change in post-exercise hyperaemia in the forearm, after either static or 
dynamic handgrip. The difference between the findings from the present study 
and those of Carlson et al. (2008) are most likely down to the significant 
differences in the methodology. They used single 1 second contractions in order 
to isolate local vasodilator factors. As well as a reduced peak vasodilatation, 
they also observed a reduced immediate vasodilatation at intensities greater 
than 10%MVC. Therefore we can hypothesise that the when forearm exercise is 
prolonged as in the present study and others (Jasperse et al., 1994; Donato et 
al., 2006), any immediate age-related impairment has been overcome.  
The current finding that vasodilator prostaglandins do not play a role in older 
subjects supports previous results from other groups (Schrage et al., 2007; 
Crecelius et al., 2010). In the study by Schrage et al. (2007), older subjects 
performed dynamic handgrip exercise at 10 and 20%MVC. They found that 
COX inhibition with intra-arterial infusion of ketorolac had no effect on exercise 
hyperaemia, either given singly or in combination with the NOS inhibitor L-
NAME. This contrasted with their previous data in young subjects 
demonstrating a transient ~12% decrease in exercise hyperaemia when 
ketorolac was infused. Thus they concluded that any vasodilator effect of 
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prostaglandins in exercise was completely abolished with ageing. This is 
consistent with the present findings in older subjects. 
4.4.6 Critical evaluation of experimental protocol 
With the benefit of hindsight, there are a number of aspects of this study that 
could be improved upon in future work. These aspects are considered below 
along with possible solutions.  
The first limitation when comparing the results of the present study with 
previous work concerns the activity level of subjects. As discussed in 4.4.1 both 
the previous studies from this laboratory, along with the present study, have 
attempted to recruit “recreationally active” subjects, a factor also common to 
studies of other groups. The problem with this classification is clear from the 
discussion above, in that the strength and activity levels of subjects are clearly 
different in different studies. This issue was also highlighted in a recent 
presentation by Mortensen from the Copenhagen Muscle Research Centre, in 
which it was acknowledged that recreationally active subjects recruited in 
Copenhagen largely commute by bicycle and therefore tend to be fitter than 
subjects recruited as “recreationally active” in countries such as the UK and US 
(Muscle blood flow regulation in small and large muscle mass exercise; a role of 
age and training status. Session 412, Experimental Biology, Washington 2011). 
One method of accurately assessing a subject’s activity would be to use a 
physical activity questionnaire such as the Minnesota Leisure Time Physical 
Activity Questionnaire (MLTPA). This requires subjects to answer detailed 
questions about their activity in the last week, both recreational activity and daily 
activities of living. Utilisation of the MLTPA questionnaire was considered when 
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designing the current protocol, but was rejected in favour of the simpler 
questionnaire in Appendix 1 due to the time taken to answer it and the 
inapplicability of some of the questions to a UK population. An alternative to 
using a subjective questionnaire would be to use a device such as a pedometer 
or an accelerometer to record activity in the previous week to obtain an 
objective measure of the amount of activity a subject was performing. However, 
this would be especially useful if assessing leg blood flow and likely of more 
limited value in the study of the forearm. Disadvantages would be the time 
taken to get accurate results and issues with subject compliance.  
A second issue regarding activity level concerns possible discrepancies 
between the activity level of subjects at the time they participate in the study 
and their previous training history. Whilst this was not considered as an issue 
when designing the present study, in view of the disparity between the present 
results and those of Win and Marshall (2005), future studies should probably 
assess lifetime training.   
An issue encountered in the present study was difficulty recruiting suitable 
healthy older subjects. Initially, recruitment was intended to be limited to 
sedentary older subjects. However, subjects who were healthy enough to be 
included (i.e. had no cardiovascular disease or other health problems) tended to 
be those who were more physically active. Therefore it soon became apparent 
that the activity levels needed to be extended to include more active subjects if 
sufficient numbers were to be recruited, although this still resulted in a ratio of 
over 7 respondents per eligible subject. This can be seen from the subject 
characteristics (Table 4.1). When comparing findings between young and older 
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subjects, it must be noted that the older subjects are more active as a group 
than the younger subjects. This is also a point to consider in the future design of 
studies. 
Concerning the protocol of the study, both trial experiments and questioning of 
subjects on completion of the study indicate that the blinding of gas and drug 
administration was satisfactory. In the present protocol, as in previous work 
from this laboratory, the administration of O2 can only be described as 
supplementary due to the use of a Venturi system at a rate of 10 litres per 
minute. Whilst this clearly does not explain the lack of effect of breathing O2 
seeing as the same apparatus has had an effect in previous studies, utilising a 
reservoir bag would enhance the quality of the study by standardising the O2 
concentration given. 
A limitation of the present study is the use of samples of venous blood only for 
measurement of muscle metabolites. One method of improving upon this would 
be to use simultaneous arterial blood sampling. This would allow both 
measurement of forearm O2 consumption and give a more accurate 
measurement of metabolite production by subtracting the concentration in the 
arterial influx from that in the venous efflux. A different approach, widely used 
by the Copenhagen Muscle Research Centre, is to use microdialysis to 
measure the concentration of metabolites within the muscle interstitium. 
Disadvantages of both methods would be the increased invasiveness of the 
protocol. 
Although using venous occlusion plethysmography to measure forearm blood 
flow has the advantage of being non-invasive and relatively simple to 
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administer, there were some limitations which became apparent in the present 
protocol. Firstly, the mercury-in-silastic strain gauge is extremely sensitive to 
any change in forearm circumference. This was an issue in the present study as 
subjects were often in some discomfort as a result of maintaining the handgrip 
and had to be reminded to remain still. It was also important to take into account 
the increase in forearm volume that occurred during exercise when calibrating 
the strain gauge, as if the resting voltage was set too high the reading could go 
off the scale during forearm blood flow measurement. A limitation of using 
venous occlusion plethysmography on 4 separate experimental days is that 
care must be taken to place the strain gauge around the same part of the 
forearm. An attempt to control for this in the present study was made by placing 
the strain gauge around the forearm at the point of the greatest circumference. 
Care also needed to be taken in placing of the cannula for venous blood 
sampling to avoid any interference with equipment touching the strain gauge. 
4.4.7 Summary 
In conclusion, the present study was novel in the use of both static and dynamic 
exercise to investigate the role of O2-dependent prostaglandins in mediating the 
hyperaemia seen immediately post-exercise. We found no evidence for O2-
dependent mediators of post-exercise hyperaemia and no evidence that 
prostaglandins mediate post-exercise hyperaemia following handgrip exercise 
at 50%MVC. Our findings in older subjects support our hypothesis that levels of 
post-exercise hyperaemia would be the same in healthy older subjects as in 
younger subjects. Our data do not support a role for PGE2 in mediating 
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vasodilatation after exercise, as concentrations assayed from venous plasma 
are unchanged after exercise compared to rest. 
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CHAPTER 5: THE O2-DEPENDENCE OF ADENOSINE IN MEDIATING EXERCISE 
HYPERAEMIA 
 
 
137 
5.1 Introduction 
In chapter 1.2.3.4 the evidence behind a role for adenosine in exercise and 
post-exercise hyperaemia was discussed. A role for adenosine in linking O2 
delivery and O2  consumption was first proposed by Berne (1963) in relation to 
the coronary circulation. Since then, adenosine has been found to be increased 
in the interstitium of the exercising quadriceps muscle in humans to an extent 
which strongly correlated with the exercise hyperaemia (Hellsten et al., 1998). 
Experiments performed in animals have generally concluded that 20-40% of the 
maintained phase of exercise hyperaemia and ~80% of the hyperaemia for 5 
minutes post-exercise is attributable to adenosine (Marshall, 2007). Findings of 
a role for adenosine in mediating exercise hyperaemia have been corroborated 
in dynamic single leg extension exercise in humans by using theophylline, the 
adenosine receptor antagonist available for use in humans (Radegran & Calbet, 
2001). Additionally it has also been shown in human forearm muscle that the 
vasodilatation during dynamic handgrip exercise is partly mediated by 
adenosine at 21% MVC, but not at lower intensities (Martin et al., 2006b). For a 
summary of human studies see Table 1.3. 
Recently it has been hypothesised that the separate mechanisms responsible 
for mediating exercise hyperaemia are interdependent (discussed in 1.2.3.5). 
With respect to adenosine mediated vasodilatation in response to exercise, 
researchers in Copenhagen have recently provided evidence that adenosine 
may primarily act via increasing levels of vasodilators such as prostaglandins 
and NO (Mortensen et al., 2009b; Nyberg et al., 2010). Specifically, they 
propose that adenosine in the interstitium is more important in exercise 
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hyperaemia than the adenosine in plasma and that in exercise interstitial 
adenosine acts on endothelium to increase prostacyclin production by the 
endothelium. 
To date, the O2-dependence of adenosine in exercise hyperaemia has not been 
investigated. Berne’s original ‘adenosine hypothesis’ (1963) proposed that 
interstitial adenosine increased due to a lack of ATP regeneration when there 
was an insufficient O2 supply. In light of the data described above in which 
interstitial adenosine is implicated in the vasodilatation of exercise, we can 
hypothesise that adenosine release into the interstitium is greater when O2 
supply and demand are mismatched (see Figure 1.2). Further, in light of 
evidence for O2-dependence of vasodilator prostaglandins by Win and Marshall 
(2005), a second mechanism through which the role of adenosine could be O2-
dependent may be via decreased adenosine mediated prostacyclin release. 
5.1.1 Hypotheses 
1. In recreationally active young men, adenosine contributes to post-
exercise hyperaemia in an O2-dependent manner following both static 
and dynamic handgrip exercise.  
2. This O2-dependence is mediated by hypoxia within the skeletal muscle.   
3. The contribution of adenosine to mediating post-exercise hyperaemia is 
reduced in older men. 
4. The magnitude of hyperaemia is not altered by ageing.  
We tested these hypotheses by measuring blood flow before and after handgrip 
exercise in healthy young and older subjects. Over four separate visits subjects 
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were randomly assigned to adenosine receptor antagonism with aminophylline 
or no antagonism and breathed either 40% O2 or room air through a facemask 
during the period of exercise only. Venous blood samples were taken to 
measure venous blood gases. 
We anticipated that both aminophylline and breathing supplementary O2 would 
reduce the magnitude of post-exercise hyperaemia in young subjects but not in 
older subjects. We anticipated that ameliorating hypoxia within skeletal muscle 
with supplementary O2 would result in a reduction in the venous concentrations 
of lactate and hydrogen ions. 
5.2 Methods 
Initially it was planned to recruit 12 young and 12 older subjects as for the study 
assessing the O2-dependence of prostaglandin mediated exercise hyperaemia. 
A similar protocol to that described in chapter 4.2 was used, with the oral aspirin 
replaced with intravenous infusion of aminophylline as described below. Both 
studies were carried out concurrently with interested volunteers initially being 
recruited for aminophylline infusion and then being offered the less invasive 
aspirin administration if they felt uneasy about an I.V. drug infusion. When the 
Queen Elizabeth hospital moved site in the summer/autumn of 2010, it was felt 
that the Department of Cardiovascular Medicine where studies took place was 
no longer adequately covered by the medical support, thus infusion of 
aminophylline was no longer ethically safe. At this point 7 young subjects 
(21.0±0.7 years; mean± S.E.M.) and 4 older (63.3±0.5) subjects had completed 
all 4 study visits, and 3 young subjects had completed 2 or 3 visits of which one 
was the air/no infusion control visit. Due to the surprising finding that subjects 
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taking part in the prostaglandin study did not exhibit any O2-dependence, it was 
decided to analyse the data from these subjects; on the basis of these results, 
described below, it was decided that it would be unethical to continue with 
aminophylline infusions.  
As with the protocol described in chapter 4.2, subjects attended the laboratory 
on 4 separate days, at least a week apart. On the first visit to the laboratory, the 
subject was familiarised with the equipment and given an opportunity to ask any 
questions. Subjects were set up and MVC was measured on the first visit as 
described in chapter 2. Either 40% O2 or room air was breathed through a mask 
during the period of contraction only, for the rest of the protocol, subjects 
breathed room air without a mask. On 2 visits, subjects had a 22gauge blue 
cannula inserted into a vein in the ante-cubital fossa of the non-exercising arm. 
This was then used to infuse aminophylline at a dose of 5mg/kg body weight 
(diluted in 40 ml saline) slowly over 20 minutes. This dose was chosen as it is 
the maximum safe loading dose used clinically (British National Formulary 49, 
March 2005). On completion of infusion, subjects rested for 10 minutes. On 
non-infusion days, subjects rested for 30 minutes. The order of all interventions 
was randomised in a single-blinded manner, such that upon completion of the 
study all subjects had received air alone (i.e. control), air/aminophylline, O2 
alone and O2/aminophylline.  
Prior to commencing exercise, a venous blood sample was taken and three 
recordings of baseline FBF were made by venous occlusion plethysmography. 
The facemask was then fitted to the subject although the gas was not switched 
on at this point. The subject began the period of static exercise at 50% MVC for 
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two minutes whilst breathing the experimental gas mixture through the 
facemask. Exercise was timed to begin 10 minutes after cessation of the 
aminophylline infusion to keep the 30 minute total rest on the couch consistent 
with the study described in Chapter 4. Immediately after the subject released 
the dynamometer another recording of FBF was taken. A venous blood sample 
was taken immediately following the measurement of FBF (approximately 10-15 
seconds after completion of the exercise). Further venous blood samples and 
FBF recordings were taken at 3 and 6 minutes after the end of the exercise. 30 
minutes following the first period of exercise this protocol was repeated with the 
subject performing two minutes of rhythmic exercise at 50% MVC, at a rate of 1 
second contraction/1 second relaxation. In addition to the above blood samples, 
on 2 visits blood samples were taken immediately prior to static and dynamic 
exercise (i.e. approximately 10 minutes and 40 minutes post infusion) for 
measurement of plasma aminophylline levels. These assays were performed by 
the Biochemistry department at the QE hospital. 
5.2.1 Analysis 
Analysis was performed as described in section 4.2.1. Briefly, all data was 
analysed using SPSS for mac (version 17.0). Data are presented as mean  
S.E.M. FBF and FVC were analysed using 3-way repeated measures ANOVA 
with within-subject factors for gas breathed, drug intervention and time. Main 
factor effects are presented using Huyne-Feldt correction to control for any 
differences in variance between groups. In cases where significance was 
detected, Bonferroni adjustment was performed in order to locate where 
differences occurred. 3 comparisons were made for time (3 post-exercise 
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timepoints vs. rest), 1 comparison was made for gas (O2 vs. air) and 1 for drug 
(aminophylline vs. no aminophylline). 
Heart rate and mean arterial blood pressure were analysed using repeated 
measures ANOVA with special contrasts defined to perform 3 pairwise 
comparisons of the 3 groups of time points (baseline, exercise and recovery).  
pO2, pCO2, pH and lactate were analysed using Generalised Estimating 
Equations to correct for data missing due to failure of cannulation (missing 
values for entire experimental visit) or malfunction of blood gas analyser 
(missing single values within visit). A table showing proportions of missing data 
points is included in Appendix 2. 
Theophylline levels were analysed using a paired t-test. 
Due to the low subject numbers in the older group, no statistics have been 
performed on the differences in ageing. 
Tables showing data as Mean±S.E.M. are included in Appendix 4 for reference. 
5.3 Results 
5.3.1 Subject characteristics 
Subject characteristics are shown in Table 5.1. Young subjects were aged 
21.0±0.7 years old (mean ± S.E.M.) compared to 63.3±0.5 years for the older 
subjects. Young subjects rated themselves as less active on a subjective 
questionnaire (Appendix 1) and reported less hours activity per week than the 
older subjects. Both young and old subjects reported predominantly leg based 
activity. 
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5.3.2 Heart rate and MABP 
The heart rate and MABP responses for both young and older subjects in 
response to 2 minutes handgrip exercise are shown in Fig. 5.1 and Fig. 5.2 
(response to static and dynamic exercise respectively). In young subjects, there 
was a significant main effect of time on heart rate in static exercise (p<0.001), 
although there were no significant differences in pairwise comparisons of 
baseline, exercise and recovery. There was a significant increase in MABP from 
baseline during static exercise (p=0.006) and a significant decrease from 
exercise levels during recovery (p=0.008). There were no significant main 
effects of supplementary O2 (heart rate p=0.093; MABP p=0.794), 
aminophylline (heart rate p=0.811; MABP p=0.057) or the two in combination 
(heart rate p=0.849; MABP p=0.650). 
In dynamic exercise, both heart rate and MABP were significantly raised from 
both baseline and recovery (all main effect of time p<0.001; all pairwise 
comparisons p<0.05). As with static exercise there were no significant main 
effects of supplementary O2, aminophylline or the two in combination. 
Statistics were not performed on older subjects due to the early curtailment of 
the study but mean heart rate and MABP are shown for those 4 subjects in 
Figures 5.1c&d (static exercise) and 5.2c&d (dynamic exercise). It can be seen 
that older subjects show a similar pattern to younger subjects. 
5.3.3 FBF and FVC 
Figure 5.3a and b show the FBF and FVC respectively for both young and older 
subjects before and after static exercise. Static handgrip exercise at 50% MVC 
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for 2 minutes resulted in a significant rise in FBF measured immediately post-
exercise in young subjects (Fig 5.3a; p<0.001). Figure 5.3a shows that FBF 
then falls from these peak values at 3 minutes and further at 6 minutes post-
exercise, whilst remaining elevated from the resting baseline (p=0.041). In 
young subjects there were no significant main effects of breathing 
supplementary O2 (p=0.88), taking aminophylline (p=0.84) or the two combined 
(p=0.054). 
FVC behaved in a similar manner (Fig. 5.3b), although the differences from 
resting baseline at 3 and 6 minutes post-exercise were not significant. There 
were no significant main effects of supplementary O2 (p=0.57), aminophylline 
(p=0.27) or the two in combination (p=0.21). The results for dynamic exercise 
for both FBF and FVC (Fig. 5.4a and b) were comparable to the static exercise 
protocol. Again there were no significant main effects of supplementary O2, 
aminophylline or the two in combination. 
Although the lack of older subjects means the study is underpowered, Figure 
5.3 and 5.4 both clearly show that the pattern for older subjects is similar to the 
younger subjects. 
5.3.4 Venous blood gas analysis 
5.3.4.1 pO2 
Figure 5.5a&b show the values for venous pO2 before and after static and 
dynamic exercise. In young subjects, resting pO2 prior to static exercise (i.e. ~ 
10 minutes post-infusion) was lower by ~12mmHg after aminophylline infusion 
(Fig. 5.5a; p<0.001). However, when resting pO2 was measured prior to 
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dynamic exercise (approximately 40 minutes post infusion), there was no longer 
any significant difference between drug conditions (p=0.689).  
Both static and dynamic exercise resulted in a peak venous pO2 at 3 minutes 
post-exercise, such that pO2 was significantly elevated from both baseline and 
from immediately post-exercise (Fig. 5.5a; p<0.001); pO2 returned to baseline 
by 6 minutes post-exercise. In the static exercise protocol, there was no 
significant main effect of breathing supplementary O2 (p=0.55), although 
aminophylline resulted in a significantly lower post exercise pO2 (p<0.001). 
There was no significant main effect of supplementary O2 and aminophylline in 
combination (p=0.07). In the dynamic exercise protocol there were no 
significant main effects of either supplementary O2, aminophylline or both in 
combination (respectively p=0.99; p=0.85; p=0.76). 
Although results must be treated with caution due to the low number of subjects 
(n=4), analysis using GEE indicates that venous pO2 was significantly increased 
from all other time points at 3 minutes following both static and dynamic 
exercise (p<0.01). There were no significant differences between baseline and 
immediately post exercise. There were no significant main effects of 
supplementary O2, aminophylline or both in combination in either the static or 
dynamic exercise protocol. 
5.3.4.2 pCO2 
Figure 5.5c&d show the venous pCO2 for young and older subjects respectively. 
In young subjects both modes of exercise resulted in a peak venous pCO2 
immediately post-exercise (i.e. pvCO2 reached a peak before pvO2). Following 
both static and dynamic exercise, pCO2 returned to baseline by 3 minutes post-
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exercise (p<0.05). There were no significant main effects of breathing 
supplementary O2 (static p=0.89; dynamic p=0.23), aminophylline (static 
p=0.49; dynamic p=0.62) or both in combination (static p=0.36; dynamic 
p=0.33) in either protocol. 
As can be seen in Figure 5.5d, pCO2 in older subjects follows the same pattern 
as the younger subjects, being significantly raised immediately post exercise 
compared to all other time points (p<0.001), with the values at 3 and 6 minutes 
being fully recovered to baseline levels. Analysis by GEE showed that the 
increase in pCO2 immediately post-dynamic exercise was significantly 
increased during aminophylline infusion (p<0.001), although this is likely an 
artefact due to the low numbers of subjects.  
5.3.4.3 Lactate 
Venous lactate concentrations are shown in Figure 5.6a&b. In young subjects 
(Fig. 5.6a) both static and dynamic exercise resulted in an increase in venous 
lactate concentrations immediately and 3 minutes post-exercise compared to 
the resting baseline (p<0.001), which began to recover by 6 minutes post-
exercise but remained raised from baseline. In the static exercise protocol, 
there were no significant main effects of either supplementary O2 (p=0.21) or 
aminophylline (p=0.86). There was a significant effect of both O2 and 
aminophylline in combination (p=0.03) due to post-exercise lactate 
concentrations being increased in the O2+aminophylline protocol. There were 
no significant main effects of any interventions in the dynamic exercise protocol. 
Lactate concentrations changed in a similar manner in older subjects (Fig. 5.6b) 
after both static and dynamic exercise (all post exercise values p<0.002 from 
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baseline). There were no significant main effects of supplementary O2, 
aminophylline or both in combination. 
5.3.4.4 pH 
Figure 5.6c&d shows the venous pH before and after static and dynamic 
handgrip exercise for young and older subjects respectively. In young subjects, 
pH decreased significantly immediately post-exercise before gradually 
recovering towards, but not reaching, resting baseline values (all time points 
p<0.001 c.f. all other time points). In the static exercise protocol, there were no 
significant main effects of supplementary O2 (p=0.95), aminophylline (p=0.16) or 
both in combination (p=0.23). During the dynamic exercise protocol however, 
aminophylline had the effect of reducing the decrease in pH from resting 
baseline at all time points post-exercise (p=0.02). There were no significant 
main effects of supplementary O2 or O2 and aminophylline in combination. 
The time course of changes seen in the older group (Fig. 5.6d) was the same 
as that seen in the younger group. Aminophylline had the overall effect of 
increasing pH compared to no infusion (static p<0.001; dynamic p=0.027). 
5.3.5 Theophylline levels 
Figure 5.7 shows venous theophylline levels measured before static and 
dynamic exercise (~10 and 40 minutes following infusion of 5mg.kg-1 
aminophylline respectively). Mean levels were 11.4mg.L-1 prior to static exercise 
and and there was no significant change compared to levels measured prior to 
dynamic exercise (p=0.074). 
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5.4 Discussion 
The studies presented within this chapter are novel in that they are the first to 
investigate the O2-dependence of adenosine as a mediator of the hyperaemia 
seen immediately post-exercise and how this role changes with ageing. It is 
also novel in the investigation of both static and dynamic exercise. Despite 
being stopped early, this study has presented some interesting findings: 
1. In contrast with our first hypothesis, breathing supplementary O2 during 
both static and dynamic handgrip exercise had no effect on post-exercise 
hyperaemia.   
2. Also in contrast to our first hypothesis, adenosine receptor blockade with 
an intravenous infusion of aminophylline had no effect on post-exercise 
hyperaemia following static or dynamic handgrip exercise.  
3. Adenosine receptor blockade results in an acute reduction in resting 
venous pO2, which appeared to be compensated for 40 minutes following 
blockade, despite theophylline levels not being significantly lower. 
4. This study found little evidence of either aminophylline or supplementary 
O2 altering metabolic activity during exercise, as evidenced by the lack of 
differences between blood gas measurements. 
5. Despite being significantly underpowered, analysis of older subjects 
indicates no effects of ageing on post-exercise hyperaemia. 
5.4.1 Effect of hyperoxia on FBF and FVC in young subjects 
At the onset of the studies presented within this thesis, our overriding 
hypothesis was that in healthy recreationally active young subjects a 
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component of the vasodilatation seen following exercise was O2-dependent. 
However, the results presented herein suggest that using the current 
methodology this is not the case.  
Potential reasons for finding a lack of O2-dependence were dealt with in section 
4.4.1. In the present study the hyperoxia/no infusion experimental visit is 
analogous to the hyperoxia/placebo visit in Chapter 4 and as subjects were 
recruited in an identical manner the discussions in Section 4.4.1 are valid here. 
Briefly, the likely reasons for discrepancies within the literature are a difference 
in the activity levels of subjects or differences in intensities between different 
studies. The fact that the study presented in this chapter supports the findings 
of the data in Chapter 4 adds weight to the hypothesis that O2 only plays a role 
in mediating post-exercise hyperaemia following intense exercise or in trained 
individuals.  
As with the findings in Chapter 4, the present results show no effect of 
supplementary O2 on peak venous lactate or pH measurements after exercise, 
which we were using as a surrogate of anaerobic metabolism. Therefore we 
cannot rule out the presence of an O2-dependent substance being produced 
within the muscle fibres. 
5.4.2 Effect of aminophylline on FBF and FVC in young subjects 
In contrast with our first hypothesis, this study observed no effect of adenosine 
receptor antagonism with aminophylline on the hyperaemia seen after either 
static or dynamic handgrip exercise. This supports the findings of Martin et al. 
(2006b; 2007) in the forearm, which demonstrate that adenosine may not be an 
obligatory mediator of exercise hyperaemia. Firstly they showed that the 
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hyperaemic response to dynamic handgrip exercise at ~21% MVC was reduced 
by 15% when aminophylline was infused intra-arterially, although adenosine 
receptor blockade had no effect at lower intensities (Martin et al., 2006b). 
Secondly, they demonstrated that increasing interstitial concentrations of 
adenosine, by using dipyridamole to block equilibrative nucleoside transporters, 
had no effect on the magnitude of the exercise hyperaemia (Martin et al., 2007). 
This was even the case in non-responders in whom they demonstrated that 
equilibrative nucleoside transporter activity was enhanced leading to more rapid 
adenosine clearance. In contrast however, Radegran and Calbet (2001) 
observed a reduction in exercise hyperaemia of ~20% in subjects performing 
dynamic knee extension at ~50%MVC with adenosine receptor antagonism with 
an intravenous infusion of theophylline (studies summarised in Table 1.3). A 
limitation of the comparison between the current data and the studies 
mentioned above is the difference in methodology of measuring blood flow. 
Both Radegran and Calbet (2001) and Martin  et al. (2006b) used Doppler 
ultrasound, thus measuring hyperaemia during exercise. In contrast, we used 
venous occlusion plethysmography, measures post-exercise hyperaemia, 
although the timescale of readings was designed to minimise this difference. 
In analysing the results of the present study, we must consider the efficacy of 
aminophylline as an adenosine receptor antagonist. Radegran and Calbet 
(2001) used an intravenous infusion of theophylline at a dose of 6.9mg.kg-1 
body weight. In the present study we used aminophylline, a more soluble 
analogue of theophylline, at a dose of 5mg.kg-1 body weight given over 20 
minutes. This drug and dose was chosen on the basis of clinical guidelines and 
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availability of adenosine receptor antagonists in the UK. In the UK, theophylline 
is only available in oral preparations (BNF 49), while aminophylline is available 
for intravenous infusion (the addition of ethylenediamine to theophylline confers 
greater solubility in water). Intravenous infusion of aminophylline was chosen for 
the present study due to difficulty in obtaining a stable plasma level of 
theophylline when using oral administration (personal communication: Prof. 
Michael Frennaux). Regarding dosing of aminophylline, care must be taken due 
to the narrow margin between therapeutic and toxic doses. Due to clinical and 
ethical considerations, dosing in the present study was limited to the maximum 
loading dose recommended in clinical settings. When comparing the plasma 
theophylline levels obtained in this study (11.4 mg.L-1) with values of 13.3mg.L-1 
(73.8M) obtained by Radegran and Calbet (2001), it is apparent that the 
present study may have under dosed the aminophylline. Levels were not 
reported in the studies by Martin et al. (2006b; 2007), although it is worth noting 
that they used intra-arterial infusions of aminophylline, which may give a greater 
local adenosine receptor antagonism in the absence of systemic side-effects. 
In addition, it has been demonstrated that aminophylline (and therefore 
theophylline) is not a complete inhibitor of adenosine receptors (Leuenberger et 
al., 1999; Casey et al., 2009). Leuenberger et. al. (1999) showed a maximum of 
40% reduction in the vasodilatation caused by adenosine infusion. Similarly, 
Casey and colleagues (2009) found that aminophylline blunted the 
vasodilatation caused by infusion of adenosine by 60% at low doses of 
adenosine, with this decreasing to 30% inhibition with higher doses. Thus it 
appears likely that some of the discrepancies seen within the literature are due 
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to the absence of an effective adenosine receptor antagonist. Methods for 
ascertaining the level of adenosine receptor blockade are discussed in section 
5.4.5. 
It is also worth noting that the study by Radegran and Calbet (2001), whilst 
using a similar percentage of peak force as the present study, was performed 
using leg exercise. When compared to our findings and those of Martin et al. 
(2006b; 2007) that adenosine is not an obligatory mediator of hyperaemia, we 
can hypothesise that the increase in leg muscle mass compared to the forearm 
muscle mass results in a greater adenosine release for a similar workload. 
Therefore adenosine may be an important mediator in leg exercise hyperaemia, 
but not in forearm exercise hyperaemia. 
However, an alternative interpretation could be placed on the present results 
when taken in the context of the findings of Chapter 4. Recent studies from the 
Copenhagen Muscle Research Centre have produced data that suggests that 
the actions of infused adenosine are dependent on prostaglandins and NO 
(Mortensen et al., 2009b; Nyberg et al., 2010). In Chapter 4 we showed that in 
the present group of subjects using these exercise protocols, vasodilator 
prostaglandins do not play a role in mediating post-exercise hyperaemia. 
Therefore we can hypothesise that the lack of prostaglandin-mediated 
vasodilatation following exercise in these subjects is consistent with the reduced 
contribution of adenosine, such that there was a reduction in adenosine-
mediated prostaglandin release.  
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5.4.3 Effect of ageing 
Whilst it is recognised that the premature cessation of the present study means 
any interpretation on the effects of ageing must be treated with caution, the data 
from 4 older subjects can be discussed in the context of the results above and 
in Chapter 4.  
We hypothesised that older subjects have a decreased reliance on adenosine in 
mediating post-exercise hyperaemia. The present results from older subjects 
did appear to show that there is no adenosine-mediated vasodilatation, 
although this was also be the case with the younger subjects. In addition, the 
data presented in Chapter 4 showed no change in post-exercise hyperaemia 
between young and old subjects. Therefore it seems likely that had the group of 
older subjects in the present study been larger, we would still see no effect of 
aminophylline or hyperoxia and there would have again been no significant 
difference between young and older subjects. 
5.4.4 Effect of adenosine receptor blockade on resting venous pO2  
The present study had the unexpected finding that infusion of aminophylline at 
a dose of 5mg. kg-1 resulted in an acute reduction in resting venous pO2 
measured ~10 minutes after cessation of the infusion. Interestingly, resting 
venous pO2 recovered back to control levels when measured prior to dynamic 
exercise (~40 minutes post-infusion). Although this has not been reported in the 
human forearm to our knowledge, research in other species and organs 
supports this finding.  
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In 1950 Fottz et al. reported an increase in cardiac O2 consumption in dogs 
following an infusion of aminophylline at a dose of 4mg.kg-1. In the same study 
they observed that coronary venous pO2 dropped and remained low for varying 
lengths of time up to 16 minutes. Similarly, 6mg.kg-1 of aminophylline has been 
shown to cause a decrease in jugular venous pO2 of ~6mmHg in men with 
chronic obstructive pulmonary disease, despite causing no change in paO2 
(Nishimura et al., 1992). They theorised that this may be due to either a 
decrease in cerebral blood flow, which they had not measured, or due to an 
increase in metabolic rate resulting in an increased O2 uptake. In light of our 
findings in the present study that aminophylline caused no change in resting 
FBF, it would seem most likely that the alterations in resting venous pO2 are 
due to an increase in metabolism. 
This is supported by findings of other researchers that methylxanthines (which 
include caffeine and theophylline/aminophylline) increase metabolic rate (Dulloo 
et al., 1989; Ide et al., 1995). Dulloo et al. (1989) found that ingesting 100mg of 
caffeine increased the metabolic rate of lean human volunteers by ~4%. It was 
also shown that the increase occurred within 20 to 40 minutes and then began 
to recover to baseline levels. Given that the caffeine in that study was 
administered orally compared to intravenous infusion in the present study, this 
may explain the apparent recovery by 40 minutes that we observed. Further 
evidence supporting an increase in metabolism due to aminophylline infusion 
can be found in a study by Ide et al. (1995). They used magnetic resonance 
spectroscopy to assess levels of inorganic phosphate (Pi) and phosphocreatine 
(PCr) in piglet diaphragm muscle. They reported that aminophylline slowed the 
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increase in Pi/PCr ratio, whilst arterial pO2 remained unchanged. They therefore 
concluded that aminophylline increased levels of aerobic metabolism.  
In conclusion, our results show a novel finding of a transient decrease in venous 
pO2. In light of research in other fields, it seems most likely that this is due to an 
increase in aerobic metabolism. 
5.4.5 Critical evaluation of the protocol    
Due to the large overlap between the methodologies used in the present study 
and those used in Chapter 4, limitations raised in section 4.4.4 are also 
applicable here.  
Additional considerations of the present protocol concern the use of 
aminophylline as an adenosine receptor antagonist. As discussed above, it has 
been shown that aminophylline does not fully inhibit adenosine receptors 
(Casey et al., 2009) and this may explain the apparent lack of adenosine 
mediated exercise hyperaemia in the present study. The efficacy of adenosine 
receptor blockade could be tested by directly infusing adenosine into the 
brachial artery and compare the vasodilatation before and after aminophylline 
infusion as used by Casey et al. (2009). Although this allows the ability to 
quantify levels of adenosine receptor blockade, a major disadvantage is the 
increased invasiveness of the protocol. Further, insertion of a brachial artery 
needle would interfere with placement of venous occlusion plethysmography 
equipment, and if removed before beginning the exercise protocol there would 
be an increased risk of bleeding. An alternative protocol, with much the same 
disadvantages, would use infusion of aminophylline directly into the brachial 
artery as used by Martin et al. (2006b). This may allow increased doses of 
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aminophylline to be targeted to the forearm vasculature whilst reducing the 
systemic effects of high dose intravenous aminophylline.  
5.4.6 Summary  
In conclusion, this study was novel in that it was the first to investigate the O2-
dependent role of adenosine as a mediator of the hyperaemia seen immediately 
post-exercise. The present study found no evidence for a role of adenosine in 
mediating post-exercise hyperaemia following either static or dynamic handgrip 
exercise. There was also no evidence that this hyperaemia was mediated by 
any substance in an O2-dependent manner. We did observe a transient 
decrease in pO2 following aminophylline infusion, which is most likely due to an 
increase in aerobic metabolism. 
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CHAPTER 6: THE EFFECT OF BREATHING 40% O2 DURING RECOVERY ON 
FATIGUE 
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6.1 Introduction 
Skeletal muscle fatigue is an important area of investigation due to the impact it 
has on human function in both health and disease. Despite this importance 
there is still no consensus as to how it is mediated. Section 1.3 gives a 
comprehensive overview of the substances that have been implicated, these 
being potassium ions (K+), inorganic phosphate (Pi) and hydrogen ions (H+). 
Despite the general view that lactate is involved in fatigue, there is no evidence 
to support this, as discussed in Section 1.3. Previous work from our laboratory 
investigated the effect of breathing supplementary 40% O2 on fatigue 
development (Fordy & Marshall, 2004). They found that breathing O2 only 
during the period of recovery between two periods of handgrip exercise at 100% 
MVE until exhaustion reduced the fatigue seen in the second period of exercise 
performed 7 minutes later. Importantly, neither pre-breathing supplementary O2 
nor breathing O2 only during the period of exercise itself had any effect on 
fatigue, therefore it was concluded that an O2 dependent mediator of fatigue 
acted during the period of recovery. However, venous blood samples were not 
collected to assay for any of the substances implicated in fatigue during this 
study and so we cannot say which mediator of fatigue is O2 dependent. The 
discussion below considers the factors that are currently implicated as 
mediators of fatigue and whether they could be O2 dependent mechanisms. 
Resting levels of K+ in plasma are typically 4-5mmol/L and levels rising to 
8mmol/L having been demonstrated during exercise (Medbo & Sejersted, 
1990). Evidence for a role of K+ in fatigue has been found by a number of 
groups, as discussed in more detail in the General Introduction (Section 1.3.1). 
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Nielsen et. al. (2004) examined leg extension in subjects who trained one leg 
for 6 weeks with the untrained leg acting as a control. They demonstrated that 
the untrained leg fatigued faster than the trained leg and that this was 
associated with a more rapid increase in interstitial K+. Further, it was 
demonstrated that venous K+ was the same at the time of fatigue in two bouts of 
exhaustive exercise, even though fatigue was reached more rapidly in the 
second bout of exercise (Bangsbo et al., 1992b). Finally, when leg interstitial 
concentrations of K+ were increased by performing arm exercise prior to leg 
exercise, this was associated with a decreased time to leg fatigue compared to 
performing leg exercise alone (Nordsborg et al., 2003). It has also been 
demonstrated in rat skeletal muscle that when the Na+/K+- ATPase was 
stimulated in various manners, which cleared K+ from the extracellular space, 
the fatigue induced by exogenous K+ administration was reduced (Clausen & 
Nielsen, 2007). Additionally, K+ is released from muscle cells via K+ATP 
channels, which respond to decreased ATP by remaining open more frequently 
(Standen, 1992). Thus it is reasonable to hypothesise that the Na+/K+-ATPase 
or K+ATP channels are potential O2 dependent mechanisms whereby increasing 
O2 supply to the muscle by breathing supplementary O2 could theoretically 
increase ATP production and therefore both reduce K+ release and increase 
extracellular K+ clearance (see Figure 1.3). 
The second substance implicated in fatigue is Pi, concentrations of which 
increase in the muscle when production via ATP breakdown outstrips uptake by 
the mitochondria (Robergs et al., 2004). Concentrations of plasma Pi in the 
venous efflux have been shown to increase following cycle exercise in healthy 
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young subjects (Yamamoto et al., 1994). However, evidence for the 
involvement of Pi in fatigue is more indirect, with initial studies injecting 
exogenous Pi into animal muscle fibres and demonstrating a reduction in force 
generation (Cooke & Pate, 1985; Westerblad & Allen, 1996). Further evidence 
of a role comes from creatine kinase knockout mice who have a high resting 
myoplasmic Pi concentration but do not produce Pi in response to fatiguing 
contractions (Dahlstedt et al., 2000). In keeping with a hypothesised role for Pi 
in mediating fatigue, initial force was lower in these mice than in wild type mice, 
but they did not show any fatigue over 100 contractions in contrast to the wild 
type mice who showed a 30% reduction in force (Dahlstedt et al., 2000). In 
relation to O2 dependency, Haseler and colleagues (1999; 2004) demonstrated 
that 100% O2 increased phosphocreatine resynthesis in trained subjects but not 
in sedentary subjects, suggesting that sedentary subjects are limited by 
mitochondrial capacity and trained subjects limited by O2 delivery. Given that 
phosphocreatine is a mechanism for removal of Pi within the muscle fibre 
(Robergs et al., 2004), we can hypothesise that increasing delivery of O2 will 
increase removal of Pi (see Figure 1.4). 
Increases in H+ (decreases in pH) have typically been assumed to be directly 
related to the development of muscle fatigue (Metzger & Moss, 1987; Cooke et 
al., 1988). As discussed in Section 1.3.3, studies performed in human subjects 
have found no evidence of a direct effect of H+, with the temporal relationship 
between fatigue and pH being out of sync (e.g. Cady et al., 1989; Sahlin & Ren, 
1989) or fatigue occurring at differing levels of pH (Bangsbo et al., 1996). 
Currently it is thought that any effect of H+ on fatigue is mediated indirectly via 
 
169 
stimulation of group III/IV afferent nerves (Westerblad et al., 2002; Allen et al., 
2008). Again we can hypothesise a mechanism by which supplementary O2 can 
reduce H+ mediated fatigue. H+ is produced when ATP exceeds mitochondrial 
respiration (Robergs et al., 2004), therefore increasing oxidative 
phosphorylation by increasing O2 delivery could potentially reduce H+ 
production (see Figure 1.5). 
The effect of ageing on fatigue development was discussed in full in section 
1.3.4. Briefly, whilst there is a reduction in strength with ageing which is not 
accounted for by reduced activity and loss of muscle volume (Goodpaster et al., 
2006), the effect of ageing on fatigue is less clear. A recent meta-analysis 
concludes that ageing leads to an increase in fatigue resistance when 
performing static exercise but there is no difference compared to young 
subjects when dynamic exercise is performed (Avin & Frey Law, 2011). 
However, there has been little data collected as to the changes in muscle 
physiology, which may lead to this increased fatigue resistance in older 
subjects. 
6.1.1 Hypotheses 
1. In recreationally active young men, fatigue is mediated by a substance or 
substances that acts in an O2-dependent manner during recovery. 
Candidates for an O2-dependent mediator of fatigue are Pi, K+ or H+.  
2. Healthy older subjects have a greater fatigue resistance than younger 
subjects. 
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We tested these hypotheses by measuring performance in two bouts of static 
handgrip exercise in healthy young and older subjects. Over two separate visits 
subjects were randomly assigned to breathe supplemental O2 or room air during 
the recovery period between the two bouts of exercise. Venous blood samples 
were taken for measurement of venous blood gases, pH, K+, lactate and Pi.  
We anticipated that fatigue seen in the second bout of exercise would be 
reduced following supplemental O2 breathing in recovery compared to air 
breathing. Supplemental O2 would reduce the venous concentrations of one or 
more of Pi, H+ or K+. We anticipated that older subjects would be able to 
maintain static handgrip contraction for longer than young subjects. This would 
be associated with a reduced venous efflux of one or more of Pi, H+ or K+ 
compared to young subjects. 
6.2 Methods 
11 young subjects and 9 older subjects attended the laboratory on 2 separate 
occasions, at least a week apart. On the first visit to the laboratory, the subject 
was familiarised with the equipment and given an opportunity to ask any 
questions. The activity questionnaire (Appendix 1) was administered at this 
point. They were then set up and MVC calculated as described in Chapter 2.  
6.2.1 Handgrip exercise 
In the present protocol, each subject performed two periods of handgrip 
exercise at 100% maximum voluntary effort (MVE) until exhaustion, the two 
periods being separated by seven minutes of recovery. In performing the 
handgrip exercise, subjects were instructed to perform a handgrip at 100% 
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MVC and then maintain their grip; the force maintained decreased over time 
until they were no longer able to grip the handgrip dynamometer. This protocol 
was very dependent upon the motivation of the subject to maintain the 
contraction. Therefore, the importance of maintaining the contraction until 
exhaustion was explained to each subject and the subject was verbally 
encouraged to maintain maximum effort throughout all periods of exercise. This 
protocol was chosen as it was felt that it was more relevant to real life fatiguing 
contractions than electrically stimulated contractions and that fatigue was more 
measurable than holding a submaximal contraction. Static exercise was used 
as it was felt that this was again a more relevant exercise modality for handgrip 
than dynamic exercise. 
6.2.2 Protocol 
After all the equipment was attached, the subject rested for 10 minutes before a 
venous blood sample was taken and three recordings of baseline FBF were 
made by venous occlusion plethysmography. The facemask was then fitted to 
the subject although the gas was not switched on at this point. The subject then 
began the first period of exercise at 100% MVE, gripping the dynamometer as 
hard as possible until they were no longer able to maintain their grip. 
Immediately after the subject released the dynamometer the gas mixture was 
switched on (either air or 40% O2) and another recording of FBF was taken. A 
venous blood sample was taken immediately following the measurement of FBF 
(approximately 10-15 seconds after completion of the exercise). The recovery 
period was 7 minutes long, further venous blood samples being taken at 3 and 
6 minutes after the end of Exercise 1 and a further capillary sample at 3 
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minutes. At the end of the 7 minute recovery period the gas was switched off 
and the subject began a second period of exercise, again gripping as hard as 
possible until exhaustion. On completion of Exercise 2 FBF was recorded and a 
venous blood sample was taken with further venous blood samples being taken 
at 3 and 6 minutes, as after Exercise 1.  
On the second experimental day subjects repeated the same protocol, 
breathing the gas that was not breathed during recovery on the first day. On 
each experimental day the subject was encouraged to try to reach the same 
100% MVC in Exercise 1 as they had achieved on the first experimental day to 
control for any differences in effort.  
6.2.3 Assays of venous efflux 
All venous samples were prepared for blood gas analysis as described in the 
General Methods (Section 2.2.5). Blood gas analysis gave measurements of K+, 
pH and lactate. 
Pi was measured for 5 young subjects on completion of the whole study using 
plasma snap frozen immediately after each experimental protocol, as described 
above. Pi was measured as free plasma orthophosphate (PO4-) using a 
Malachite Green Phosphate Assay Kit (POMG-25H, BioAssay Systems, USA). 
Briefly, samples were diluted to 1:500 to bring them within the detection range 
of the assay. 80l of the diluted sample was pipetted into a 96 well plate and 
20l of Malachite Green reagent was added to the well. Then plate was then 
incubated at room temperature for 10 minutes and then read using a plate 
reader (Synergy HT, BioTek) at 620nm. Each sample was analysed in duplicate 
and mean absorbance values were calculated for the samples and for 
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standards. Absorbance values were converted to [Pi] using a linear equation 
from the standard curve data. 
6.2.3 Statistical analysis 
In this chapter, the term “time to voluntary exhaustion” (TVE) is used to describe 
the duration of the period between initiation and release of the contraction. 
“Peak force” is the maximum force attained at the onset of the contraction. For 
analysis, the integral of the area under the curve of the whole contraction was 
also computed as a measure of the Tension-Time Index (TTI; the equivalent of 
workload when performing static exercise). 
In the present study, due to changes in the calibration of the dynamometer, it 
was not possible to calculate peak force in the same units for young and old. As 
a result, peak force achieved in contraction 1 of that experimental day is taken 
as 100% MVC for that day and the peak force achieved in contraction 2 of that 
day is expressed as a percentage of that value. 
All data are expressed as the meanS.E.M. of the subjects. Statistical analysis 
was carried out using SPSS 17.0 for Mac. Force data, blood metabolite data, 
FBF and FVC were analysed using repeated measures ANOVA with within 
subjects factors for gas breathed and time. For force data, 1 comparison was 
made for time and 1 for gas breathed. For blood gases, 6 comparisons were 
made for time (post-exercise vs. baseline) and 1 for gas breathed. Blood 
metabolites were analysed as a change from baseline. Heart rate and blood 
pressure were analysed using repeated measures ANOVA.  
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6.3 Results 
6.3.1 Subject characteristics 
Subject characteristics are shown in Table 6.1. Young subjects were aged 
20.89±0.45 (mean +/-SEM) years old compared to 60.89±1.9 years for the older 
subjects. There was no significant difference between young and older subjects 
on self-assessed activity levels or hours of activity per week. Both young and 
old subjects reported predominantly leg-based activity. 
6.3.2 Peak force 
There was no difference in the peak force obtained during exercise 1 on either 
experimental day in either young or old subjects. Figure 6.1 a and b show the 
percentage of peak force achieved in exercise 1 and 2 for young and older 
subjects respectively. Peak force achieved by both young and older subjects 
was lower in the second bout of handgrip exercise compared to that achieved in 
the first bout (Fig. 6.1 a&b; p<0.001). Breathing 40% O2 or room air during 
recovery had no effect on the change in peak force between the two bouts of 
exercise in either the young or the older group (p=0.98; p=0.51 respectively). 
There was no significant difference in the decrease in peak force seen in 
exercise 2 with ageing. As mentioned in section 6.2.3, changes in the 
calibration of the dynamometer between young and older subjects mean we are 
unable to compare absolute levels of force between young and old. 
6.3.3 Time to voluntary exhaustion (TVE) 
Figure 6.2a shows the time to voluntary exhaustion achieved by a group of 
recreationally active young men. There was no significant reduction in TVE in 
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the second exercise bout compared to the first (p=0.47). As with the peak force, 
there was no significant main effect of breathing 40% O2 during recovery 
(p=0.51). 
The data for older subjects are shown in Fig. 6.2b. The TVE in exercise 2 was 
significantly shorter than in exercise 1 (p=0.02). As with the young subjects, 
there was no significant main effect of breathing 40% O2 in recovery (p=0.58).  
It should be noted that mean TVE was ~2 times greater for older subjects than 
younger subjects for every exercise bout, but the difference was not significant 
(p=0.29).  
6.3.4 Tension-Time Index (TTI) 
In young subjects, the TTI in the second exercise bout was significantly lower 
than that performed in the first bout of exercise (Fig. 6.3a; p<0.001). This 
decrease in TTI was unaffected by breathing supplemental O2 compared to 
room air in the recovery period (p=0.65).  
Older subjects (Fig. 6.3b) followed the same pattern, with a significant decrease 
in TTI in the second exercise period compared to the first exercise bout of that 
experimental day (p<0.001). The mean TTI in both exercise bouts was lower on 
the air breathing experimental day than the O2 breathing day (p=0.04) but the 
decrease in TTI from exercise 1 to exercise 2 was not affected (p=0.4). 
The TTI of older subjects was significantly greater than that achieved by 
younger subjects for all exercise bouts (p=0.03). 
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6.3.5 FBF, FVC and MABP 
Table 6.2 shows the FBF, FVC and MABP at rest and immediately following 
both periods of exercise for young subjects. FBF was significantly raised from 
resting levels following both exercise 1 and 2, although there was no significant 
difference between the response following exercise 1 and 2. Breathing 40% O2 
during the 7 minute recovery period between the two bouts of exercise had no 
significant effect on the FBF after either period of exercise.  
Older subjects had a similar response to young subjects, with a significant 
increase in FBF post exercise, but no difference between post-exercise 1 and 2 
and no difference when 40% O2 was breathed in recovery.  
As there were no significant changes in MABP, changes in FVC for young and 
older subjects are comparable to that of FBF, demonstrating that changes in 
FBF are due to changes in vascular tone. 
6.3.6 Lactate 
In young subjects lactate was increased significantly immediately post-exercise 
compared to the resting baseline (Fig. 6.4a; p<0.05) and gradually decreased 
such that the levels at 6 minutes post-exercise showed a significant recovery 
relative to immediately post-exercise, whilst still being raised from baseline. 
Lactate concentrations following the second period of exercise followed the 
same pattern, achieving comparable levels initially and decreasing to a similar 
level. There was no significant main effect of breathing 40% O2 during recovery 
on either the recovery of lactate concentrations following exercise 1 or on the 
lactate concentrations seen after exercise 2 (p=0.907).  
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The same pattern was seen in older subjects (Fig. 6.4b). There was no 
significant difference between the lactate concentrations measured at rest or 
post-exercise between young and older subjects (p=0.847). 
6.3.7 pH 
The venous pH measured in young subjects decreased significantly post- 
exercise compared to resting baseline (Fig 6.5a; p<0.05). There was a 
significant recovery at 3 minutes post-exercise that was still below baseline and 
then a total recovery by 6 minutes post-exercise. There was no significant 
difference in the response following exercise 1 and exercise 2. There was no 
effect of breathing 40% O2 on venous pH at any timepoint (p=0.504). 
Older subjects (Fig. 6.5b) showed a similar decrease in pH post-exercise 
followed by a recovery by 6 minutes post-exercise. Similarly there was no effect 
of breathing 40% O2 during recovery. There was no significant difference in pH 
between young and older groups at any time point (p=0.367). 
6.3.8 K+ 
There was no clear pattern of response in K+ in either young or older subjects 
(Fig. 6.6 a&b respectively). In fact, venous K+ was significantly decreased from 
baseline at 6 minutes post-exercise 1 and at 3 and 6 minutes post-exercise 2 in 
both young and older subjects. There was no significant main effect of breathing 
40% O2 at any timepoint (p=0.484). There was no significant difference in 
response between young and older subjects (p=0.644). 
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6.3.9 Pi 
Venous Pi was measured in a sub-group of 5 younger subjects (Fig. 6.7). 
Venous plasma concentrations increased significantly following exercise and 
then returned to baseline levels by 3 minutes post-exercise when air was 
breathed in recovery (p=0.05). The same pattern can be seen following 
exercise 2. There was no significant change in venous Pi at any time point 
when 40% O2 was breathed in recovery (p=0.49). 
6.4 Discussion 
The study presented in this section is the first to use venous blood sampling to 
investigate the role of O2-dependent substances in exercise. It was also the first 
to investigate the effect of ageing in this context. The main findings of the 
present study were: 
1. In contrast to our first hypothesis, breathing supplemental 40% O2 in the 
7 minute recovery period following a period of handgrip exercise had no 
effect on the fatigue seen in a second period of exercise. This was the 
case regardless of whether fatigue was measured using peak force, TVE 
or TTI. 
2. Supplemental O2 had no effect on the levels of K+, pH or lactate 
measured in the venous efflux post-exercise.  
3. The rise in venous Pi measured after exercise when air was breathed in 
recovery was not present when 40% O2 was breathed.  
4. In agreement with our second hypothesis, older subjects had enhanced 
fatigue resistance compared to younger subjects, as demonstrated by 
 
179 
the significantly increased TTI produced in every period of exercise. 
There were no differences in the levels of venous metabolites measured 
compared to young subjects. 
6.4.1 Effect of 40% O2 on fatigue in young subjects 
This study was only the second study to investigate the role of O2-dependent 
substances on fatigue. Force data was measured for two periods of handgrip 
exercise at 100% MVE until exhaustion, separated by a seven minute recovery 
period. Comparison between the two periods of exercise was used to show 
fatigue development, with the specific variables measured being peak force, 
time until voluntary exhaustion (TVE) and the Tension-Time index (TTI). As 
expected, we observed the development of fatigue when room air was breathed 
in recovery, as demonstrated by a significant reduction in peak force and TTI in 
exercise 2 compared to exercise 1. There was no significant change in TVE 
between the two exercise bouts. Given that all subjects maintained contractions 
well and that the pattern of force decline was the same in both exercise bouts, 
the maintained TVE in exercise 2 is due to the lower peak force and TTI. In 
contrast to our first hypothesis, breathing supplemental O2 during recovery had 
no effect on either peak force or TTI, demonstrating that an O2-dependent 
mediator of fatigue was not playing a role. As when air was breathed during 
recovery, TVE was not significantly different in exercise 2 compared to exercise 
1 when supplemental O2 was breathed.  
These findings contrast with the only previous study in the literature 
investigating the effect of supplemental O2 on fatigue (Fordy 2004). Unlike in 
our data, fatigue in normoxia was demonstrated by a reduction in TVE in the 
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second bout of exercise, whilst peak force remained unchanged. In light of our 
present findings that TVE was maintained in exercise 2 due to a reduction in 
force and TTI, it seems likely that the maintained peak force demonstrated by 
Fordy is responsible for their observations of reduction in TVE.  
The previous data concluded that supplemental O2 reduced fatigue based on 
observations that the reduction in TVE had been ameliorated such that it was 
no longer significantly different to the TVE in exercise 1. Therefore, it seems 
likely that the differences in how fatigue manifests between the two studies may 
be partly responsible for the differences in effect of supplemental O2. Based on 
these two studies it would seem that fatigue resulting in decreased force is not 
mediated by an O2-dependent substance, but fatigue manifesting as reduced 
holding time is. 
Apparent differences in fitness of subjects recruited to the two studies may also 
provide an explanation for differences in the observed effect of supplemental 
O2. As has been discussed in Chapter 4, forearm circumference can be used as 
a representative index of total muscle mass (Section 4.4.2). The mean forearm 
circumference in the previous study was 28.3cm, which is greater than the 
27cm in the present study, thus possibly supporting the assumption that 
participants in Fordy’s study were fitter than the present group of subjects. 
Further evidence for a possible difference in fitness is that the TVE achieved by 
subjects in Fordy’s study was greater than that achieved in the present study 
(~250 seconds vs. ~180 seconds). The notion that the effect of supplemental O2 
is dependent on the activity levels of the subjects is supported by the 
observations of Haseler et al. (1999; 2004), discussed in section 4.4.2. They 
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found that only trained subjects were able to utilise supplemental O2, and that 
this was likely due to more efficient muscles. 
Given the present results, there is no evidence that breathing supplemental O2 
had any effect on fatigue and thus O2-dependent substances are not obligatory 
mediators of fatigue. Based on previous literature, we can suggest that the role 
of O2-dependent substances is dependent on the manner in which fatigue is 
manifested and the activity levels of the subjects involved, such that they play a 
role in trained subjects but not in sedentary individuals. 
6.4.2 Effect of ageing on fatigue 
As was hypothesised, the present study has found evidence that fatigue 
resistance is increased in older subjects, as demonstrated by the significantly 
increased TTI. Also of note, TVE was nearly twice as long in older subjects as 
in younger subjects in exercise 1, despite this not reaching significance. This 
finding concurs with the results of a recent meta-analysis (Avin & Frey Law, 
2011) which concluded that older subjects had reduced fatigue when 
performing static exercise. Specifically, the present data contributes to existing 
data by demonstrating fatigue resistance in the forearm, whereas previous 
studies have found similar results in the thumb (Chan et al., 2000; Ditor & Hicks, 
2000), ankle (Kent-Braun et al., 2002; Lanza et al., 2004) and elbow flexors 
(Hunter et al., 2005). 
In light of research by Lexell and colleagues (Lexell et al., 1986; Lexell et al., 
1988) showing a reduction in Type II muscle fibres in vastus lateralis muscle 
with age, it seems possible that this fatigue resistance is due to a shift towards 
slow twitch Type 1 fibres that has been shown in ageing. It has been 
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demonstrated in vitro using mouse muscle fibres that slow twitch Type 1 fibres 
are more efficient at maintaining ATP levels (Crow & Kushmerick, 1982). 
Additionally, it has been shown in endurance-trained cyclists that those with the 
highest percentage of Type 1 fibres are the most energetically efficient, both in 
their trained sport of cycling and when performing a protocol of 2 legged knee 
extension that they had not previously been exposed to (Coyle et al., 1992).  
However, it must be noted that all of these findings have been made in leg 
muscle. Although we were unable to find any studies which directly looked at 
whether proportions of Type I and II muscle fibres change in the forearm with 
ageing, there is some evidence to suggest that arm and leg muscle ages 
differently. White and Carrington (1993) measured muscle twitch speeds in 
young and older subjects. They found that older subjects had slower twitch 
speeds than young subjects in the calf, but biceps twitch speed was unaffected 
by ageing. This suggests that fibre type may change in the leg but not in the 
arm. Therefore, although we can hypothesise that that the greater fatigue 
resistance seen in the older subjects is due to an increased efficiency resulting 
from a shift towards Type I fibres, this is still an area that needs more definitive 
research as there is no real evidence for this phenomenon in the forearm.  
6.4.3 Effects of 40% O2 on FBF and FVC 
Both FBC and FVC significantly increased following both periods of exercise 
compared to resting levels but there was no significant difference between 
breathing either air or 40% O2 during the recovery period between the two bouts 
of exercise. These results correlate with previous data that showed that 40% O2 
only had an effect on FBF or FVC when administered during the period of 
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exercise, not during recovery (Fordy & Marshall, 2004). This finding is 
significant for the interpretation of venous metabolites as they will be removed 
from the muscle at the same rate, regardless of whether air or 40% O2 was 
breathed during the recovery period between the two periods of exercise. 
6.4.4 Effects of 40% O2 on venous metabolites 
There were no significant differences between young and old subjects in the 
concentrations of venous metabolites measured or their response to breathing 
40% O2. Therefore young and old subjects will be considered together in the 
discussion below. 
6.4.4.1 Venous pH and lactate concentrations 
The resting levels of pH and lactate found in this study are within normal 
physiological levels and the measurements taken following exercise were 
similar both to those found in previous studies from this laboratory (Fordy & 
Marshall, 2004) and in other studies (Sjogaard et al., 1988; Boushel et al., 
1998). It was hypothesised that pH would not decrease as much when O2 was 
breathed during the recovery period as it may increase mitochondrial oxidative 
phosphorylation and so reduce H+ formation (see Figure 1.5). It could also be 
expected that O2 may reduce the lactate concentration as lactate is produced 
as a result of anaerobic metabolism (Robergs et al., 2004). The results of the 
present study show no significant difference in either pH or lactate 
concentration between the two experimental days. This contrasts with previous 
data showing that breathing 40% O2 during the period of contraction reduced 
both venous lactate concentration and the fall in pH by ~30% (Fordy & Marshall, 
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2004). Similarly, a study by Pedersen et al. (1999) found that supplementary O2 
breathed before and during maximum dynamic leg exercise reduced exercising 
venous lactate concentrations by a similar amount, although they observed no 
effect of supplementary O2 on pH levels. 
We can hypothesise that by giving the O2 during the exercise, as opposed to 
during recovery as in this study, the supplementary O2 had a greater effect on 
mitochondrial oxidative phosphorylation and so reduced the build-up of H+ and 
lactate. An alternative explanation for the lack of effect of O2 on venous pH may 
be increased phosphocreatine synthesis. During recovery creatine kinase 
phosphorylates creatine to form phosphocreatine and produces H+ as a by-
product (Robergs et al., 2004). This concept is supported by studies by Haseler 
and colleagues (1999; 2004) in which supplementary O2 increased 
phosphocreatine resynthesis in trained athletes but not in sedentary subjects. 
These findings are supported by observations in young subjects in the present 
study that the increase in Pi post-exercise was abolished by breathing 40% O2. 
Given that phosphocreatine is a mechanism for removal of Pi within the muscle 
fibre (Robergs et al., 2004), it is plausible that supplementary O2 did  increase 
oxidative phosphorylation, but that the reduction in H+ was offset by an 
increased rate of H+ production from phosphocreatine resynthesis.  
6.4.4.2 Venous K+ 
The resting values of venous K+ found in this study were ~4.5mmol/L which 
correlates well with values found in previous studies (Medbo & Sejersted, 
1990). Further, the peak concentrations found in this study were similar to 
values found by other groups using static (Sjogaard et al., 1988) and dynamic 
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(Boushel et al., 1998) hand-grip exercise, although the rise post-exercise in the 
present study was not significant. The peak values of 4.95mmol.L-1 shown post-
exercise in the present study were lower than the 5.2mmol.L-1 shown in a 
similar handgrip protocol by Fordy (2004), despite similar resting levels. This 
may represent either lower fitness (therefore able to produce less effort) or 
reduced motivation to continue the contraction in the subjects in the present 
study, as discussed above (Section 6.4.1). Similarly, peak values found in the 
present study were significantly lower than the maximum concentrations of 
~8mM found by Medbo and Sejersted (1990) in subjects performing exhaustive 
treadmill exercise. Given the non-significant rise in K+ seen in the present study, 
it seems unlikely that K+ is an obligatory mediator of fatigue. However, we can 
hypothesise that K+ release from muscle cells is positively correlated with the 
intensity of the contraction and with the muscle mass used during the exercise, 
thus may play an increased role in mediating fatigue in these circumstances. 
This correlates well with a recent study showing that interstitial K+ measured in 
leg muscle was higher when arm exercise was performed prior to leg exercise 
than when leg exercise was performed alone and that this was associated with 
an increased time to fatigue (Nordsborg et al., 2003). 
K+ is released from contracting skeletal muscle fibres via K+IR and K+ATP and is 
taken back up into the muscle fibres by Na+/K+-ATPase (Standen, 1992; 
Clausen, 2003). We hypothesised that 40% O2 would attenuate the increase in 
K+ by increasing levels of ATP and therefore both reducing K+ efflux via K+ATP 
channels and increasing the level of K+ re-uptake by preventing inactivation of 
the Na+/K+-ATPase due to decreased levels of ATP (see Figure 1.3). However, 
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the results of this study showed no significant difference between venous K+ 
concentrations in either condition, suggesting that this does not occur in the 
present exercise protocol.  
In conclusion, we found no role for K+ as a mediator of fatigue in the present 
data. A plausible explanation for the findings in the present study is that 
changes in the venous concentration of K+ measured post-exercise were not 
great enough to be affected by breathing supplemental O2. We can hypothesise 
that in more intense contractions, or in exercise using a greater portion of body 
muscle mass, K+ may play a greater role in fatigue and that breathing 
supplementary O2 may reduce the accumulation of K+. 
6.4.4.3 Venous plasma inorganic phosphate 
This study was the first to attempt to quantify venous efflux of Pi following 
handgrip exercise. The results of the present study showed a significant 
increase in plasma [Pi] from baseline immediately post-exercise when air was 
breathed during recovery. Resting values of Pi found in this study are around 
expected values (Yamamoto et al., 1994; Rhoades & Bell, 2009) and values 
post-exercise are similar to the 1.46mmol.L-1 shown by Yamamoto et al. (1994) 
following cycling exercise. It should be noted that the increase in venous [Pi] 
found in this study following fatiguing exercise may be lower than the increase 
in [Pi] occurring in the muscle interstitium, as concentrations between 3 and 41 
mmol.kg-1 muscle dry weight have been found using muscle biopsies (review: 
Fitts, 1994).  
This rise in Pi observed post-exercise would initially appear to support the view 
in the literature that Pi is involved in mediating fatigue. Many of the previous 
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studies which implicate Pi in the development of fatigue have been performed 
on single muscle fibres (e.g. Cooke & Pate, 1985) or in isolated muscles (e.g. 
Dahlstedt et al., 2000; 2001) from animals. Studies investigating the role of Pi in 
fatigue development in humans have concentrated on using Nuclear Magnetic 
Resonance imaging (NMR) (Miller et al., 1988) to measure the [Pi] within 
skeletal muscle and have found increased concentrations with fatiguing 
exercise. The present data significantly add to the literature by demonstrating a 
significant increase in venous [Pi] following fatiguing handgrip exercise, despite 
that fact that this methodology may underestimate the changes occurring within 
the muscle.  
Further, the change in [Pi] may also be significantly underestimated due to the 
delay between completing exercise and sampling of venous blood. 
Measurement of forearm blood flow occurred immediately post-exercise, 
therefore the first venous blood sample taken after exercise was realistically 
taken at approximately 20 seconds after completion of exercise. Studies by 
Haseler et al. (1999; 2004) found that the time constant for phosphocreatine 
recovery when breathing normoxic air was ~25 seconds in trained athletes and 
~30 seconds in sedentary subjects. Therefore it is possible that [Pi] had already 
decreased from peak levels as a result of Pi removal by PCr resynthesis at the 
time of venous blood sampling. This delay in sampling venous blood combined 
with a short time constant for phosphocreatine recovery means that it is 
biologically plausible to observe an effect of supplemental O2 in the immediately 
post-exercise blood sample. 
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The previously mentioned studies by Haseler and colleagues found that the PCr 
recovery rate increased as a result of breathing an increased concentration of 
O2 in trained athletes. Therefore, in the present study, it was hypothesised that 
breathing 40% supplemental O2 during the recovery period between two 
periods of maximum handgrip exercise until exhaustion would reduce the 
concentration of Pi found in plasma by increasing phosphocreatine resynthesis 
(see Figure 1.4). Interestingly, the present findings showed that breathing 40% 
O2 in recovery abolished the post-exercise peak in venous [Pi]. In light of the 
work by Haseler (1999; 2004), it is likely that this represents an increased 
clearance of extracellular Pi by increased PCr resynthesis. Alternatively, given 
that Pi accumulates when ATP breakdown exceeds resynthesis (Robergs et al., 
2004), we can hypothesise that supplementary O2 increased oxidative 
phosphorylation during recovery, thus limiting accumulation of Pi. This may 
explain our findings that breathing 40% O2 during recovery also abolished the 
peak in [Pi] following exercise 2. It is reasonable to hypothesise that increased 
oxidative phosphorylation occurs concurrently with increased phosphocreatine 
resynthesis.  
6.4.5 Critical evaluation of the experimental protocol 
Some limitations of the present protocol are in common with the experiments 
presented in previous chapters. Issues concerning recruitment of suitable 
subjects and the use of venous occlusion plethysmography have been covered 
in Section 4.4.6. 
A limitation specific to this protocol was the use of 100% MVE until exhaustion. 
As discussed in section 6.2.1, this methodology is particularly susceptible to the 
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motivation of the subject to carry on as opposed to stopping when the 
discomfort starts and this may explain differences in TVE between the present 
study and previous work (Fordy & Marshall, 2004). Future work could consider 
using alternative methods to measure fatigue, such as measuring the time a 
subject is able to maintain a specific force for, or using repeated short MVC 
contractions and measuring the decrease in force output. 
A limitation with the sampling of venous blood immediately after completion of 
exercise has been mentioned in Section 6.4.4, in that samples were taken 
approximately 20 seconds after release of the contraction as a result of 
obtaining venous occlusion plethysmography measurements. This may have 
led to an underestimation of values immediately after exercise as some 
recovery may already have taken place. Considering that both the present study 
and previous work from this laboratory (Fordy & Marshall, 2004) have 
demonstrated no effect of breathing supplementary O2 in recovery on FBF or 
FVC, it is reasonable to suggest that future studies can omit plethysmography 
work when using a similar protocol. 
 A further limitation of using venous blood samples to measure the metabolites 
released by skeletal muscle fibres are that values are likely to be significantly 
diluted. An interesting alternative would be to perform microdialysis (as used by 
e.g. Hellsten et al., 1998) to measure the concentrations within the skeletal 
muscle interstitium, as this would give a more accurate view of the 
concentrations of metabolites the muscle fibres are actually exposed to. 
Additionally it would be interesting to take arterial blood samples so that arterio-
venous difference in concentrations of metabolites could be calculated. This 
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would give a more accurate picture of the uptake and release of substances by 
the active muscle.  
6.4.6 Summary 
In conclusion, the present study has found no evidence of an O2-dependent 
mediator of fatigue in either young or older subjects. Breathing supplemental 
40% O2 did not alter the venous concentrations of pH, K+ or lactate, but it did 
abolish the post-exercise rise in Pi. The present data also showed that older 
subjects were more fatigue resistant than younger subjects when using static 
forearm exercise, although concentrations of metabolites in the venous efflux 
were not significantly different from younger subjects suggesting that this is not 
the source of increased fatigue resistance.  
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CHAPTER 7: GENERAL DISCUSSION 
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The global aims of the studies presented in this thesis were to investigate the 
role of O2-dependent substances in exercise. Specifically, we hypothesised that 
O2-dependent substances produced during exercise mediate a component of 
the vasodilatation seen immediately following handgrip exercise, and that O2-
dependent substances acting during recovery mediate a portion of fatigue. 
Novel aspects of the studies presented in this thesis were the use both static 
and dynamic exercise protocols to investigate post-exercise hyperaemia. 
Venous blood sampling was utilised to measure the concentration of various 
metabolites from the forearm and monitor any changes that occur as a result of 
breathing supplementary O2 or pharmacological intervention. Finally, we added 
new insights into the changes in post-exercise hyperaemia and fatigue 
development that occur with healthy human ageing. The studies included in this 
thesis were the first to investigate the effect of ageing on the role of O2-
dependent substances in exercise. 
The NIRS study (Chapter 3) used a novel protocol to address the question of 
whether occlusion occurs within active muscle. It expanded on previous 
literature by using a technique to specifically investigate active muscle rather 
than the whole limb. This was important in the validity of the protocol in 
subsequent studies, as if blood flow were mechanically occluded by the 
contraction force, O2 would not be able to reach the active muscle to effect 
vasodilatation. If blood flow occurs in active muscle contracting maximally it is 
reasonable to assume that significant blood flow occurs during exercise at 50% 
MVC. 
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Using NIRS we monitored levels of oxyhaemoglobin and deoxyhaemoglobin 
within the active flexor digitorum superficialis muscle during handgrip exercise. 
By comparing values measured during exercise with values obtained during 
complete arterial occlusion, we concluded that significant blood flow still occurs 
within contracting muscle during maximal static contraction.  
Many substances have been postulated to mediate a component of exercise 
and post-exercise hyperaemia, including NO, prostaglandins, adenosine and 
EDHF. Based on the literature, we hypothesised that a portion of post-exercise 
hyperaemia is mediated by one of these substances produced during exercise 
in an O2-dependent manner. We focussed on the roles of prostaglandins and 
adenosine. Contrary to our hypotheses however, our data in both Chapter 4 and 
5 showed no effect of supplementary O2 on the magnitude of post-exercise 
hyperaemia following either static or dynamic exercise. It appears that 
differences in the literature concerning the effect of supplemental O2 may be 
due to differences in activity levels of subjects studied. This notion is consistent 
with the findings of Haseler and colleagues (Haseler et al., 1999; Haseler et al., 
2004), who found that phosphocreatine resynthesis is limited by mitochondrial 
efficiency in sedentary subjects, not by O2 delivery. Thus we can hypothesise 
that in active subjects with more efficient muscles, supplementary O2 can be 
utilised to reduce production of vasodilator metabolites which are produced 
during normoxic exercise. By contrast, in less active or sedentary subjects, the 
reduced efficiency of the muscle means that the supplementary O2 can not be 
utilised and so the magnitude of hyperaemia is not affected. Differences in 
methodology between studies also allow for the possibility that the intensity of 
 
203 
the stimulus may play a role in the effect of supplementary O2, with no O2-
dependence seen at lower intensities and O2-dependence during more intense 
exercise protocols. 
Secondly, we observed no role for prostaglandins in mediating post-exercise 
hyperaemia. This finding supports observations made by other groups 
(Shoemaker et al., 1996; Mortensen et al., 2007), although there is some 
contrasting data in the literature (Wilson & Kapoor, 1993; Duffy et al., 1999; Win 
& Marshall, 2005). Our findings are consistent with the fact that we observed no 
change in the forearm venous efflux of PGE metabolites. Whilst previous 
studies have found an increased levels of PGE2 post-exercise in the venous 
efflux (Wilson & Kapoor, 1993) and in the muscle interstitium (Karamouzis et al., 
2001a; Karamouzis et al., 2001b), it is of interest that two of the above studies 
have observed that this is only the case above a certain threshold of intensity 
(Karamouzis et al., 2001b; Boushel et al., 2002). We therefore propose that the 
differences in the literature represent evidence that prostaglandins mediate a 
component of exercise and post-exercise hyperaemia above a certain threshold 
but are not obligatory below this threshold. 
Concerning the role of adenosine in mediating post-exercise hyperaemia, we 
show no effects of adenosine receptor blockade on the vasodilatation post-
exercise. This can be partly explained by the methodological constraints of 
using aminophylline. As discussed, aminophylline is not a complete adenosine 
receptor antagonist, with values of between 30% and 60% inhibition being 
reported (Leuenberger et al., 1999; Casey et al., 2009). Despite these technical 
challenges, our data agree with findings that adenosine is not an obligatory 
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mediator of hyperaemia in the forearm (Martin et al., 2006; 2007). An alternative 
hypothesis fits with the notion discussed above of a threshold of intensity above 
which prostaglandins play a role in exercise hyperaemia. It has recently been 
shown that the actions of infused adenosine are dependent on prostaglandins 
and NO (Mortensen et al., 2009; Nyberg et al., 2010). Therefore we can 
hypothesise that a similar interdependency occurs in exercise hyperaemia, in 
which both adenosine and prostaglandins play an interdependent role above a 
certain intensity threshold. 
The post-exercise hyperaemia that we observed in the present studies is not 
explained by prostaglandins or adenosine individually. An interesting topic for 
future work is to assess what substance is causing this vasodilatation. A 
plausible candidate is NO, based on previous studies which show that NO is 
responsible for mediating a portion of post-exercise hyperaemia (Shoemaker et 
al., 1997; Radegran & Saltin, 1999). An alternative theory may be the effect of 
interdependency and redundancy, such that single blockade as utilised in our 
studies results in increased importance of another substance to compensate. 
An interesting finding following aminophylline infusion was the presence of a 
transient decrease in venous pO2 at rest, approximately 10 minutes following 
aminophylline infusion, which had recovered by 40 minutes post-infusion. To 
our knowledge, this was a novel finding in the human forearm, although it 
supports previous literature that methylxanthines (the family to which 
aminophylline belongs) increase metabolic rate (Dulloo et al., 1989; Ide et al., 
1995). We conclude that this transient decrease in venous pO2 is due to an 
increase in aerobic metabolism resulting in a greater O2 uptake. 
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We hypothesised that a component of the fatigue associated with sustained 
static handgrip contraction was O2-dependent and concentrated on the roles of 
K+, pH and Pi. Contrary to our hypothesis, we observed no effect of breathing 
40% O2 on the fatigue seen in a second period of handgrip exercise in young 
subjects. Differences between these findings and the only previous literature on 
the subject (Fordy & Marshall, 2004) appear to be partly due to differences in 
how fatigue was manifested. Thus, we concluded that supplemental O2 does 
not play a role in ameliorating fatigue associated with a decrease in force, but 
may play more of a role when fatigue appears as a reduction in holding time. As 
with post-exercise hyperaemia, differences in the literature appear to be partly 
due to activity levels of the subjects studied, with O2-dependent substances 
only playing a role in trained subjects and not in sedentary individuals.  
As far as we are aware this is the first study to measure changes in venous 
concentration of Pi in an attempt to investigate any role in fatigue production. 
We found that venous Pi increased post-exercise when air was breathed during 
recovery in the subgroup of young subjects in whom Pi was assayed. This 
finding supports a role for Pi in fatigue production, which to date has only been 
demonstrated in experiments using isolated muscle (Cooke & Pate, 1985; 
Dahlstedt et al., 2000; Dahlstedt et al., 2001) or using indirect observations in 
humans (Miller et al., 1988). Interestingly, the present findings support the 
concept that [Pi] can be altered by increasing inspired O2, where increased O2 
delivery results in an accelerated removal of Pi via conversion to 
phosphocreatine. 
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We observed role for K+ in mediating fatigue, which contrasts with the previous 
literature (Medbo & Sejersted, 1990). This may be due to the changes in 
venous K+ being of insufficient magnitude or may represent K+ not playing a role 
in fatigue. Our results for pH show a significant increase in H+ following 
exercise. In light of the literature on pH (discussed in section 1.3.3) it seems 
most likely that if pH is playing a role, it is via indirect mechanisms (Westerblad 
& Allen, 2002).  
The literature reports opposing data concerning the effect of ageing on the 
magnitude of exercise and post-exercise hyperaemia, with studies showing both 
a decrease (Carlson et al., 2008) and no change (Jasperse et al., 1994; Donato 
et al., 2006). We demonstrated no effect of ageing on the magnitude of post-
exercise hyperaemia following either static or dynamic handgrip exercise. 
Based on these and previous findings, we conclude that in healthy older 
subjects there is no impairment of exercise hyperaemia when exercise is 
prolonged past the single 1-second contractions used by Carlson et al. (2008). 
Additionally we observed no role for prostaglandins in mediating post-exercise 
hyperaemia in older subjects, a finding that is consistent with previous literature 
(Schrage et al., 2004; 2007). Admittedly, the number of  older subjects in the 
adenosine study was low, but in light of the data reported  in young subjects 
and in the prostaglandin study, it seems a reasonable assumption that 
adenosine receptor antagonism would have had no effect if a larger number of 
older subjects had been tested. Finally, we showed that fatigue resistance is 
increased in older subjects compared to young subjects. These data support 
the consensus in the present literature. As with young subjects we found no 
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effect of supplemental O2 on the magnitude of fatigue. Based on literature 
looking at leg muscle, we propose that changes in muscle fatiguability with age 
are due to a shift in muscle fibre type towards a slow twitch Type I phenotype. 
In summary, the studies presented in this thesis have aimed to investigate the 
role of O2-dependent substances in exercise. We found no evidence for a role 
of O2-dependent substances in mediating post-exercise hyperaemia, with 
neither prostaglandins nor adenosine appearing to play an obligatory role. 
Based on previous literature, we can hypothesise that candidates for mediating 
the post-exercise hyperaemia seen in these studies may be either NO or EDHF. 
We also observed no effect of supplemental O2 on the magnitude of fatigue 
observed following static exercise, demonstrating that O2 –dependent 
substances are not obligatory mediators of fatigue. However, we propose that 
O2 plays more of a role in mediating both post-exercise hyperaemia and fatigue 
in individuals who are trained, as opposed to the sedentary subjects tested in 
this thesis. Ageing had no effect on the magnitude of post-exercise hyperaemia 
following static or dynamic handgrip exercise, but older subjects were more 
fatigue resistant. 
7.1 Future directions 
The studies described in this thesis have raised some interesting questions for 
future research, especially with regard to the effect of the role of activity levels 
in determining factors contributing to exercise hyperaemia. Of particular interest 
for future study is the apparent difference in mechanisms of exercise 
hyperaemia between active subjects and less active subjects. This question 
could be answered by repeating the protocol in Chapter 4 in groups of young 
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men classified by their activity status, calculated either by using a more rigorous 
activity questionnaire or by using peak grip strength as a proxy.  
A fundamental question is that if exercise hyperaemia is not being mediated by 
O2-dependent substances such as prostaglandins or adenosine, what 
substance is taking this role? It may be that inhibition of prostaglandins, or more 
likely adenosine, is not sufficient to totally block their actions. EDHF is a 
possible contributor, which would be worth investigating. In addition, NO has 
been shown to contribute to recovery blood flow, and may contribute to exercise 
hyperaemia in more intense exercise, as was described in section 1.2.3.2. 
Therefore, it is possible that NO is playing a role in mediating the hyperaemia 
seen in Chapters 4 and 5, especially given that blood flow is measured post-
exercise. 
An alternative direction would be the use of animal models. This would have the 
advantage of being easier to control for lifetime activity levels. Additionally, 
more effective adenosine receptor antagonists are available for use in animals 
(Marshall, 2007), thus this model may be better suited to test hypotheses 
regarding any O2-dependent role of adenosine.  
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Appendix 1: Screening questionnaire 
Name: ________________________________  D.O.B.: _____________ 
Activity level:  
How would you describe your present level of activity? 
Sedentary Moderate Active  Highly Active 
 
How many hours per week do you spend doing exercise? ________________ hours 
What form of exercise do you undertake? 
____________________________________________________________________________
____________________________________________________________________________
________________________________________________________________ 
 
Medical status: 
Do you have any history of cardiovascular or respiratory disorder?     Y/N 
Do you have any history of high blood pressure?     Y/N 
Do you suffer from dizziness?       Y/N 
Have you ever suffered from Diabetes / Asthma / Epilepsy?    Y/N 
Do you have any previous or current injury which may affect your ability to exercise? 
           Y/N 
Have you seen a doctor in the last 6 months for exercise related reasons?  Y/N 
Are you currently on any medication? (Including non-prescription).  Y/N 
 
Smoking habits: 
Never 
Used to smoke   How many/day? _______ 
Occasionally smoke  How many/day? _______ 
Regularly smoke  How many/day? _______ 
 
Declaration 
I declare that all information given above has been read, understood and is correct to the best 
of my knowledge. 
Signature: _________________________  Date: _________________ 
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Appendix 2: Missing data for blood gases in Chapter 4 and 5 
Chapter 3: Prostaglandin study 
Test Group 
Total data 
points 
Missing data 
points % missing 
pO2 Young static 192 26 13.5 
  
Young 
dynamic 192 31 16.1 
  Older static 192 27 14.1 
  Older dynamic 192 25 13 
        
pCO2 Young static 192 25 13 
  
Young 
dynamic 192 30 15.6 
  Older static 192 20 10.4 
  Older dynamic 192 24 12.5 
        
Lactate Young static 192 27 14.1 
  
Young 
dynamic 192 32 16.7 
  Older static 192 20 10.4 
  Older dynamic 192 21 10.9 
        
pH Young static 192 25 13 
  
Young 
dynamic 192 30 15.6 
  Older static 192 20 10.4 
  Older dynamic 192 20 10.4 
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Chapter 4: Adenosine study 
Test Group 
Total data 
points 
Missing data 
points % missing 
pO2 Young static 160 27 16.9 
  
Young 
dynamic 160 22 13.8 
  Older static / / / 
  Older dynamic / / / 
        
pCO2 Young static 160 25 15.6 
  
Young 
dynamic 160 20 12.5 
  Older static / / / 
  Older dynamic / / / 
        
Lactate Young static 160 25 15.6 
  
Young 
dynamic 160 20 12.5 
  Older static / / / 
  Older dynamic / / / 
        
pH Young static 160 25 15.6 
  
Young 
dynamic 160 20 12.5 
  Older static / / / 
  Older dynamic / / / 
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Appendix 3: Mean±S.E.M. values for Chapter 4 data 
Values for FBF 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 2.8 0.3 2.3 0.2 2.3 0.2 2.2 0.2 
 Ex+0 24.4 3.0 23.8 1.9 21.8 1.7 21.8 2.0 
 Ex+3 13.1 2.1 14.0 1.6 15.0 2.1 13.1 1.4 
 Ex+6 9.0 1.9 10.3 1.5 10.8 1.5 9.8 1.2 
                    
Older Static Baseline 2.6 0.2 2.4 0.2 2.6 0.3 2.8 0.2 
 Ex+0 27.8 4.8 24.2 3.3 22.7 2.2 26.1 2.6 
 Ex+3 18.1 2.0 15.6 1.9 14.6 2.0 13.0 2.1 
 Ex+6 9.6 2.3 9.2 2.1 8.4 1.2 7.7 1.6 
                    
Young Dynamic Baseline 2.7 0.3 2.9 0.2 2.7 0.3 2.7 0.4 
 Ex+0 22.4 3.4 24.1 2.7 20.0 2.0 23.5 1.5 
 Ex+3 10.1 1.6 11.9 1.3 9.3 1.4 11.9 1.9 
 Ex+6 6.6 1.2 8.0 1.2 7.4 0.9 8.4 1.9 
                    
Older Dynamic Baseline 3.1 0.3 2.7 0.3 2.8 0.2 2.9 0.2 
 Ex+0 28.1 5.1 30.9 3.5 26.6 2.9 28.0 3.2 
 Ex+3 15.2 3.4 13.5 1.9 12.9 1.5 10.8 2.1 
 Ex+6 9.7 1.6 8.7 1.5 7.3 0.9 8.3 1.4 
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Values for FVC 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 0.032 0.004 0.027 0.003 0.027 0.003 0.026 0.003 
 Ex+0 0.245 0.039 0.241 0.024 0.217 0.019 0.216 0.021 
 Ex+3 0.142 0.024 0.157 0.019 0.165 0.024 0.147 0.017 
 Ex+6 0.099 0.021 0.112 0.019 0.119 0.015 0.113 0.015 
                    
Older Static Baseline 0.027 0.002 0.027 0.002 0.029 0.003 0.032 0.003 
 Ex+0 0.260 0.049 0.260 0.039 0.237 0.024 0.270 0.030 
 Ex+3 0.177 0.022 0.178 0.025 0.167 0.027 0.147 0.028 
 Ex+6 0.087 0.024 0.101 0.023 0.087 0.017 0.085 0.018 
                    
Young Dynamic Baseline 0.029 0.003 0.029 0.002 0.029 0.003 0.031 0.003 
 Ex+0 0.216 0.031 0.239 0.040 0.199 0.022 0.239 0.015 
 Ex+3 0.103 0.015 0.114 0.012 0.097 0.014 0.128 0.020 
 Ex+6 0.069 0.012 0.069 0.010 0.076 0.009 0.087 0.016 
                    
Older Dynamic Baseline 0.031 0.003 0.029 0.003 0.030 0.002 0.032 0.003 
 Ex+0 0.283 0.067 0.313 0.038 0.272 0.032 0.283 0.032 
 Ex+3 0.165 0.045 0.140 0.020 0.136 0.016 0.119 0.025 
 Ex+6 0.098 0.019 0.093 0.018 0.076 0.010 0.085 0.018 
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Values for pO2 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 41.18 4.717 42.73 3.464 48.44 6.388 43.3 4.238 
 Ex+0 50.45 2.225 48.64 1.429 50.78 2.222 48.55 1.631 
 Ex+3 54.2 4.005 57.82 2.11 55.89 3.075 53.73 2.848 
 Ex+6 45.45 3.659 51 2.244 50.44 3.141 49.18 2.614 
                    
Young Dynamic Baseline 37.18 4.031 41.91 2.956 39.9 4.135 41.8 4.242 
 Ex+0 43.36 1.608 44.73 2.566 43.6 3.067 42.89 2.771 
 Ex+3 46.78 3.027 46.5 2.794 47 3.902 50 2.934 
 Ex+6 42.45 3.599 42.36 2.715 44.3 3.856 45.38 2.982 
                    
Older Static Baseline 45 4.698 43.36 3.473 36.75 3.139 41.27 4.328 
 Ex+0 50.5 2.113 50.09 1.866 49.25 1.955 47.4 1.485 
 Ex+3 55.86 2.923 55.36 2.245 54.45 2.383 53.27 2.864 
 Ex+6 49.62 3.348 49.73 2.265 47.17 3.233 46.64 3.449 
                    
Older Dynamic Baseline 38.5 5.392 41.73 3.456 39.83 3.823 41.36 5.468 
 Ex+0 47.63 1.647 45.45 1.631 44.5 1.525 45.64 1.448 
 Ex+3 51.13 3.085 49.73 2.324 48.45 2.262 50.18 2.834 
 Ex+6 48.88 3.232 47.36 2.051 45.33 3.016 46.36 3.031 
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Values for pCO2 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 53.73 2.059 51.27 1.674 49.33 2.034 50.36 1.416 
 Ex+0 81.64 5.542 77.91 4.473 88 9.023 80.55 6.547 
 Ex+3 54.1 1.779 51 1.25 51.33 1.958 57.18 2.869 
 Ex+6 50.91 1.676 49.91 0.939 49.22 1.73 51.09 1.224 
                 
Young Dynamic Baseline 51.36 1.473 49.64 1.073 50.2 1.413 47.6 3.718 
 Ex+0 80.18 4.101 77.27 3.89 77.7 4.331 80.5 8.168 
 Ex+3 54.33 0.799 53.4 0.98 51.8 2.102 55.11 2.182 
 Ex+6 51.91 1.455 51.27 0.776 50.3 2.281 51.5 1.547 
                    
Older Static Baseline 51.25 2.274 49.09 2.069 51.08 1.852 53.42 2.601 
 Ex+0 80.38 6.153 80.91 5.838 82.67 3.117 78.42 4.926 
 Ex+3 51.63 2.322 53.36 1.562 52.42 1.786 51.67 1.345 
 Ex+6 50.75 2.119 50.27 1.573 49.92 1.869 50.17 1.392 
                 
Older Dynamic Baseline 50 1.871 48.45 1.681 48.25 1.754 49.92 1.362 
 Ex+0 77.88 4.498 75.360 4.642 72.73 2.905 78.5 4.08 
 Ex+3 54.25 1.473 54.45 1.97 52.1 1.1 51.83 1.98 
 Ex+6 50.75 1.688 49 1.779 49.91 1.304 51 1.619 
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Values for lactate 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 1.4 0.2 1.1 0.1 1.2 0.1 1.1 0.1 
 Ex+0 4.4 0.3 4.6 0.5 4.7 0.4 4.6 0.5 
 Ex+3 4.7 0.4 4.2 0.4 4.6 0.3 4.6 0.5 
 Ex+6 3.8 0.3 3.5 0.4 3.4 0.3 3.9 0.4 
                 
Young Dynamic Baseline 1.3 0.1 1.1 0.1 1.3 0.1 1.2 0.1 
 Ex+0 4.6 0.3 4.2 0.3 3.7 0.3 4.5 0.4 
 Ex+3 4.7 0.4 4.1 0.4 3.5 0.4 4.3 0.5 
 Ex+6 3.6 0.4 2.9 0.3 2.8 0.5 3.3 0.5 
                    
Older Static Baseline 1.1 0.1 1.2 0.2 1.0 0.1 1.3 0.2 
 Ex+0 4.3 0.4 4.2 0.3 4.2 0.2 4.1 0.3 
 Ex+3 4.2 0.4 4.2 0.3 4.1 0.3 3.9 0.4 
 Ex+6 3.3 0.3 3.4 0.4 3.1 0.3 3.3 0.4 
                 
Older Dynamic Baseline 1.0 0.1 1.3 0.2 1.1 0.1 1.2 0.1 
 Ex+0 4.3 0.4 3.9 0.4 3.9 0.2 4.0 0.4 
 Ex+3 3.9 0.3 3.7 0.4 3.5 0.3 3.5 0.4 
 Ex+6 2.9 0.4 2.7 0.4 2.8 0.3 2.6 0.4 
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Values for pH 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 7.36 0.01 7.38 0.01 7.38 0.01 7.38 0.01 
 Ex+0 7.21 0.02 7.22 0.02 7.19 0.03 7.22 0.02 
 Ex+3 7.30 0.01 7.32 0.01 7.31 0.01 7.29 0.01 
 Ex+6 7.33 0.01 7.33 0.01 7.34 0.01 7.33 0.01 
                 
Young Dynamic Baseline 7.37 0.01 7.38 0.01 7.38 0.01 7.39 0.01 
 Ex+0 7.20 0.02 7.22 0.01 7.23 0.02 7.21 0.02 
 Ex+3 7.28 0.01 7.30 0.01 7.32 0.01 7.30 0.01 
 Ex+6 7.32 0.01 7.34 0.01 7.35 0.01 7.33 0.01 
                    
Older Static Baseline 7.37 0.01 7.39 0.01 7.38 0.01 7.38 0.01 
 Ex+0 7.22 0.03 7.22 0.03 7.21 0.01 7.24 0.02 
 Ex+3 7.32 0.01 7.31 0.01 7.31 0.01 7.33 0.01 
 Ex+6 7.34 0.01 7.34 0.01 7.34 0.01 7.36 0.01 
                 
Older Dynamic Baseline 7.38 0.01 7.39 0.01 7.38 0.01 7.39 0.01 
 Ex+0 7.22 0.02 7.24 0.02 7.23 0.01 7.23 0.02 
 Ex+3 7.30 0.01 7.31 0.02 7.32 0.01 7.33 0.01 
 Ex+6 7.34 0.01 7.35 0.01 7.34 0.01 7.36 0.01 
                    
 
 241 
Values for PGE metabolite assay 
   Air / Placebo Air / Aspirin O2 / Placebo O2 / Aspirin 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Rest 13.80 3.78 9.35 2.04 11.74 3.22 10.30 2.47 
  Post-exercise 12.75 3.28 9.48 2.34 12.58 3.79 11.68 3.22 
Older Rest 8.88 2.09 6.56 1.11 9.01 1.77 6.39 1.11 
  Post-exercise 9.17 1.84 6.00 0.98 6.97 1.09 6.60 0.90 
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Appendix 4: Mean±S.E.M. values for Chapter 5 data 
FBF 
   Air   Air / Aminophylline O2    O2 / Aminophylline 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 2.3 0.2 2.4 0.4 2.3 0.4 2.0 0.2 
 Ex+0 23.2 3.1 24.0 2.2 23.2 2.1 24.0 4.2 
 Ex+3 11.9 1.7 13.8 1.7 12.0 2.4 13.5 2.2 
 Ex+6 8.6 1.4 9.6 1.3 8.4 2.4 8.9 1.6 
                    
Older Static Baseline 2.7 0.3 2.5 0.1 2.3 0.4 2.8 0.1 
 Ex+0 27.7 3.5 26.9 2.6 27.8 4.0 39.0 8.6 
 Ex+3 11.7 2.6 11.9 2.2 10.0 1.7 17.7 2.8 
 Ex+6 6.6 1.5 7.1 1.5 4.8 1.0 9.4 3.8 
                    
Young Dynamic Baseline 2.6 0.3 3.2 0.3 2.5 0.4 2.9 0.3 
 Ex+0 22.2 2.1 25.4 3.9 23.3 2.3 23.6 3.4 
 Ex+3 11.4 1.7 13.3 1.9 9.0 1.6 10.9 1.9 
 Ex+6 8.7 1.2 9.1 2.0 7.0 1.2 8.8 2.0 
                    
Older Dynamic Baseline 3.6 0.6 2.7 0.3 2.4 0.3 2.6 0.5 
 Ex+0 24.1 2.6 27.9 3.9 25.0 1.6 27.3 2.9 
 Ex+3 10.6 3.2 12.4 3.5 9.1 1.7 12.1 2.9 
 Ex+6 5.0 0.8 6.9 1.3 6.3 0.9 6.1 1.1 
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FVC 
   Air   Air / Aminophylline O2    O2 / Aminophylline 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 0.029 0.003 0.024 0.004 0.029 0.007 0.021 0.003 
 Ex+0 0.250 0.034 0.219 0.023 0.258 0.025 0.252 0.052 
 Ex+3 0.144 0.026 0.137 0.019 0.156 0.040 0.149 0.027 
 Ex+6 0.109 0.022 0.098 0.014 0.112 0.041 0.098 0.020 
                 
Older Static Baseline 0.031 0.005 0.027 0.003 0.022 0.004 0.030 0.004 
 Ex+0 0.296 0.041 0.304 0.044 0.251 0.043 0.382 0.059 
 Ex+3 0.130 0.035 0.127 0.023 0.097 0.018 0.205 0.057 
 Ex+6 0.072 0.017 0.079 0.020 0.047 0.012 0.120 0.060 
                    
Young Dynamic Baseline 0.028 0.003 0.032 0.003 0.028 0.006 0.030 0.004 
 Ex+0 0.219 0.024 0.235 0.034 0.248 0.036 0.224 0.033 
 Ex+3 0.128 0.023 0.132 0.022 0.104 0.025 0.119 0.021 
 Ex+6 0.094 0.014 0.093 0.026 0.082 0.021 0.093 0.023 
                 
Older Dynamic Baseline 0.038 0.008 0.030 0.004 0.023 0.005 0.030 0.008 
 Ex+0 0.242 0.037 0.294 0.039 0.219 0.008 0.273 0.023 
 Ex+3 0.111 0.037 0.125 0.026 0.084 0.014 0.126 0.029 
 Ex+6 0.052 0.011 0.071 0.011 0.056 0.009 0.068 0.019 
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pO2 
   Air   Air / Aminophylline O2    O2 / Aminophylline 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 48.33 2.986 38.29 1.409 50.57 6.747 34 2.228 
 Ex+0 49.44 1.973 46.57 1.616 48.89 1.359 46.44 2.021 
 Ex+3 55.56 2.911 55.13 2.741 54.5 2.236 50.67 1.803 
 Ex+6 49.33 3.082 51.88 2.531 52.89 3.259 49 2.693 
                 
Young Dynamic Baseline 39.56 2.887 42.88 3.056 43.44 3.06 39 2.427 
 Ex+0 45 2.728 42.75 2.858 46.11 3.002 43.78 1.935 
 Ex+3 49.56 2.583 49.38 2.556 48.5 3.012 49.63 2.236 
 Ex+6 45.56 3.363 46.38 2.611 42.33 3.371 46.33 1.581 
                    
Older Static Baseline 48.5 6.436 44.33 2.603 50.75 6.638 50 4.041 
 Ex+0 45.75 2.496 45 2.887 47.75 2.175 44.33 2.404 
 Ex+3 51.75 3.449 58.67 2.963 58.5 7.9 54.33 2.333 
 Ex+6 46.5 5.737 57.33 2.667 49.75 5.452 51 7.81 
                    
Older Dynamic Baseline 46.25 6.511 44.33 3.93 45.75 8.616 49 7.572 
 Ex+0 41 3.851 46.000 1.155 43.25 2.869 50.67 6.692 
 Ex+3 49 2.944 54.33 6.36 54 1.472 49 3 
 Ex+6 48.5 3.797 47 5.508 44 3.189 48 6 
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pCO2 
   Air   Air / Aminophylline O2    O2 / Aminophylline 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 49.78 1.024 49.63 1.954 49.29 1.426 49.25 0.796 
 Ex+0 77.44 2.784 76.88 5.051 72.33 3.416 80.5 3.14 
 Ex+3 52.56 1.375 48.75 1.306 53 2.309 51.56 1.538 
 Ex+6 49.67 1.354 45.13 1.043 49 0.957 49.13 1.457 
                 
Young Dynamic Baseline 49.78 1.422 46.37 0.596 49.44 1.827 46.33 1.093 
 Ex+0 77.56 4.953 77.63 4.127 72.11 2.884 80 3.912 
 Ex+3 55 2.285 49.5 1.389 51.78 1.597 49.56 1.375 
 Ex+6 50.67 1.633 48.5 1.165 51.22 1.69 49.22 0.909 
                    
Older Static Baseline 40.25 3.521 38 6.028 43.5 1.936 42.67 1.202 
 Ex+0 63 5.874 79.33 11.333 70 9.055 70.67 3.756 
 Ex+3 46.25 1.652 45 0.577 44.75 2.358 46.33 2.333 
 Ex+6 42.25 4.27 43.33 1.764 43 3.189 43 1 
                    
Older Dynamic Baseline 41 4.453 44.67 2.333 41.25 4.82 42.67 2.603 
 Ex+0 63.5 7.03 66 2.646 66.75 7.857 62.33 6.888 
 Ex+3 47 1.581 46.67 1.856 49.5 1.443 45 3 
 Ex+6 45 2.273 44.67 1.764 46.75 3.038 44 5 
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Lactate 
   Air   Air / Aminophylline O2    O2 / Aminophylline 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 1.28 0.15 0.93 0.14 1.20 0.19 1.18 0.14 
 Ex+0 4.27 0.17 4.20 0.43 4.36 0.52 5.15 0.58 
 Ex+3 4.46 0.23 4.26 0.37 4.34 0.52 4.90 0.52 
 Ex+6 3.64 0.33 3.19 0.30 3.39 0.53 4.73 0.49 
                 
Young Dynamic Baseline 1.32 0.18 1.08 0.13 1.48 0.40 1.27 0.11 
 Ex+0 4.14 0.37 4.19 0.48 3.48 0.35 4.58 0.46 
 Ex+3 3.97 0.40 3.85 0.46 3.47 0.42 4.32 0.40 
 Ex+6 2.98 0.36 2.83 0.42 2.52 0.43 3.34 0.29 
                    
Older Static Baseline 1.05 0.16 0.97 0.26 1.25 0.18 1.03 0.03 
 Ex+0 3.65 0.33 4.17 0.29 4.28 0.31 3.63 0.28 
 Ex+3 2.85 0.46 3.23 0.23 3.40 0.42 3.23 0.37 
 Ex+6 2.18 0.29 2.17 0.22 2.35 0.35 1.97 0.23 
                 
Older Dynamic Baseline 0.93 0.11 0.95 0.05 1.10 0.14 1.00 0.06 
 Ex+0 3.65 0.61 3.27 0.19 4.08 0.23 3.23 0.57 
 Ex+3 2.68 0.53 2.63 0.09 3.48 0.57 2.70 0.00 
 Ex+6 1.88 0.35 2.00 0.15 3.80 1.25 1.85 0.25 
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pH 
   Air   Air / Aminophylline O2    O2 / Aminophylline 
    Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M. 
Young Static Baseline 7.3811 0.00964 7.3925 0.00818 7.3829 0.00837 7.3988 0.00789 
 Ex+0 7.23 0.01202 7.2363 0.01523 7.2489 0.01541 7.2212 0.01329 
 Ex+3 7.3244 0.01725 7.3337 0.00844 7.3156 0.01676 7.33 0.01027 
 Ex+6 7.3356 0.01168 7.3738 0.00706 7.35 0.01414 7.35 0.01268 
                 
Young Dynamic Baseline 7.3767 0.00866 7.405 0.00189 7.3722 0.01152 7.3978 0.00662 
 Ex+0 7.2233 0.02154 7.2312 0.01381 7.2456 0.01345 7.2133 0.01658 
 Ex+3 7.3033 0.01708 7.3313 0.00811 7.3178 0.0131 7.3278 0.00894 
 Ex+6 7.3356 0.01425 7.36 0.00845 7.34 0.0128 7.3478 0.00596 
                    
Older Static Baseline 7.4 0.0108 7.4133 0.00333 7.3925 0.00479 7.42 0.01 
 Ex+0 7.26 0.01291 7.2533 0.01667 7.23 0.01633 7.2633 0.00667 
 Ex+3 7.3375 0.01377 7.3767 0.01202 7.345 0.00645 7.3567 0.01202 
 Ex+6 7.3625 0.0125 7.4033 0.01453 7.365 0.00645 7.4 0.01 
                 
Older Dynamic Baseline 7.395 0.00645 7.4133 0.01202 7.38 0.00913 7.41 0.01 
 Ex+0 7.2475 0.01436 7.29 0.00577 7.2225 0.0075 7.2833 0.04842 
 Ex+3 7.335 0.01323 7.3633 0.00882 7.3175 0.0125 7.345 0.005 
 Ex+6 7.3525 0.00854 7.3967 0.02186 7.3325 0.01031 7.37 0.02 
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Theophylline levels 
  Mean SEM 
Pre-static 11.4 1.0208 
Pre-dynamic 9.417 0.4665 
 
